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Abstract 
 
This thesis comprises of three studies investigating the repair of brachial plexus 
avulsion injury from three different perspectives. The first aim of this thesis was to 
investigate the long-term effects of reimplantation surgery in patients with complete 
brachial plexus avulsion injury using standardized assessments. Patients are assessed 
with clinical examination, neurophysiological studies and patient-reported outcome 
questionnaires.  It is shown that patients who have undergone brachial plexus re-
implantation surgery demonstrate small, yet significant, improved function in motor 
and sensory recovery compared with patients who have not had this surgical 
intervention. These results are encouraging, but functional improvements are limited. 
One strategy aimed at further improving the effects of re-implantationis the 
transplantation of OECs during the surgical repair. The second study presented in 
this thesis comprises of a prospective observational study of human biopsies of nasal 
mucosa by endonasal dissection of the mucosa of the nasal septum during the 
approach for routine sinus surgery. Samples are cultured in the laboratory, and the 
yield of olfactory ensheathing cells is compared as to the location, size, and weight 
of the biopsies and patient characteristics including age, smoking, nasal disease 
severity. OEC yield is associated with mucosal disease and patients age. The third 
aim of this thesis is to develop novel MRI techniques that can be used in human 
trials of cell mediated repair of the brachial plexus to assess patients’ spinal cord 
regeneration after OEC transplantation and provide a more robust outcome measure 
for comparing different strategies of brachial plexus repair. We focus on magnetic 
resonance spectroscopy and demonstrate that this technique is sensitive to 
pathological changes that occur in the spinal cord above the injury. Myo-Inositol to 
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creatine ratio is correlated with disability and is negatively correlated to time from 
injury. The implications of the above findings are discussed.  
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Chapter 1  
 
An introduction to the brachial plexus avulsion injury and 
brachial plexus re-implantation 
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1.1 The brachial plexus   
 
The brachial plexus (BP) is a network of nerves responsible for cutaneous and motor 
innervation of the entire upper limb. It is formed by the union of ventral rami of C5 
through T1. As all spinal nerves, the brachial plexus also arises from the spinal cord 
by rootlets, which converge to form rootlet bundles, which in turn, combine to give 
ventral and dorsal roots (Figure 1.1). The dorsal and ventral roots of each cord 
segment pass through the corresponding intervertebral foramen, in or near which 
they unite to form a mixed spinal nerve containing both afferent and efferent 
neurons. The dorsal and ventral roots are functionally distinct. The dorsal roots 
contain primary afferent neurons running from peripheral sensory receptors to the 
spinal cord and brainstem. The nerve cell bodies of primary sensory neurons are 
located in the dorsal root ganglia (DRG). The ventral roots of the spinal nerves carry 
efferent neurons dendrites, cell body and proximal part of axons motor neuron are 
located within the ventral horn in the spinal grey mater of the spinal cord. The distal 
axon emerges from the ventral root and extends to the target muscles.  
 
     
 
 
 
 
Figure 1.1: Transverse section through the rodent cervical spinal cord showing the 
relationship between the spinal cord, dorsal and ventral roots, spinal nerves, and 
vertebral column.  
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1.2 The transitional zone  
Each rootlet has an intramedullary segment within the central nervous system 
(CNS), an emergent segment, were it passes through the CNS surface, and a free 
segment peripheral to this (Fraher et al. 1985). The intramedullary segments contain 
CNS tissue and the free segment contains peripheral nervous system (PNS) tissue. 
Where the two meet, they interdigitate to form the PNS-CNS transitional zone (TR). 
Hence, the TR is characterized by the presence of a projection of CNS tissue from 
the spinal cord together with PNS tissue in the most proximal part of the root. Nerve 
fibres in the PNS extend into the CNS or vice versa and traverse the TR. Peripheral 
to the TR, myelin sheaths are produced by Schwann cells, whereas, central to it 
myelin sheaths are produced by oligodendrocytes.  
 
The transitional zone may lie in a variety of locations in the rootlet.  Central nervous 
system tissue may project distally beyond the CNS surface. In other cases such as in 
the cervical spinal cord, this protrusion of CNS tissue in the free part of the rootlet is 
absent and the transitional zone may rest at the level of the CNS surface or lie 
slightly deep to the surface of the spinal cord (Fraher et al. 1985). The central 
nervous system component is covered by a specialized thickening (glia limitans) 
composed of astrocytic foot processes. Astrocytic processes also extend distally into 
the rootlet among Schwann cells, forming the glial fringe that projects about 100 m 
distally (Figure 1.2). Closer to the CNS part, the astrocytic fringe is thicker and 
encloses individual nerve fibres in a cul-de-sac fashion (Carlstedt 1977). Around the 
perimeter of the fibre bundle at and deep to the plane of the CNS surface, the 
transitional zone is also surrounded by a thick collar of astrocytic tissue, which is not 
traversed by any nerve fibres. Where the transitional zone extends well into the 
 26 
rootlet for long segments, the central tissue component is similar to that of CNS tract 
with its surface bounded by astrocytic processes continuous to the glia limitans 
(Fraher 1992).  
 
The basement membrane coating the glial fringe is reflected over to the nerve fibres 
and is continuous with the Schwann cell basement membrane. Here, there is a unique 
apposition between astrocytes and Schwann cells. The capillaries in the endoneurial 
space of the PNS compartment do not cross the PNS-CNS borderline with the nerve 
fibres but deviate out to join vessels in the pia mater, indicating that the different 
permeability properties of vessels in the nerve and spinal cord maintain different 
types of barriers. Therefore, the TR holds a position of conceptual importance with 
regard to neuronal organization, as well as, a model system for the experimental 
investigations. 
 
Figure 1.2: Coronal section through the transitional zone of a normal rodent L4 
rootlet. Double immunostaining with laminin (green) and glial fibrillary acidic 
protein (GFAP) (red) to demonstrate peripheral nerve tissue and CNS/spinal cord 
tissue respectively. Scale bar 100 m. (Image from Li et al., (2004) Exp Neurol 
188(2): 300-8 (Li et al. 2004). Permission to reproduce this image has been granted 
by Elsevier Limited) 
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1.3 Root avulsion injury  
 
In traumatic lesions of the BP, the nerves can be crushed, stretched, ruptured, or 
avulsed from the spinal cord (Figure 1.3). Ruptures may occur at any site from the 
spinal nerve distal to the dorsal root ganglion to the terminal branches resulting in 
postganglionic injuries i.e. a peripheral nervous system injury.  Avulsive injury may 
be of two types: a peripheral intradural avulsion occurs if the nerve root is torn 
proximal to the dorsal root ganglion but remnants of the root remain attached to the 
spinal cord; a central avulsion injury occurs when there is an interruption of root or 
rootlet continuity at the surface of the spinal cord proximal to or at the transitional 
zone of the spinal cord; which is effectively a CNS injury (Spinner et al. 2008) and 
may be considered a “longitudinal spinal cord injury” (Carlstedt 2008). 
 
Combination of complete and partial ruptures and avulsions can also occur. The 
most frequent pattern is complete avulsion of dorsal and ventral roots. The 
combination of intact dorsal and avulsed ventral roots is more common than spared 
ventral and avulsed dorsal roots (Carlstedt 2008).  
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Figure 1.3: Types of root injury: In central intradural avulsion injury a root is torn 
off the spinal cord at its surface at the transitional zone of the spinal cord; In 
peripheral intradural avulsion the nerve root is torn proximal to the dorsal root 
ganglion but remnants of the root remain attached to the spinal cord; 
Postganglionic injuries involve ruptures of the nerve distal to the DRG. 
 
 
1.4 Clinical features of brachial plexus avulsion  
 
Avulsion of one or more roots is clinically diagnosed in about 70% of severe BP 
traction injuries (Narakas 1993) and is most often caused by high kinetic motor 
vehicle accidents (Terzis et al. 2000). The roots supplying the BP are particularly at 
risk of avulsion due to the loose suspension of the shoulder girdle compared to the 
lumbosacral plexus, which is better protected within the bony pelvis. In addition, the 
lower roots of the BP (C8 and T1) are more easily avulsed than the upper roots BP 
(C5 and C7), because the latter are supported by ligaments at the neural foramina 
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and former have a more straight course as they are exiting the spinal cord and course 
towards the exiting foramina (Carlstedt 2008).  
 
A complete brachial plexus avulsion involves all five sets of dorsal and ventral roots 
(C5 to T1) supplying the BP. Motorcycle accidents account for most cases due to the 
increased traction forces applied to the BP when the rider falls on the shoulder, 
forcing the head and shoulder apart. Other causes of BP injuries in adults include 
falls from a roof or tree, skiing accidents, penetrating injuries and iatrogenic insults 
(Terzis et al. 2000; Kandenwein et al. 2005).  
 
Complete brachial plexus avulsion is characterized by a completely paralyzed and 
anaesthetic arm. Neuropathic pain, which is severe and resistant to pharmacological 
treatments commonly follows avulsion injuries (Berman et al. 1998; Htut et al. 
2006). Interestingly, a significant correlation between pain intensity and number of 
affected roots has been demonstrated and allodynia was shown to be more frequent 
in the border zone of affected and unaffected dermatomes (Htut et al. 2006). 
 
 
1.5 Diagnosis of brachial plexus avulsion 
 
A careful clinical history together with a meticulous clinical examination can often 
give a good indication of complete BP avulsion injury at presentation. On inspection, 
a positive Horner’s sign, which involves drooping of the upper eyelid from loss of 
sympathetic innervation to the superior tarsal muscle, anhidrosis and miosis suggests 
avulsion of the lower roots. This sign, however, is not always present immediately 
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after injury but develops soon after. Abrasions and ecchymosis in the supraclavicular 
area suggests tearing of deep structures and give an indication about the force of 
injury. Fluid collections at the posterolateral aspect of the neck due to rupture of the 
dural sac and formation of pseudomeningocoeles also indicate violent injury to the 
forequarter. Paralysis of the ipsilateral hemidiaphragm may also be present if higher 
roots are also involved (C3, 4, 5). 
 
The BP can be palpated just lateral to the sternocleidomastoid muscle. Often in BP 
avulsion injury, the plexus is pulled underneath the clavicle and cannot be felt in the 
neck. Tapping in the supraclavicular area can elicit a sharp electric sensation 
shooting down the arm in the corresponding dermatomal distribution (positive 
Tinel’s sign), indicating that there is at least one spinal nerve ruptured outside the 
spinal canal as opposed to intradural avulsion. Spared function in any muscle of the 
upper limb indicates one or more spinal root rupture or sparing.  
 
On examination, in complete BP injury there is complete loss of motor and sensory 
function in the whole arm. Specific muscles can be examined to rule out remnant 
roots. Activity in the serratus anterior muscle, innervated by the long thoracic nerve, 
indicates the presence of one or more proximal stumps of ventral roots C5-C7.  
Activity in the clavicular part of pectoralis major indicates sparing or rupture of the 
upper part of the BP (C5-C7 via the lateral pectoral nerve). Activity in the 
supraspinatus muscle innervated by the suprascapular nerve indicates sparing of C5 
+/- C6 ventral root. All sensory modalities should also be meticulously examined in 
all dermatomes involving the arm.  
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Clinical examination, however, cannot regularly distinguish between pre- and post- 
ganglionic injury. Electrophysiological assessment in the immediate posttraumatic 
period is of little value as typical denervation signs are evident 2 to 3 weeks 
following injury. Neurophysiological examination may demonstrate persisting 
conduction of afferent fibres after pre-ganglionic injury. Furthermore, these 
investigations are limited by the variation in the distribution of spinal nerves and the 
presence of more than one lesion, with both pre- and post- ganglionic involvement 
(Tavakkolizadeh et al. 2001).  
 
The imaging of traction injuries to the adult BP also poses great challenges to the 
interested radiologist. The aim of imaging is to differentiate between central and 
peripheral intradural rupture. Myelography may demonstrate individual nerve roots 
or residual tufts of avulsed roots, a diverticulum at the level of the avulsed spinal, 
partial elongation of the root pouch with bleb formation or extradural collections. 
However, it is also associated with high rates of erroneous results. MRI is not an 
optimal method for visualizing the intraspinal BP, as it is limited by slice thickness, 
but is best used for visualization of extraspinal parts of the BP and to exclude spinal 
cord lesions. 
 
The ‘gold standard’ diagnostic tool for root avulsion still remains direct intradural 
inspection of injured roots via a hemilaminectomy. Complete avulsions, partial 
avulsions and proximal intradural tears can be visualized. Concomitantly, the 
components of the BP can be ‘marked’ for subsequent BP repair.  
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1.6 Pathological processes following root avulsion  
 
Injury at the CNS-PNS junction or proximal to this leads to profound pathological 
processes regarded as unfavourable to axonal regeneration.  
 
 
1.6.1 Effects of root avulsion on non-neuronal tissue  
 
Mechanical stress on the TR provokes a vigorous outgrowth of interweaving 
astrocytic processes and invasion of leptomeningeal cells surrounded by an 
expanded extracellular space containing numerous collagen fibres, phagocytic 
inflammatory cells and various extracellular molecules inhibitory to nerve 
regeneration forming a glial scar (Risling et al. 1993; Nomura et al. 2002). Various 
kinds of inhibiting factors that are upregulated around the lesion site have been 
postulated to prevent the regrowth of severed axons beyond the lesion site. 
Chondroitin sulfate proteoglycans (CSPG), a complex family of macromolecules 
secreted by almost all cell types at the injury site and especially astrocytes, are well 
known for their growth-inhibitory effects. They have been shown to induce neurite 
retraction and growth cone collapse. Other growth-repelling molecules include 
tenascin (McKeon et al. 1991), semaphorin 3A (Pasterkamp et al. 2001), myelin-
associated molecules (Chen et al. 2000) and subtypes of the Eph receptors and their 
ligands ephrins (Bundesen et al. 2003).  Failure of regeneration in the CNS has long 
been thought to be, in part, due to the development of this growth-inhibitory 
environment following injury and attempts to eliminate the molecules or neutralize 
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the inhibitory effect have been reported to enhance axonal regeneration in the 
damaged brain and spinal cord (Fawcett 1997).  
 
 
1.6.2 Effects of root avulsion on nerve cells 
 
Avulsion injury leads to rapid death of both primary sensory and motoneurons. 
Avulsion of ventral roots in experimental animals has demonstrated apoptosis in up 
to 50% of injured motoneurons within two weeks after the lesion, and further 
decrease with time to up to 90%. Apoptosis of motoneurones is thought to be due to 
disconnection from the periphery interrupting the supply of neurotrophic factor 
support together with vascular trauma (Wu 1993; Koliatsos et al. 1994; Novikov et 
al. 1995; Kishino et al. 1997; Piehl et al. 1998; Bergerot et al. 2004). Other 
mechanisms leading to motoneuron death such as inflammatory response to avulsion 
by means of microglial activation by cytokines have also been described (Olsson et 
al. 2000). The surviving motoneurons appear to enter a metabolic state with the 
primary goal being survival and production of new axons. This is reflected by an 
increase in mRNA expression of proteins linked with cell survival such as growth 
factors (e.g. brain-derived neurotrophic factor (BDNF)), growth factor receptors and 
proteins for axonal growth such as GAP-43 (Olsson et al. 2000).  
 
Transection of the spinal nerve close to the DRG provokes apoptotic cell death of 
primary sensory neurons in the DRG (Hu et al. 2003). After avulsion, a significant 
increase in apoptotic cell death has been observed in the dorsal columns and dorsal 
horn of affected animals, which was significantly more than in rhizotomised animals 
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(Chew et al. 2008), suggesting that avulsion has more severe effects on cell survival 
than rhizotomy, probably due to the more central location of the lesion. The 
disappearance of sensory neurons triggers changes in connectivity leading to 
abnormal signaling (Mannion et al. 2000). This is believed to partly explain the 
pathophysiological mechanism of the classical neuropathic pain, which affects 
patients with BP avulsion injury. However, it has also been suggested that a primary 
sensory afferent injury is not necessary for the development of neuropathic pain, as 
allodynia and hyperalgesia has been observed after ventral root transection injury in 
the rat (Li et al. 2002; Sheth et al. 2002). The allodynia induced by ventral root 
avulsion has also been associated with a glial and inflammatory response in the 
dorsal gray matter and dorsal funiculus ipsilateral to the lesion (Bigbee et al. 2007). 
Although pain induced by ventral root avulsion alone is not yet well understood, it 
has been suggested that Wallerian degeneration of the lesioned efferent axons in 
mixed nerves causes release of degenerative by-products and subsequent changes in 
adjacent uninjured primary afferent fibres (Wu et al. 2002). 
 
Furthermore, an increased and prolonged expression of c-fos, a proto-oncogene 
related to the family of transcription factors, after experimental root transection has 
been demonstrated in both motor and sensory neurons. Examination of human DRGs 
following root avulsion injury also showed significantly higher levels of GDNF, a 
growth factor to both sensory and motoneurones, in avulsed DRG neurons compared 
to control postmortem human DRGs and increased levels of Interleukin 6, a member 
of the neuropoietic cytokine family required for nerve regeneration (Bar et al. 1998). 
These substances may aid survival or have a role in nerve fibre sprouting and 
regrowth (Carlstedt 2008). 
 35 
1.7 Regeneration across the ventral root following CNS injury 
 
Observations of Ramon y Cajal in 1928, that severed motor axons after spinal cord 
injury have the capacity to regrow into neighbouring ventral roots, was 
reinvestigated by Aguayo and colleagues (Richardson et al. 1980; Aguayo et al. 
1987) and confirmed with electron microscopy and intracellular labeling with 
horseradish peroxidase (Risling et al. 1983). In this experiment, the intramedullary 
portions of motor axons forming the L7 ventral root of the cat were divided through 
small longitudinal incisions in the ventral funiculus.  During the first postoperative 
month increasing numbers of unmyelinated and thinly myelinated large-diameter 
axons coursed through the lesion and entered the denervated ventral root. It was also 
shown that at least some of the regenerating axons came from large neurons, 
presumably -motoneurons in the ventral horn nuclei (Risling et al. 1983). This 
finding led to a series of experiments in search for factors influencing regeneration.  
 
It was, subsequently, shown that after proximal lesions at the CNS-PNS interface 
followed by a major loss of motoneurons, a number of reactions occur in the severed 
cells, which are similar to those that take place after peripheral nerve lesions. Such 
processes include increased immunoreactivity for the low affinity neurotrophin 
receptor (p75) (Risling et al. 1992), mRNA for growth-associated protein GAF-43 
(Linda et al. 1992), as well as increased immunoreactivity and mRNA for calcitonin 
gene related peptide (CGRP) (Piehl et al. 1998) and downregulation 
immunoreactivity and mRNA for the N-methyl-D-aspartate (NMDA) type of 
glutamate receptor (Piehl et al. 1995). Furthermore, a number of neurotrophic factors 
have been reported to have a beneficial effect on motoneuron survival and axon 
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outgrowth, the most important of which include BDNF (Koliatsos et al. 1993), NT-3 
and NT-4 (Vejsada et al. 1995). Several other molecules with putative relevance to 
motoneuron survival and regeneration have been identified but will not be discussed 
here, as the list is exhaustive and beyond the scope of this background chapter.  
 
With the background that spinal motoneurons are able to survive and generate new 
axons even after central lesions, it was suggested that motoneurons could be rescued 
by providing them a peripheral nerve conduit after ventral root avulsion. This could 
be achieved by re-implanting the avulsed ventral roots back into the spinal cord.  
Attempts of re-implantation of lumbar ventral roots supplying the hindleg muscles of 
the rat and cat demonstrated that motoneurons can project myelinated axons and 
reinnervate the re-implanted ventral root by intracellular recordings and staining 
with horseradish peroxidase (Carlstedt et al. 1986; Cullheim et al. 1989; Cullheim et 
al. 1999). These were also shown to possess apposing synaptic boutons, be activated 
by electrical stimulation of the re-implanted ventral root, fire action potentials 
secondary to the generation of an excitatory postsynaptic potential (EPSP) following 
nerve stimulation and cause isometric muscle twitches in the soleus and 
gastrognemius muscle. It was also demonstrated that the regenerating axon could 
travel via new roots through CNS tissue and away from the motor nucleus to the re-
implanted ventral root for several hundred microns before reaching the PNS.  
 
Re-implantation of the avulsed ventral root has been demonstrated to have both 
neurotrophic and neurotropic effects on lesioned motoneurons including, an increase 
in protection and survival of lesioned motoneurons and a stimulation of axonal 
regeneration into the implanted root (Hallin et al. 1999; Gu et al. 2004; Eggers et al. 
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2010). Eggers et al., (Eggers et al. 2010) performed unilateral avulsion and re-
implantation of lumbar ventral roots L3, L4, and L5 and showed that re-implantation 
can prolong the survival of motoneurons up to one month post-lesion. The first 
regenerating motor axons enter the re-implanted ventral roots during the first week 
and large numbers of fibres gradually enter the lumbar plexus between 2 and 4 
weeks, indicating that they enter the re-implanted roots and plexus over an extended 
period of time. 
 
Furthermore, a single ventral root re-implantation has been shown to exert 
neurotropic effects in more than one spinal level in multilevel root avulsion (Hoang 
et al. 2006). A rostro-caudal gradient of this neurotropic effect has also been shown, 
with the greatest advantage for root reinnervation by axotomized neurons located at 
the closest proximity to the implantation site (Hoang et al. 2006).  
 
The neurotropic cues, which may be provided by an implanted ventral root and may 
be responsible for the root reinnervation by both autonomic and motor neurons, are 
not fully understood. However, a variety of neurotrophic factors provided by the 
implant may potentially be able to promote the observed axonal regeneration.  In 
Eggers et al., experiments (Eggers et al. 2010) motor axon counts showed that 
relatively few axons reach the distal sciatic nerve in the 16-week post-lesion period. 
The observed apparent spatio-temporal decline in the regenerative capacity of motor 
axons correlated with an observed initial increase and subsequent decline in 
expression of glial cell line-derived neurotrophic factor (GDNF) and BDNF.  
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Despite the beneficial effects of re-implantation, in the rat and cat, the ability of the 
motoneurons to find their original pathways to the muscles is poor, with a substantial 
degree of cross-innervation and probable functional consequences. Studies in 
primates provided evidence for a larger potential for plasticity. In the initial 
reinnervation phase, there was synkinesis of antagonistic muscles succeeded by 
adequate voluntary movement. Adequate movements were primarily observed in 
proximal muscle groups in the arm 2-3 months after corrective surgery but 
reinnervation of distal targets remained poor (Carlstedt et al. 1993; Hallin et al. 
1999). It has been suggested that the distal nerve is losing its capacity to support 
regenerating motor axons following prolonged denervation.  
 
Work has, therefore, concentrated in finding adjuvant strategies aiming at further 
improving and supporting the effects of re-implantation. A growing list of 
pharmacological agents and neurotrophic factors has been tested in rodent models of 
BP and cauda equina injuries. Proof for the neuroprotective effects of BDNF and 
GDNF has been demonstrated using a variety of delivery methods including 
intrathecal administration, application of gelfoam soaked with GDNF-containing 
solution and gene therapy approaches (Li et al. 1995; Novikov et al. 1997; Blits et al. 
2004). In a more recent study, Riluzole, a drug used for the treatment of amyotrophic 
lateral sclerosis, has demonstrated a significant neuroprotective effect of 
motoneurons after a lumbar ventral root avulsion injury. The combination of GDNF 
and riluzole caused an augmented production of new processes in an already reduced 
population of motoneurons and drastically improved function in experimental 
animals (Bergerot et al. 2004). Other putative pharmacological candidates that have 
received extensive attention with promising effects on regeneration include 
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nimodipine, N-acetyl cysteine and minocycline hydrochloride (Havton et al. 2009).  
 
Varieties of cell types and grafting platforms are also being studied because of their 
considerable potential for promoting axonal regeneration. Particular emphasis has 
been given to glial cells of the peripheral system such as Schwann cells (SCs) and 
olfactory ensheathing cells (OECs) due to their dual capacity for stimulating fibre 
growth, as well as, remyelination. Chapter 3 focuses on the properties of OEC to 
introduce the second experiment of this thesis. SCs are by far the most extensively 
studied cell type. SCs have neurotrophic, extracellular matrix and cell adhesion 
properties favourable to axonal regeneration in the peripheral nervous system. 
Numerous studies have demonstrated that peripheral nerve grafts can induce and 
support axonal regeneration over long distances from CNS neuronal populations 
(Bray et al. 1987; Li et al. 1994). Behavioural efficacy in chronic rodent spinal cord 
contusion models has also been reported (Takami et al. 2002; Barakat et al. 2005). In 
addition, a number of preclinical studies have demonstrated the ability of SCs to 
enhance the regeneration of sensory axons from the dorsal root ganglia as well as 
propriospinal axons adjacent to the injury site. These studies, however, also pointed 
out the limitations of SCs in that they do not permit axons that enter SCs grafts to 
exit and re-enter the host spinal cord. In addition, they provoke a more robust 
astrocytic reaction resulting in less effective integration into the host spinal cord. 
Lastly, although harvesting of SCs is relatively easy, it takes several weeks before 
enough cells can be generated for transplantation.  
 
Neural stem/progenitor (NSPCs) cells are said to be precursors of neurons, astroglia 
and oligodendrocytes. They can be harvested from the subventricular zones of rodent 
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brain and spinal cord. Expressions of astrocytes, oligodendrocytes and neuronal 
markers have been observed to variable degrees, although they differentiate 
primarily into astroglial cells with some oligodendrocytes. Neuronal differentiation 
is rare (Karimi-Abdolrezaee et al. 2006; Parr et al. 2007). Behavioural improvements 
have been shown in contusion, compression and sharp lesion models of SCI, 
including acute primate cervical contusion model (Iwanami et al. 2005). Given the 
controversy over the use of human abortion material in most countries, the optimal 
source for NSPC for transplantation purposes is yet to be determined 
(Kachramanoglou et al. 2011). 
 
Other potential candidates include neural and glial restricted precursors. Convincing 
behavioural improvements with glial precursors have only been demonstrated when 
used in conjunction with overexpression of a neurotrophin (Cao et al. 2005). Studies 
on these cells are limited, and the extent to which the observed benefits are related to 
myelination, neuroprotection or plasticity are still speculative. Harvesting from 
abortion materials meets the same ethical and practical issues to NSPCs 
(Kachramanoglou et al. 2011). 
 
Furthermore, during the last one-half century, devices and systems have been 
developed that can apply electrical currents to neural tissues in a synchronized 
fashion for the purpose of restoring a degree of control over abnormal or absent body 
functions, a technique referred to as functional electrical stimulation (Ragnarsson 
2008). To generate muscle contraction, the stimulus is generally applied to a 
peripheral nerve, anywhere along the length of the nerve from its origin to its motor 
point where it connects with the muscle. There is substantial scientific evidence that 
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shows that physical exercise of the paralysed body parts is of substantial clinical 
value and likely essential for maintenance of neural circuitry. It is thought that it 
reverse wasting, improve strength, endurance, and cardiovascular fitness; and may 
reduce the progression of osteoporosis (Creasey et al. 2004). In addition, there is 
evidence that shows that functional electrical stimulation not only stimulates 
production of endorphins, but contributes to the upregulation of BDNF, which may 
promote synaptic and functional plasticity within the brain and spinal cord 
(Vaynman et al. 2005). Significant achievements have been made in restoring limb 
function. Application of upper limb functional electrical stimulation systems is 
limited by the extent of LMN destruction within the injured cervical spinal cord. 
Useful hand grasp can be provided in C5 and C6 tetraplegia with preserved C7 and 
C8 neurological segments, reducing dependence on adapted equipment and 
assistants (Ragnarsson 2008). 
 
 
1.8 Intraspinal implantation of ventral roots in humans (Brachial plexus re-
implantation) 
 
Encouraged by the findings of animal experiments, repair of avulsed roots was 
performed in humans following BP avulsion injury first by Carlstedt and colleagues 
(Carlstedt et al. 1995). 
 
1.8.1 Operative technique of brachial plexus re-implantation in humans 
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The patient is placed in the lateral position with the affected side up and the head is 
held in a Mayfield clamp with the neck slightly flexed toward the unaffected side. 
The operating table is positioned head up to prevent venous congestion. A skin 
incision is made over the sternoclavicular joint and extended laterally and cranially 
into the posterior triangle of the neck, towards the C4 and C5 spinous processes. The 
spinal accessory nerve is identified and protected as it emerges from the dorsal 
aspect of the upper part of the sternocleidomastoid muscle. The BP is then identified 
and dissected. Occasionally, the ganglia and roots may have not been pulled out of 
the intervertebral foramina. They may be found in between the scalene muscles or 
further distally or may have even been pulled beneath the clavicle. Subsequently, the 
lateral masses of C5 - C7 and transverse process of T1 are approached between the 
levator scapulae and the posterior and medial scalenus muscles and the longissimus 
muscle is split longitudinally to approach the spine. The paravertebral muscles are 
dissected off the hemilaminae and C5 - C7 hemilaminectomy and medial facectomy 
is performed. The denticulate ligaments are cut and held by stay sutures and the 
spinal cord is, then, gently rotated to bring its ventrolateral aspect into view. The 
detached nerve roots are, subsequently, retrieved through the intervertebral foramina 
or through a small incision in the dura mater. Implantation of nerve rootlets is 
performed by making 2-3 mm longitudinal slits in the pia mater of the spinal cord as 
close as possible to the ventral root exit zone. The roots are positioned 1-2 mm deep 
to the pia mater in the spinal cord and the position retained using fibrin glue.  
 
When the avulsed roots cannot be brought close enough to the spinal cord, a nerve 
graft is taken from the superficial radial nerve of the forearm. The graft is attached/ 
 43 
stitched distally to avulsed roots and proximally the nerve graft is separated into 2 or 
3 fascicles and implanted into the spinal cord as described above.  
 
Spinal cord monitoring is performed throughout the procedure to avoid an injury to 
the spinal cord particularly when tilted and during re-implantation of the roots.  
 
 
1.8.2 Preliminary studies of functional recovery following BP re-implantation  
 
The first human case BP re-implantation following avulsion injury was reported in 
1995 (Carlstedt et al. 1995). This was a 25-year-old woman who presented with 
Horner’s syndrome and paralysis of wrist and finger movements. In addition, there 
was weakness in the shoulder and elbow movements (C5-7). Sensory testing 
revealed normal sensation in the C6 dermatome, reduced sensation in the third finger 
and complete loss of sensation in the C8-T1 distribution. Open exploration of the BP 
revealed that there were a combination of supraganglionic rupture and avulsion 
injury of the C8 and T1 roots. The remainder of the roots of the BP were in 
continuity. The proximal ends of C8 and T1 ventral roots were reconnected to their 
corresponding spinal nerves via 7-8 cm long sural nerve grafts. Three years after, 
there was activity of the shoulder elbow and wrist, reduced flexion activity in the 
index finger but full power in the flexion of the three ulnar fingers. There was 
complete loss of power in the intrinsic muscles of the hand. Activity in the finger 
extensors and thumb was not reported at three years. Some activity was noted in the 
18-month follow-up assessment in the finger extensors, except thumb. 
Electromyography showed reinnervation potentials in the flexor digitorum 
profundus, the ulnar wrist flexor and finger extensor muscles. Sensory activity was 
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reported normal in the median and radial nerve distribution but remained absent in 
the ulnar nerve distribution. 
 
Subsequently, a case series of 10 cases was published (Carlstedt et al. 2000). This 
report included one female and seven male adult patients and two babies with 
obstetric injury to the BP. Two had complete BP avulsion injury, three patients had a 
mixture of ruptures and avulsions observed only when the dura was opened and one 
patient had pure ruptures of two ventral roots. The remainder four patients had 
incomplete injuries with avulsions of two roots supplying the BP. In one patient the 
dorsal roots were in continuity with the spinal cord whereas the ventral roots were 
avulsed. Repair was performed by re-implantation of nerve grafts apposed to two or 
three avulsed ventral roots. Assessment of neurological recovery was performed 
mainly by clinical examination. In some patients standard electromyography, central 
magnetic stimulation to assess muscle co-contractions and sensory function tests 
including thermal threshold, light touch threshold and axon reflex vasodilation were 
performed but only documented in illustrative cases. The first electrophysiological 
signs of reinnervation occurred 9 to 15 months of surgery with MRC Grade 1 power 
in relevant muscles. Useful function of MRC Grade 3 was reported in three patients. 
In 5 patients the best motor recovery was power of Grade 1-2.  
 
A subsequent case study reported partial recovery of hand function in a pre-
adolescent boy who underwent re-implantation surgery for complete BP avulsion 
injury (Carlstedt et al. 2004). Nerve grafts were connected distally to the upper, 
middle and lower trunks of the BP. Re-implantation was performed in combination 
with nerve transfers; the accessory nerve was transferred to the suprascapular nerve, 
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a cervical plexus motor branch was transferred to the upper trunk and 
supraclavicular sensory nerves were joined to the sensory parts of the C7, C8 and T1 
spinal nerves. Proximal muscle group recovery started 8-10 months after surgery. At 
two years after surgery there was normal power (Grade 5/5) serratus anterior muscle, 
Grade 4/5 in the deltoid, biceps and forearm muscles, wrist and finger flexors, Grade 
2/5 in the triceps and intrinsic muscles of the hand, but no clinical function in the 
wrist or finger extensors.  
 
Other interesting observations made in studies of BP re-implantation in humans 
include the finding of greatest motor recovery in patients in whom surgery was 
performed within 1 month after injury (Carlstedt et al. 2000; Htut et al. 2007) and 
co-contractions between antagonistic muscles (for example biceps-triceps), which 
compromised function but reduced with time (Carlstedt et al. 2000). In addition, re-
implantation has been shown to have effects on sensory function with return of 
sensation in the avulsed dermatomes (Carlstedt et al. 2000) and improvement in the 
intractable neuropathic pain associated with root avulsion injury (Carlstedt et al. 
2000; Carlstedt et al. 2004). Interestingly, pain relief has been reported to precede 
restoration of muscle function (Berman et al. 1998; Kato et al. 2006). The 
mechanism of pain improvement in these patients is currently uncertain but it has 
been suggested that it may be due to recovery or regeneration of proprioceptors in 
reinnervated muscles, which inhibit pain transmission in the dorsal columns (Htut et 
al. 2007). 
 
In the above studies, re-implantation was thought to be responsible for the functional 
recovery observed. However, the above studies are descriptive and lack objective 
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methods of assessment of neurological recovery, a comparison group and 
homogeneity in subjects’ injury.  In addition, the study of patients with incomplete 
BP injuries and the well-established fact that there is significant variation in the 
segmental innervation of individual muscles raises the question whether recovery of 
function could be due to reinnervation from uninjured spinal roots.  
 
 
1.9 Assessment of clinical recovery and regeneration 
 
1.9.1 Principles of Needle electromyography  
 
The degree of injury involvement and reinnervation in a given muscle can be 
investigated by means of electromyography (EMG) techniques, aiming at the 
estimation of parameters of a motor unit action potential. The motor unit consists of 
an anterior horn cell, its axon, and all the muscle fibres innervated by that axon and 
its branches. The motor unit action potential (MUAP) is the electrical field generated 
by the voluntary contraction of muscle fibres belonging to one motor unit as 
recorded by the tip of a nearby needle electrode.  An MUAP is characterized by its 
amplitude, duration, shape, rate of firing and number of phases. The amplitude of an 
MUAP is proportional to the number of muscle fibers that contract with activation of 
a motor neuron. The duration reveals the synchrony of firing of the muscle fibres. 
Under normal circumstances, muscle fibers belonging to one motor unit are all 
depolarized and repolarized somewhat synchronously and their MUAP has a di- or 
tri-phasic configuration. 
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Neurological recovery after transection of a nerve occurs in two forms: true axonal 
regeneration and the reinnervation of denervated muscle fibres by terminal collateral 
sprouting. Both processes show abnormal electrical configurations of increased 
polyphasicity, as reinnervation takes place from regenerating or sprouting axons that 
reach the muscle through the distal nerve stump at scattered time intervals. Two 
types of polyphasic potentials can form following axonal degeneration: (1) nascent 
potentials and (2) motor units formed from terminal collateral sprouting: 
 
For true axonal regeneration to occur, there must be an intact anterior horn cell and 
an intact endoneurial tube. The axon distal to the site of injury undergoes Wallerian 
degeneration. The proximal axon forms a bud that begins to regenerate distally 
through the endoneurial tube toward the denervated muscle. This process occurs at a 
rate of 3–4 mm/day so axonal regeneration is length-dependent. New axons reach 
muscle fibres that have been denervated for varying times and belonged to different 
motor unit. MUAPs from such motor units are called "nascent" potentials of small 
amplitude (100-200 µv), short duration (3 - 5 ms), and polyphasic. With continuing 
maturation of the motor unit, nascent units become of longer duration, higher 
amplitude and less polyphasic. Eventually, they may reach normal size for the 
muscle being examined.  
 
With collateral sprouting from undamaged adjacent axons, more muscle fibres are 
activated by the stimulation of one motor unit, resulting in high amplitude, short 
duration MUAPs (Lee et al. 2004).  
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In chronic denervation processes, surviving nerve fibres increase their motor unit 
territory and fibre density, producing high amplitude, long duration MUAPs. The 
duration is prolonged because there are more fibres to depolarise, and the increase in 
the number of phases is due to the lack of synchronization between the host and 
newly acquired fibres. 
 
Neurological recovery is also dependent on healthy viable muscle tissue. This is 
necessary for the release of nerve growth factors from denervated muscle. These 
factors act as a catalyst to stimulate the axon to regenerate. If the denervated muscle 
becomes fibrotic, these factors may no longer be released. Muscle tissue must also 
remain viable and electrically active if a regenerating axon is going to establish a 
connection with a functional neuromuscular junction. Chronically denervated muscle 
will eventually become fibrotic and electrically inactive. This usually happens 
somewhere between 18 and 24 months. In myopathy, the motor unit territory and 
fiber density decrease because of the muscle fiber degeneration, producing small 
amplitude, short duration MUAPs (Lee et al. 2004). 
 
Furthermore, observations at rest can provide further information. Insertional 
activity is the electrical response of muscle membrane to insertion of the EMG 
needle. Increased insertion activity, or persistent abnormal spontaneous electrical 
activity, is secondary to a hyperexcitable muscle membrane. Several abnormal 
spontaneous potentials beyond the cessation of needle insertion, including 
fibrillations (low amplitude, short biphasic or triphasic potentials), positive sharp 
waves (PSWs) (positive deflections followed by a prolonged negative wave), and 
fasciculations are observed with denervation within 2-3 weeks (Lee et al. 2004).  
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Moreover, the rate and pattern of MUAP firing or recruitment can also assist in 
evaluating disease processes. With increasing effort of contraction, the firing 
frequency of individual motor units increases and progressively more and larger unit 
are activated in normal subjects. Reduced recruitment occurs whenever a lesion 
results in a reduced number of functionally intact motoneurons and axons. In 
myopathy, the muscle fibre content of each motor unit is reduced and the number of 
motor units required to maintain a given force increases. This recruitment pattern is 
called “early or increased recruitment”.  
 
The recruitment pattern at maximal voluntary contraction is called “interference 
pattern” due to the increasing degree of superimposition of action potentials from 
different units. Reduced interference pattern signifies a decreased number of MUAPs 
being activated and is suggestive of a neurogenic lesion.   
 
 
1.9.2 Principles of nerve conduction studies 
 
The propagation of action potentials along a nerve can be recorded by using surface 
electrodes. A recording from a mixed nerve is referred as compound nerve action 
potential (CNAP). Recordings from a pure sensory nerve is referred to as sensory 
nerve action potentials (SNAP), whereas when motor nerves are stimulated 
recordings are called compound muscle action potential (CMAP). Typically SNAPs 
and CNAPs are measured by stimulating a peripheral nerve and recording the 
response a known distance away (Robinson 2000). They both are characterized by 
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two measures: (1) speed of conduction (latency or velocity) and (2) amplitude of 
response. The latency and velocity conduction is affected by temperature in normal 
healthy subjects and are slowed in pathological conditions involving loss of axons or 
demyelination. Distal lesions between the sites of stimulation and recording will 
decrease the amplitude of CNAP immediately, as conduction cannot traverse the 
lesion.  Proximal lesions, such as in the BP, that separate sensory axons from their 
cell bodies in the DRGs, will show reduced-amplitude SNAP (Robinson 2000).  
 
To evaluate conduction velocity along a motor nerve, motor nerves are stimulated at 
two places the distance between the two stimulation sites is divided by the difference 
in latency to cancel out the conduction time across the neuromuscular junction and 
muscle depolarisation. The amplitude of the response is diminished by defects of the 
neuromuscular junction or loss of anterior horn cells. A root lesion proximal to the 
DRG would diminish the amplitude of CMAP but not that of SNAP.   
 
The F-wave is an electrophysiological artefact produced by antidromic activation of 
motoneurons following distal electrical stimulation of motor nerve fibres. F-waves 
are commonly recorded using surface electrodes from hand muscles (abductor 
pollicis brevis and abductor digiti minimi). Because F-waves traverse the entire 
length of a peripheral nerve between the spinal cord and muscle, F-waves provide a 
means of examining transmission between stimulation sites in the arm and the 
related motoneurons in the cervical cord. Because a different population of anterior 
horn cells is stimulated with each stimulation, each F wave has a slightly different 
shape, amplitude and latency. The latency of the F-wave (typically 25-32 ms in the 
upper extremities and 45-56 ms in the lower extremities) is the most commonly used 
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parameter for assessing the F-wave and reflects the conduction time between the site 
of the stimulation of the peripheral nerve and the spinal cord for reactivation of the 
motoneurons. 
 
 
1.9.3 Sympathetic skin response  
 
The sympathetic skin response (SSR) is defined as a momentary change of the 
electrical potential of the skin and provides a non-invasive approach to investigate 
the function of the sympathetic system. It reflects sympathetic cholinergic sudomotor 
function, which induces changes in skin resistance to electrical conduction. It is a 
result of polysynaptic reflex arch activation. The efferent part of the SSR reflex arch 
consists of myelinated sympathetic fibres of neurons from intermediolateral nucleus 
in T1-L2 part of the spinal cord that terminate in paravertebral sympathetic ganglia. 
Postganglionic fibres are nonmyelinated (type C) and innervated eccrine sweat 
glands (Vetrugno et al. 2003). The central part of the reflex arch presumed to be 
polysynaptic with a connection to the structures of hypothalamus, ventrolateral part 
of the brainstem, medial and basal parts of the frontal lobe and medial part of the 
temporal lobe (Vetrugno et al. 2003).  
 
Response is most often biphasic in the hands with negative and positive phases. 
Although its use remains controversial, SSR can assist the localization of the lesion 
to the effector glands or nerve fibers. However, an abnormal SSR can result from 
abnormal autonomic efferents but also from atrophy of effector sweat glands after 
chronic denervation and from altered perception (afferent sensory fibers of the arc) 
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and therefore, simultaneous nerve conduction studies are required for interpretation 
of findings.  
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1.10 Hypothesis Formulation 
 
The following chapter of this thesis was designed to investigate the long-term effects 
of a homogeneous group of patients with complete BP injury with objective 
experimental methods. To that end, neurophysiological tests and standardised 
patient-reported outcome measures as well as clinical examination were utilized to 
investigate these effects. Correlations of functional recovery with factors that may 
affect recovery were also examined to determine their contribution to functional 
outcomes. The central hypothesis of the following chapter is that patients with BP 
re-implantation after complete BP injury will demonstrate better functional recovery 
in clinical examination and evidence of regeneration in neurophysiological 
experiments compared to patients without re-implantation. With that bigger 
framework in mind and in view of the existing literature presented in this 
introduction we expect to find the following: 
 
a) An improved functional recovery in patients with re-implantation compared to 
patients with complete BP injury but without surgical repair.  
b) An improved functional recovery in proximal muscles compared to more distal 
musculature.  
c) Electrophysiological evidence of reinnervation in muscle supplied by re-
implanted ventral roots. 
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Chapter 2 
 
The long-term outcome of brachial plexus re-implantation following 
complete brachial plexus avulsion injury  
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2.1 Introduction 
 
This chapter presents a prospective observational study aiming at revealing the 
functional recovery of the affected arm in patients that have undergone BP re-
implantation surgery after complete BP avulsion injury. The motor and sensory 
function of patients who have had re-implantation surgery are assessed with clinical, 
neurophysiological and patient reported outcome measures and compared to patients 
who were treated conservatively for their injury.  
 
2.2 Aims and objectives: 
 
The aims of this chapter are twofold. The first aim is to explore the clinical, 
neurophysiological and patient reported recovery in the patients following complete 
BP avulsion injury and re-implantation surgery. The second aim is demonstrate 
whether there is a difference in functional recovery between patients who had had re-
implantation surgery and patients with complete BP avulsion injury but without re-
implantation of ventral roots.   
 
 
2.3 Methods  
 
2.3.1 Patients 
 
Potential patients were identified via evidence of BP re-implantation procedure in 
the surgical books and a log provided by the surgeons. To the date of data collection 
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for this study (2010), twenty-five patients who have had re-implantation surgery (re-
implantation group) after complete BP avulsion and sixteen patients with complete 
BP avulsion injury who have had no surgical intervention (control group) were 
identified for participation in our study. The remaining patients were not assessed for 
one of the following reasons: (a) had been lost to follow up,  (b) patients declined 
participation, (c) have had amputation of the affected arm or, (e) had associated 
lower limb weakness.  
 
Of the above, 15 patients in the re-implantation group and 7 patients in the control 
group were included in the study. All 15 patients in the re-implantation group 
underwent BP re-implantation surgery at the National hospital for Neurology and 
Neurosurgery, London. Initially, hospital records were inspected for evidence of a 
completely paralyzed arm, complete loss of sensation from C5-T1, evidence of 
Tinel’s sign and Horner’s syndrome at presentation. Subsequently, the operation 
record of the exploration procedure was then inspected for evidence of complete BP 
injury. Diagnosis was also correlated with findings of other available investigations, 
including preoperative CT myelography, MRI and electrophysiological studies. 
Patients with evidence of brain or spinal cord injury on preoperative MRI, root 
rupture during the exploration procedure and any electrophysiological response in 
perioperative electrophysiological studies were excluded. Only patients with 
traumatic BP injury were included.  
 
Seven patients with clinical, electrophysiological and perioperative evidence (as per 
the re-implantation group) of complete BP supraganglionic avulsion injury who did 
not undergo re-implantation surgery were recruited as control patients. One patient 
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had undergone nerve transfers for repair of the accessory nerve to the suprascapular 
nerve and 4
th
 and 5
th
 intercostal nerves to the musculocutaneous nerve.  
 
 
2.3.2 Motor and sensory clinical assessment 
 
All patients were assessed clinically based on the Medical Research Council (MRC) 
to estimate limb and axial muscle strength. A summated muscle score based on the 
MRC clinical scale was also used to assess global power in the affected arm (“global 
MRC score”). This was obtained the following way: on the affected side, seven 
selected upper limb muscles or muscle groups were tested and scored from 0 to 5 
according to the MRC muscle strength scale. Muscles included are the deltoid (C5-
6)/ supraspinatous (C4-6), infraspinatous (C5-6), pectoralis (C5-6), biceps brachii 
(C5-6), triceps (C6-C8), for wrist movements extensor carpi radialis (C5-6) and 
ulnaris (C7-8)/ flexor carpi radialis (C6-7) and ulnaris (C7-8, T1) and finger 
movements flexor digitorum superficialis (C7-8, T1) and profundus (C7-8, T1)/ 
flexor digiti minimi (C7-8, T1)/ flexor pollicis (C8-T1)/ extensor digitorum (C7-
8)/extensor indicis (C7-8)/extensor pollicis brevis (C8-T1) and longus (C7-8, T1) 
interossei (C8-T1). The segmental muscle innervation was based on MRC UK 
memorandum (MedicalResearchCouncil 1976). Modifications to the MRC scale add 
either a minus or a plus to the score. For example, 4- represents a muscle that is 
slightly weaker than one with a score of 4 and equals to 3.5. MRC scores for each 
muscle/muscle groups were added to obtain the “global MRC score”, which has a 
range from 0 to 35. In addition, the presence of Horner’s syndrome was documented 
and Tinel’s sign was tested.  
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2.3.3 Sensory examination 
 
All patients underwent sensory testing, which included: (a) light touch using cotton 
wool and (b) pinprick with blunt pin. The sites of testing followed the dermatomes 
based on the MRC UK memorandum (MedicalResearchCouncil 1976). These were 
recorded as being either normal or altered. (c) Vibration sense using a 128 Hz tuning 
fork and (d) proprioception and (c) cold temperature sense by touching. These were 
tested clinically at the shoulder, elbow and wrist. Examination was performed with 
their eyes closed. The unaffected arm was examined first.  
 
If a patient reported referred sensations, defined as sensations that are perceived to 
emanate from the other areas of the body than the body part being stimulated, a more 
detailed examination was conducted and patients were asked to describe the 
sensation and location perceived to the best of their ability. Perceived sensations 
were drawn on a schematic diagram of the arm. Patients were told that the sensitivity 
of the upper arm was assessed and were not informed of the possibility of 
experiencing abnormal or referred sensations. Similarly, when patients reported an 
insensate area within a dermatome, a more careful examination was performed in an 
attempt to localize the insensate region. This was, also, drawn on a schematic 
diagram of the arm. Lastly, observations of allodynia were also recorded, defined as 
pain caused by stimuli that were non-noxious in the intact contralateral limb or 
normal subjects.  
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2.3.4 Electrophysiological assessment 
Neurophysiological studies were performed in all 7 of control patients and 13 out of 
the 15 patients (86.6%) who have had re-implantation surgery. The remainder two of 
the re-implantation patients refused or did not turn up for their appointment. The 
neurophysiological examination was performed in all patients by an experienced 
EMG neurophysiologist (M.K.), who was blinded to the status of the patients.  
 
All neurophysiological tests were performed using a Viking™ NCS, EMG, EP, IOM 
System (CareFusion, San Diego, CA, USA; Version 12) and stimulator Digitimer 
DS5 (Digitimer, Welwyn Garden City, UK).  
 
 
2.3.4.1 Motor nerve conduction studies 
 
The median and ulnar nerve motor conduction data were determined using surface 
electrodes for stimulation at the elbow and proximal to the wrist and for recording 
over the abductor pollicis brevis muscle (APB) and over the abductor digiti minimi 
muscle (ADM). For each nerve, the following conduction data were recorded: distal 
motor latency (DML), conduction velocity, amplitude and F-wave latency stimulated 
at the wrist.  
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2.3.4.2 Sensory nerve conduction studies 
 
Sensory conduction velocity (SCV) of the median, ulnar and radial nerves were 
assessed. SCV of the median nerve was determined orthodromically from (a) the 
second finger, (b) the third finger and (c) palm to the wrist. The SCV of the ulnar 
nerve was tested from (a) the fifth finger and (b) the palm to the wrist and the SCV 
of the radial nerve was tested from the forearm to the wrist.  
 
 
2.3.4.3 Electromyography 
 
Needle electromyography (EMG) was performed with TECA
®
 Elite Disposable 
Concentric Needle Electrode (37 mm, 26G; CareFusion, Middleton, WI, USA) and 
conventional EMG recorder, Viking Select EMG machine (CareFusion, San Diego, 
CA, USA; Version 12). EMG was attempted in the following muscles: deltoid, 
biceps, triceps, infraspinatous, first dorsal interosseous (DFIO), flexor digitorum 
superficialis (FDS), extensor digitorum communis (EDC). After needle insertion, 
pathologic spontaneous activity, shown as fibrillation potentials and positive sharp 
waves (PSW) were first determined. These were rated as “0” no fibrillation 
potentials/PSWs, “+1”, “+2” and ”+3” with increasing severity. The patient was then 
asked to contract the muscle of interest to assess the presence of motor unit action 
potentials (MUAPs) under voluntary control and if present these were recorded. The 
duration, amplitude, degree of polyphasicity, recruitment and interference patterns 
were studied. The grading of muscle reinnervation was based on the configuration of 
the MUAPs. Reinnervation was graded as follows: “0” No recorded MUAPs; “1” 
MUAPs of increased duration/reduced amplitude/increased polyphasicity; “2” 
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MUAPs of increased duration/increased amplitude/increased polyphasicity; “3” 
MUAPs of increased duration/normal amplitude/minimal polyphasicity; “4” MUAPs 
of minimally increased duration and amplitude/no polyphasicity. Assessment of 
recruitment was made at minimal muscle contraction to determine the recruitment 
pattern and at maximal voluntary contraction to assess the interference pattern. 
 
 
 
2.3.4.4 Sympathetic skin response 
 
In addition, the sympathetic skin response (SSR) latency was determined using 
standard surface silver (Ag-Ag-Cl) electrodes stimulating the median nerve on the 
palm of the affected arm. Single square-wave electrical stimulus with intensity of 10-
30 mA and duration of 0.1 - 0.5 ms was applied.  
 
2.3.5 Outcome measures 
 
To gain an insight into the way patients perceive their health and the impact of their 
disability to their quality of life, four validated patient-reported outcome measures 
(PROMs) were given to the patient to complete prior to their examination. Patients 
completed these questionnaires without any help or explanation of the questions. The 
validated patient-reported outcome measures used are described below:  
 
Firstly, the visual analogue scale (VAS) was used to assess the severity of pain in BP 
avulsion injury patients. The VAS scale consists of a 10-cm line anchored by 2 
extremes of pain, with zero representing “no pain” and 10 representing ‘‘worst 
imaginable pain’’. Pain was defined as every form of pain in the hand (Appendix 1).  
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Secondly, to assess the global function of the arm, the Disabilities of the Arm, 
Shoulder and Hand (DASH) questionnaire was used (Appendix 2). The DASH is a 
self-administered outcome instrument focused on musculoskeletal disorders of the 
upper extremity. It emphasizes physical function but also includes questions on 
social and emotional function. It consists of 30 items measuring the degree of 
difficulty a person has in performing various daily activities including the severity of 
pain symptoms, activity-related pain, tingling, weakness and stiffness (five items), 
and the effect of the condition on social activities (one item), work (one item), sleep 
(one item), and self-image (one item), measured on a 5-point Likert scale (1 to 5). 
The scores of all items are added to calculate a DASH score ranging from 0 to 100. 
Higher DASH scores reflect greater disability. The DASH questionnaire also 
contains two optional modules concerning the patient’s ability to practice a sport or a 
musical instrument and to work. For each module, four items ask about the patient’s 
physical ability to perform the activity (Beaton et al. 2001).   
 
Secondly, the Michigan Hand Outcomes Questionnaire (MHQ) which measures a 
person’s perception of their hands in terms of function, appearance, pain, and 
satisfaction (Appendix 3). It consists of 37 items on six subscales: (1) overall hand 
function, (2) activities of daily living, (3) pain, (4) work performance, (5) aesthetics, 
and (6) patient satisfaction with hand function. Items are scored on a 5-point Likert 
scale from 1 (very good/not at all difficult/always/ very mild/very satisfied) to 5 
(very poor/very difficult/ never/severe/very dissatisfied). Raw scores are converted 
to a scale from 0 - 100 according to a scoring algorithm. Ranges for subscales are: 
hand function (5 - 25), unilateral ADL (5 - 25), bilateral ADL (7 - 35), work (5 - 25), 
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pain (0 - 24), aesthetics (4 - 20), and satisfaction (6 - 30). Higher scores indicate 
better performance in all domains except pain (Chung et al. 1998; Chung et al. 
1999). 
 
Lastly, the SF-36, a generic, multi-purpose, short-form health survey comparing the 
relative burden of diseases, and in differentiating the health benefits produced by a 
wide range of different treatments (Appendix 4). It consists of 36 items and yields an 
8-scale profile of functional health and well-being scores as well as 
psychometrically-based physical and mental health summary measures and a 
preference-based health utility index (Ware et al. 1992).  
 
 
2.3.6 Statistical analysis 
 
All statistical analysis was performed using STATA statistical software Version 11 
(StataCorp LP, College Station, TX). A Wilcoxon-Mann-Whitney test (z) was used 
to compare parameters after testing for normality. A Spearman’s rank correlation 
coefficient (rho) was used to test for statistical correlations between two continuous 
variables. Statistical significance was accepted at the 5% level (p < 0.05), unless 
otherwise stated. 
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2.4 Results  
2.4.1 Description of patients 
 
Of the seven control patients included in the study, five were men and two women. 
All patients sustained their injury in motor vehicle accidents. Their average age was 
43 years (sd; 8.8 years of age, range; 28-57 year of age).  All control patients were 
right-handed from birth. Three injured their right arm (57.14%) and four injured 
their left (42.86%). The median period from the day of injury to assessment for this 
study was 156 months (sd; 95.5, range; 74-338 months). The mean of days from 
injury to exploration was 205 days (sd; 173.81, range 48-483 days).  
 
All 15 patients in the re-implantation group were men with a mean age of 32 years 
(sd; 9.71 range; 18-48 year of age). Thirteen re-implantation patients were natively 
right-handed (86.67%) and two were left-handed (13.33%). Of the 13 right-handed, 
five injured their right arm (38%) and eight injured the left (62%). Both natively left-
handed patients injured the left arm (100%).  
 
The median period from injury to exploration was 11.9 days (sd; 8.95, range; 1-33 
days). The mean period from the day of injury to the day of re-implantation was 33.3 
days (sd; 30.29 days, range 4 - 138 days). Re-implantation surgery took place within 
40 days from injury in all patients, except in one patient who was not fit for surgery 
immediately and was operated 138 days after his injury. All patients had re-
implantation of roots C5, C6 and C7 via grafts obtained from the superficial radial or 
medial cutaneous nerve of the ipsilateral forearm as described in section 1.8.1. All 
patients had their avulsed dorsal roots trimmed distally to the level of a normal 
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looking dorsal root or the to the junction with the ventral root. The median period 
from the day of injury to assessment for this study was 60.6 months (sd; 50.3, range; 
10-155 months).  
 
Three out of the seven control patients (42%) analgesics and nine out of 15 re-
implantation patients (60%) were on analgesic treatment consisting of different 
combinations of oral morphine, pregabalin, amitryptyline and Diclofenac
®
. All 
subjects of both groups not taking analgesics mentioned they had stopped taking 
analgesics because they suffered their side effects without pain control.    
 
 
2.4.2 Clinical assessment of motor function 
 
MRC scores are summarised in Table 2.1 and 2.2. In summary, of the seven control 
patients, two (28.6%) had movement in the deltoid muscle, 0 in the pectoralis 
muscle, one (14.3%) in the infraspinatous muscle, three (42.8%) in the biceps, two 
(28.6%) in the triceps and none showed wrist or finger movement. Of the 15 patients 
in the re-implantation group, movement was noted in 12 (80%), 10 (66.6%), 10 
(66.6%), in the deltoid muscle, pectoralis muscle and infraspinatous muscle 
respectively and 9 (60%), 9 (60%), 1 (6.6%), 2 (13.3%) in biceps muscle, triceps 
muscle, wrist and finger movement respectively. No co-activation of antagonistic 
muscle function or co-contractions was observed.  
 
A two-sample Wilcoxon rank-sum test revealed a statistically significant difference 
in deltoid (z = -2.19, p = 0.028), pectoralis (z = -2.72, p = 0.007) and infraspinatous 
power (z = -2.09, p = 0.037) between the control and re-implantation groups. There 
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was no difference between the two groups in the power of the biceps (z = -0.30, p = 
0.764), triceps (z = -1.185, p = 0.236), wrist movements (z = -0.68, p = 0.494) or 
finger movements (z =  -0.98, p = 0.323). The group mean “global MRC score” of 
the control group was 2.57 (sd; 3.26, range; 0-7) and significantly lower (z = -2.17, p 
= 0.03) then that of the re-implantation group estimated at 6.93 (sd; 4.79, range 0-
14).  
 
Table 2.1: Results of motor examination of the affected arm; values reflect MRC 
grades.   
 
Patient 
Trape
zius 
Del
toid 
Pector
alis 
Infras
pi-
natou
s 
Bic
eps 
Tric
eps 
Wrist 
move-
ments 
Fin
ger 
mo
ve-
me
nts 
Global 
MRC 
score 
(out 
of  35) 
Control 1 5 2 0 0 1 3 0 0 6 
Control 2 5 0 0 2 2.5 0 0 0 5 
Control 3 0 0 0 0 0 0 0 0 0 
Control 4 4 0 0 0 0 0 0 0 0 
Control 5 5 1 0 0 3.5 1 0 0 6 
Control 6 5 0 0 0 0 0 0 0 0 
Control 7 0 0 0 0 0 0 0 0 0 
          
Reimplant 1  3 2 1 0 4 3 0 0 10 
Reimplant 2 5 1 1 1 0 1 0 0 4 
Reimplant 3 5 0 0 0 0 0 0 0 0 
Reimplant 4 4 0 0 0 0 0 0 0 0 
Reimplant 5 5 4 3 3 1 3 0 0 14 
Reimplant 6 4 4 3 1 1 1 0 0 10 
Reimplant 7 4 3 2 1 2 1 0 0 9 
Reimplant 8 4 2 2 1 1 0 0 2 8 
Reimplant 9 4 0 0 1 1 1 0 0 3 
Reimplant 10 5 1 1 3 0 0 1 3 9 
Reimplant 11 5 3 3 3 2 3 0 0 13 
Reimplant 12 4 1 0 0 0 1 0 0 2 
Reimplant 13 5 1 0 0 0 0 0 0 1 
Reimplant 14 5 2 3 4 2 0 0 0 11 
Reimplant 15 5 1 3 3 1 2 0 0 10 
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Table 2.2: Mean MRC scores, SD and range for each muscle group tested.  
 
 Control group Re-implantation group 
Mean SD Range Mean SD Range 
Trapezius 3.43 2.37 0-5 4.46 0.64 3-5 
Deltoid  0.57 0.96 0-2 1.73 1.28 0-4 
Pectoralis 0 0 0-0 1.46 1.30 0-3 
Infraspinatous  0.29 0.76 0-2 1.40 1.40 0-4 
Biceps 1 1.44 0-3.5 1.00 1.13 0-4 
Triceps 0.57 1.13 0-3 1.07 1.16 0-3 
Wrist movement 0 0 0-0 0.07 0.26 0-1 
Finger movement  0 0 0-0 0.33 0.90 0-3 
 
 
2.4.3 Clinical assessment of sensory recovery 
 
2.4.3.1 Dermatomal distribution     
 
Of the seven control patients, four (57%) reported altered or reduced light touch 
sensation in the distribution of the C5 root, two (28%) in the C6, C7, and C8 
dermatome and one in T1 distribution.  On examination of pinprick sensation, three 
(43%) perceived sensation in the C5 territory, two (28%) in C6 and C7 distribution, 
one in C8 and another in T1. Horner’s syndrome was present in four out of seven 
control patients  (57 %) and six out of 15 re-implantation patients (40 %).  
 
Of the 15 patients in the re-implantation group, 14 (93%) reported light touch and 13 
(87%) pinprick in the C5 distribution. Eight (53%) had light touch sensation and 
seven (47%) pinprick in the C6 territory. In C7 distribution, only two (13%) reported 
light touch and one (7%) reported pinprick. One patient (7%) reported sensation in 
the C8 territory in both pinprick and light touch and eight out of 15 (53%) patients 
had sensation in the T1 distribution in light touch and seven (47%) in pinprick.  
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Reduced temperature sensation was perceived in the region of the shoulder in four 
controls and 13 re-implantation patients, at the elbow two controls and seven re-
implantation subjects, and none at the wrist from either group.  
 
A two-sample Wilcoxon rank-sum test revealed a statistically significant difference 
between the two groups in the frequency of patients with recovery in soft touch and 
pinprick sensation in the C5 dermatome (z = -2.003, p = 0.045 and z = -2.100, p = 
0.036 for soft touch and pinprick sensation respectively). Recovery of soft touch or 
pinprick sensation in the remainder of dermatomes was not found to be statistically 
different (Table 2.3). There was no significant difference in the number of patients 
with temperature sensation in the shoulder or wrist. However, a two-sample 
Wilcoxon rank-sum test showed a statistically significant difference in the frequency 
of patients with temperature sensation in the region of the elbow (Table 2.3). 
 
Vibration was perceived at the shoulder in 4 controls and 12 re-implantation patients, 
at the elbow in 1 control and 3 re-implantation patients, and at the wrist in one 
control and two re-implantation patients. Proprioception was accurate at the shoulder 
in four controls and 13 re-implantation patients, at the elbow in two controls but 
seven re-implantation patients and at the wrist none in either patient group. There 
was no difference between groups in the number of patients perceiving 
proprioception or vibration sense at the shoulder, elbow or wrist.  
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Table 2.3: Mann-Whitney z-scores and p values comparing the frequency of patients 
with return of sensory modalities tested between the two groups of patients. Asterisk 
(*) denotes statistical significance (p <0.05). Chi
2 
statistic and p values comparing 
the frequency of normal sensation for each dermatome and modality between 
groups.   
 
 
Soft touch  z-score p value Chi
2
 p value  
C5 -2.003* 0.0452* 0.66 0.045 
C6 -1.342 0.1797  1.66 
C7 0.843 0.3991 - - 
C8 1.362 0.1731 0.35 0.55 
T1 -1.695 0.0900 0.74 0.39 
Pinprick z-score P value   
C5 -2.100* 0.0358* 3.3 0.036 
C6 -0.856 0.3918 2.22 0.14 
C7 1.362 0.1731 - - 
C8 1.362 0.1731 - - 
T1 -1.437 0.1508 1.66 0.19 
Proprioception z-score P value   
Shoulder -1.504 0.1327 3.3 0.07 
Elbow -0.786 0.4321 0.74 0.78 
Wrist - - 0.74 0.39 
Vibration z-score P value   
Shoulder -1.095 0.2733 0.29 1.11 
Elbow -0.316 0.7518 - - 
Wrist -0.990 0.3222 0.55 0.35 
Temperature z-score P value   
Shoulder -1.36 0.173 0.74 0.39 
Elbow -2.139* 0.0325* 3.59 0.11 
Wrist -0.990 0.3222 0.74 0.39 
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Furthermore, in the re-implantation group, dermatomes were not entirely innervated 
but often there were insensate patches within one dermatome (Table 2.4). Two 
patients described insensate patches in the lateral aspect of the upper arm. Another 
two patients reported an abrupt end of sensation at the level of the elbow and one 
midway the forearm but with some reduced sensation in anterior lateral aspect of the 
wrist. 
 
2.4.3.2 Abnormal sensations 
 
2.4.3.2.1 Tinel’s sign  
 
Tinel's sign on percussion in the region of the nerve roots at the base of the neck was 
present in four patients with re-implantation but no control patients. In all four re-
implantation patients percussion over the region of the nerve roots provoked 
paraesthesia (pins and needles) in the whole upper arm and forearm. In addition, 
paraesthesia was also elicited in the dorsal central aspect of the hand in one patient 
and in another subject in the thumb.  
 
 
2.4.3.2.2 Referred sensations 
Two patients of the re-implantation group described perception of sensations in 
remote locations not stimulated (Table 2.4 and Figure 2.1). Specifically, one patient 
perceived sensation in the little finger (C8 distribution) on testing sensation at the 
thumb (C6) and medial aspect of the forearm (T1 dermatome). In addition, the same 
patient reported sensation in the thumb on stimulating at the base of the neck (C4 
dermatome) and at the lateral aspect of the upper arm (C5 dermatome). A different 
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patient reported sensation in the medial aspect of axilla (T2) on stimulating the 
medial forearm (T1). Another patient reported pins and needles in the lateral aspect 
of the elbow on testing soft touch of C5 distribution with a cotton wool away from 
the region felt.   
 
1)   2)  
 
Figure 2.1: Schematic representation of referred sensation in two patients. 1.) 
Sensation in the thumb and index finger on stimulating at the lateral aspect of the 
upper arm and sensation in T2 distribution on stimulating at the medial forearm; 2) 
Sensation in little finger when touching the thumb, sensation in little finger when 
inner aspect of forearm, sensation in the thumb on stimulating at C4 distribution and 
sensation in the thumb on stimulating at C5 distribution. 
 
2.4.3.2.3 Allodynia 
 
One control patient reported hypersensitivity in what was assumed to be the T1/T2 
border on light touch examination. Two re-implantation patients reported 
hyperesthesia in the C5 territory on soft touch and pinprick testing.  
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Table 2.4: Results of sensory examination 
 
 
 
 
 
PATIENT LIGHT TOUCH PIN PRICK 
C4 C5 C6 C7 C8 T1 C4 C5 C6 C7 C8 T1 
Control 1 N A A A A A
1
 N A A/R A A A 
Control 2 X  X X X X  X X X X X 
Control 3 N X   N X N X   N X 
Control 4 X X X X X X X X X X X X 
Control 5 N N X X X X N N X X X X 
Control 6  /A X X X X  /A X X X X 
Control 7 X X X X X X X X X X X X 
             
Re-impl 1  N N X X X X N N X X X X 
Re-impl 2 N  A X X X X  X X X X 
Re-impl 3 N  X X X X N X X X X X 
Re-impl 4 A
1
 A X X X  R
3
 A X X X  
Re-impl 5 N / A1 X X X R
2
 N / A1 X X X R
2
 
Re-impl 6 N N  X X X N  N X X X 
Re-impl 7 N N* A* X X N N A* A X X R 
Re-impl 8 N N N X X N N   X X  
Re-impl 9 N X X X X X N X X X X X 
Re-impl 10 N N^ N  X  N N^ N  X  
Re-impl 11 N N* N/ X X  N N* N X X N/ 
Re-impl 12 N N/A X X X A N/A N/A X X X A 
Re-impl 13 N N N/R
3
 A  N/R
4
 N/R
5
 R
6 
X X N X 
Re-impl 14 N N  X X X N N  X X X 
Re-impl 15 N N^ N* X X N/* N N^ N* X X N/* 
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Table 2.4: Cont.   
Abbreviations:  
N = Normal 
X = No sensation 
A = Altered sensation: does not feel as it supposed to or pins and needles; A
1
 = allodynia  
 = Reduced sensation 
- Except for a patch in the region of the regimental badge 
^ Patch lower down the arm without sensation 
* Sensation to just above the elbow, no sensation below elbow  
 No sensation halfway down the forearm except patch in anterior medial aspect of the wrist with 
reduced sensation  
R = Referred sensation 
1. Sensation in the thumb and index finger on stimulating at the lateral aspect of the upper arm 
(C5) 
2. Sensation felt in T2 distribution (medial aspect of axilla) on stimulating at the medial 
forearm (T1) 
3. Sensation in little finger (C8) when touching the thumb (C6)  
4. Sensation in little finger (C8) when inner aspect of forearm (T1)  
5. Sensation in the thumb on stimulating at C4 distribution 
6. Sensation in the thumb on stimulating at C5 distribution 
T = Tinel’s positive in re-implantation patients 5,8 (dorsal hand), 9 and 13 (thumb) 
 
 
 75 
Table 2.4: Cont.   
 
PATIENT JOINT POSITION SENSE VIBRATION 
SHOUL
DER 
ELBOW WRIS
T 
SHOULDE
R 
ELBO
W 
WRIS
T 
Control 1 X X X X X X 
Control 2 N N X N N X 
Control 3  X X  X X 
Control 4 X X X X X X 
Control 5 N N X  X X 
Control 6  X X  X X 
Control 7 X X X X X X 
       
Reimplant 1   X X  X X 
Reimplant 2 X X X X X X 
Reimplant 3   X   X 
Reimplant 4  X X  X X 
Reimplant 5 N X X N X X 
Reimplant 6 N N X X X X 
Reimplant 7 N N X N X X 
Reimplant 8 N N X N X X 
Reimplant 9 X X X X X X 
Reimplant 10 N X X N X X 
Reimplant 11 N  X N N N 
Reimplant 12 N N X  X X 
Reimplant 13 N N X A A A 
Reimplant 14 N X X N X X 
Reimplant 15 N X X N X X 
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2.4.4 Results of Neurophysiological assessment  
 
2.4.4.1 Results of nerve conduction studies in the control group 
 
None of the seven control patients showed evidence of response in the motor 
conduction studies from either the median or ulnar nerve.  
 
In one control patient there was a reduced SSR but absent SNAPs (Control 1). In 
another two patients no SNAPs or SSR were observed (Control 4 and 6). Reduced 
SNAPs along the median nerve, but not ulnar nerve, with absent SSR were observed 
on one control patient (Control 3). Reduced median and ulnar nerve SNAPs and SSR 
were observed in three control patients (Control 2,5,7).  
 
 
2.4.4.2 Results of nerve conduction studies in the re-implantation group 
 
Of the 15 subjects in the re-implantation group, CMAPs were recorded in one patient 
on stimulation of both the median and ulnar (Re-implantation 10). The median nerve 
demonstrated prolonged DML of 33.7 ms, decreased a CMAP amplitude of 3.5 mV 
and 3.1 mV when stimulated at the wrist and elbow respectively, and prolonged F-
wave latency of 33.7 ms. The ulnar nerve demonstrated normal distal motor latency 
of 2.7 ms, decreased CMAP amplitude of 6.6 mV, 3.9 mV and 3.7 mV when 
stimulated at the wrist, below the elbow and above the elbow respectively, and 
prolonged F-wave latency of 31 ms. 
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Two patients of the re-implantation group showed evidence of SNAPs when 
stimulated at the index and middle finger and recorded at the wrist (Re-implantation 
9 and 10). Five patients showed SNAPs when stimulated at the palm and recorded at 
the wrist (Re-implantation 3,9,10,11 and 12), including the two patients with 
responses from the index and middle finger (Re-implantation 9 and 10). The same 
two patients also showed ulnar nerve conduction velocities when stimulated at the 
little finger and recorded at the wrist. All SNAPs recorded were of reduced 
amplitude and increased latency. None of the re-implantation patients showed 
evidence of response to radial nerve stimulation.   
 
There was no significant difference in SSR amplitude and latency between the re-
implantation and control group (SSR amplitude: z = 0.951; p = 0.3416, SSR latency: 
z = 0; p = 0.9158). 
 
 
2.4.4.3 Results of needle EMG studies in the control group 
 
MUAPs were recorded from one patient in the deltoid, biceps and triceps (Control 1) 
and another in the biceps (Control 4). The patient with accessory nerve to the 
suprascapular nerve and 4
th
 and 5
th
 intercostal nerves to the musculocutaneous nerve 
transfers (Control 2) demonstrated MUAPs in the biceps and infraspinatous muscles.  
 
 
2.4.4.4 Results of needle EMG studies in the re-implantation group 
 
 78 
The results of the needle EMG studies for all re-implantation patients are given in 
Table 2.5. Evidence of innervation of upper limb muscles was observed in total of 
eight out of the 12 patients examined (67%). MUAPs were detectable from the 
deltoid muscle in six patients, from the biceps in seven subjects, from the triceps in 
five, infraspinatous in five and FDIO in one. In addition, distant to the needle 
MUAPs were observed in FDS in another patient. Furthermore, there was 
neurophysiological evidence of ongoing reinnervation with polyphasic nascent units 
in three patients in the deltoid muscle, five in the biceps, four in the triceps and 
infraspinatous muscle. 
 
All patients in the re-implantation group demonstrated fibrillation potentials/PSWs. 
A spearman correlation coefficient did not reveal a correlation between the extent of 
fibrillation potentials/PSWs and time since the re-implantation procedure in the 
deltoid, infraspinatous, biceps or triceps (rho = -0.11; p = 0.72, rho = -0.89; p = 0.11, 
rho = -0.17; p = 0.59, rho = -0.17; p = 0.59 respectively). In addition, there was no 
significant correlation between time since the re-implantation and grade of 
reinnervation for deltoid, infraspinatous, biceps or triceps (rho 0.15; p = 0.63, rho = -
0.08; p = 0.86, rho = 0.033; p = 0.92, rho = -0.011; p = 0.97 respectively).  
 
Early recruitment of large units was noted in deltoid muscle in three patients, in the 
biceps in four patients, triceps in three and infraspinatous in one.  
 
Of note, there was a single unit firing in the dorsal, but not the anterior, part of the 
deltoid when the patient tried to clench the fist, but not when trying to abduct the 
shoulder.  
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2.4.4.5 Comparison of needle EMG studies between groups 
 
Comparison of the grade reinnervation between the two groups revealed statistically 
significant differences in the reinnervation of the infraspinatous (z = -2.448; p = 
0.0144), biceps (z = -2.21; p = 0.0264), triceps (z =  -2.42; p = 0.0154). There was 
no significant difference deltoid muscle reinnervation (z = -1.58; p = 0.113).  
 
 
2.4.5 Outcome measures  
 
2.4.5.1 Description of pain and correlation of pain scores to motor and sensory 
recovery 
 
All 15 patients in the re-implantation group and three out of five in the control group 
reported experiencing severe pain in the affected arm. The description of pain was 
very similar in all patients; a background dull pain involving the whole arm with 
intermittent bursts of shooting pain down the forearm, wrist, hand or fingers. Four 
patients in the re-implantation group and one of the control group reported 
worsening of their arm pain with cold weather. No alleviating factors were reported. 
One patient described considerable improvement in pain soon after the re-
implantation procedure.  
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Table 2.5: Raw Needle EMG data of the re-implantation group.  
 
 
DELTOID 
Fibri
/ 
PSW 
Dur
ation 
Amplit
ude 
Polyph
asicity 
Recruitment Interference 
Reimplant 1  . . . . . . 
Reimplant 2 3   normal Reduced, large units recruiting early severe decrease_single units 
Reimplant 3 3 . . . No MUAPs  . 
Reimplant 4 2 . . . No MUAPs  . 
Reimplant 5 . . . . . . 
Reimplant 6 2  normal  nascent units, reduced moderate decrease 
Reimplant 7 2    Reduced, large units recruiting early moderate decrease 
Reimplant 8 2    nascent units, reduced severe decrease_single units 
Reimplant 9 2 . . . No MUAPs . 
Reimplant 10 3 . . . No MUAPs . 
Reimplant 11 3  normal  nascent units, reduced moderate decrease 
Reimplant 12 3 . . . No MUAPs moderate decrease 
Reimplant 13 2   normal Reduced, large units recruiting early severe decrease_single units 
Reimplant 14 2 . . . No MUAPs  
Reimplant 15 0 . . . No MUAPs  
 
BICEPS 
Fibri
/ 
PSW 
Dur
ation 
Amplit
ude 
Polyph
asicity 
Recruitment Interference 
Reimplant 1  . . . . . . 
Reimplant 2 3    Reduced, large units recruiting early severe decrease_single units 
Reimplant 3 3 . . . No MUAPs . 
Reimplant 4 . . . . . . 
Reimplant 5 . . . . . . 
Reimplant 6 2    Reduced, large units recruiting early severe decrease_single units 
Reimplant 7 3  normal   
nascent units, reduced, large units 
recruiting early 
severe decrease_single units 
Reimplant 8 2    nascent units, reduced severe decrease_single units 
Reimplant 9 2 . . . distant single units . 
Reimplant 10 3    nascent units, reduced severe decrease_single units 
Reimplant 11 2 . . . No MUAPs . 
Reimplant 12 3 . . . No MUAPs . 
Reimplant 13 3 . . . No MUAPs . 
Reimplant 14 2    
nascent units, reduced, large units 
recruiting early 
severe decrease_single units 
Reimplant 15 
3 
norm
al  
  nascent units, reduced severe decrease_single units 
 
TRICEPS 
Fibri
/ 
PSW 
Dur
ation 
Amplit
ude 
Polyph
asicity 
Recruitment Interference 
Reimplant 1  . . . . . . 
Reimplant 2 3    Reduced, large units recruiting early severe decrease_single units 
Reimplant 3 3 . . . No MUAPs . 
Reimplant 4 . . . . . . 
Reimplant 5 . . . . . . 
Reimplant 6 2    Reduced, large units recruiting early severe decrease_single units 
Reimplant 7 3    
nascent units, reduced, large units 
recruiting early 
severe decrease_single units 
Reimplant 8 2 . . . No MUAPs . 
Reimplant 9 2 . . . No MUAPs . 
Reimplant 10 3    nascent units, reduced  . 
Reimplant 11 2 . . . nascent units, distant units . 
Reimplant 12 3    nascent units, reduced  severe decrease_single units 
Reimplant 13 3 . . . No MUAPs . 
Reimplant 14 2 . . . No MUAPs . 
Reimplant 15 3 . . . No MUAPs . 
INFRASPINA
TOUS 
Fibri
/ 
PSW 
Dur
ation 
Amplit
ude 
Polyph
asicity 
Recruitment Interference 
Reimplant 1  . . . . . . 
Reimplant 2 . . . . . . 
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Reimplant 3 . . . . . . 
Reimplant 4 . . . . . . 
Reimplant 5 . . . . . . 
Reimplant 6 . . . . . . 
Reimplant 7 . . . . . . 
Reimplant 8 . . . . . . 
Reimplant 9 . . . . . . 
Reimplant 10 3    nascent units, reduced severe decrease_single units 
Reimplant 11 2   normal 
nascent units, reduced, large units 
recruiting early 
  
Reimplant 12 . . . . . . 
Reimplant 13 . . . . . . 
Reimplant 14 
2 
norm
al 
normal  nascent units, reduced severe decrease_single units 
Reimplant 15 3 
norm
al 
normal  nascent units, reduced severe decrease_single units 
 
 
Of the 15 re-implantation patients, five patients reported pain in the hand in general, 
one in the palm, two in the dorsal aspect of the hand, four in the thumb or index 
finger (C6 dermatomal distribution), one in the 5
th
 finger, 1 in the forearm, two in the 
whole arm in general and one reported very mild pain to no pain. Interestingly, of the 
four who reported pain in the thumb or index finger, three had normal or reduced 
sensation in the C6 distribution.  
 
The average VAS score reported by patients in the control group was 6.9 (sd; 2.01, 
range; 5-8.5), whereas in the re-implantation group the average VAS score was 5.4 
(sd; 2.03, range; 2-8) (Figure 2.2). A two-sample Mann-Whitney test did not reveal a 
statistically significant difference in VAS scores between the two groups (z = 1.07, p 
= 0.29). 
 
Similarly, a Spearman correlation coefficient did not demonstrate a statistical 
significant correlation between VAS score and global MRC score (rho = 0.42; p 
=0.11) (Figure 2.3) or a correlation between VAS score and number of dorsal roots 
with sensory recovery (out of 5; C5 through to T1) (z = -0.12; p = 0.67) (Figure 2.4). 
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Figure 2.2: VAS scores for the control and re-implantation group. The line across 
the box represents the sample median (Control group: median; 7, Reimplantation 
group: median; 6). Whiskers represent the sample maximum and minimum (Control 
group: max; 5, min; 10, Reimplantation group: max; 2,min; 10). 
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Figure 2.3: The relationship of VAS score and MRC scale in re-implantation 
patients. There was no statistically significant association between VAS and MRC 
scale (z = 0.42; p=0.11). 
 
 
Figure 2.4: The relationship of VAS score and number of sensitive roots in re-
implantation patients. There was no statistically significant association (z = -0.12; p 
=0.67). 
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2.4.5.2 Results of the DASH outcome measure including work and social 
demographics.  
 
The mean DASH score for the control group was 31.8 (sd = 11.94; range = 11.7 – 
46.7) and the re-implantation group 47.17 (sd = 22.98; range 12 - 89). There was no 
statistical significant difference in the DASH score between the two groups (z = -
1.693, p = 0.09) as shown by a two-sample Mann-Whitney test. 
 
At the time of the interview, 9 out of 15 patients (60%) within the re-implantation 
group and 3 out of 7 patients (42.86%) of the control group were working. Of the 7 
control patients only 4 completed the DASH work questionnaire, which showed a 
mean of 31.8 (sd; 11.94, range; 11.7-46.7). In the re-implantation group, 9 out of the 
total 15 patients completed the DASH work questionnaire, which gave a means of 
47.17 (sd; 22.98, range; 12.5-89.2). There was no statistical significant difference in 
the DASH work score between groups (z = -0.23, p = 0.82).  
 
Regarding sporting activities, only one control patient played sports (14.29%), who 
scored 25 in the DASH sport score, whereas 6 (40%) out of 15 engaged in sporting 
activities in the re-implantation group. 8 (53%) out of the 15 re-implantation patients 
and one (14.29%) of the control group completed the DASH sport questionnaire. 
The group mean for the re-implantation was 53.12 (sd; 38.23, range; 12.5 - 100), 
whereas the one control patient scored 25 in the DASH sport questionnaire. There 
was no statistical difference in the DASH sport score between groups (z = -0.399, p 
= 0.69).  
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2.4.5.3 Results of the MHQ outcome measure  
 
The mean MHQ total score in the control group was 23.89 (sd = 9.21; range 11.33 – 
29.28) in the control group and 25.676  (sd = 15.17; range = 1.43 - 54.29) in the re-
implantation group. A two-sample Mann-Whitney test did not reveal a statistically 
significant difference in MHQ total scores between the two groups (z = 0.04, p = 
0.97) (Table 2.6). 
 
 
 
 Table 2.6:  Results of MHQ 
 
 
 
 
 
 
2.4.5.4 Results of the SF36 outcome measure 
 
The mean scores for the SF36 physical health summary in the control group was 
42.57 (sd = 3.1; range = 36 - 46) and for the SF36 mental health summary 42.85 (sd 
 
 
Mean SD Min Max 
Control  Reimplant Control  Reimplant 
 
Control  Reimplant Control  Reimplant 
Overall score for 
function of 
affected hand 
0.71 1.78 1.88 6.68 0 0 5 25 
Overall ability to 
work 
42.86 44.64 36.15 35.92 0 0 95 100 
Overall score for 
function relative 
to pain 
54.14 68.75 30.26 21.00 11 0 85 100 
Overall score for 
ADL  
20.72 20.59 17.68 15.76 0 25 44.64 100 
MHQ total score 23.89 25.68 9.21 15.17 11.33 0 39.28 48.21 
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= 10.53; range = 24 - 55). The re-implantation group scored 39.06 (sd = 9.69; range 
= 23 - 53) in the SF36 physical healthy summary and 42.27 (sd = 14,82; range = 16 - 
64) in the SF36 mental health summary. There was no statistical difference between 
groups in the SF36 physical health summary or the SF36 mental health summary (z 
= 0.83, p = 0.38 and z = 0.035, p = 0.97 respectively). 
 
 
 
 
 
2.5 Discussion  
 
In the current study we assessed 15 patients who have had complete BP and re-
implantation surgery and compared their functional and electrophysiological 
evidence of reinnervation a mean of 13 years after injury with patients who have had 
BP avulsion injury without re-implantation surgery.  This is the first study to 
investigate the effects of re-implantation surgery in the chronic phase of recovery 
and compared with a control group of patients. In addition, to our knowledge, EMG 
data have not been correlated thus far with clinical function after reconstruction by 
re-implantation surgery.  
 
2.5.1 Recovery of motor function  
 
Patients who have had re-implantation surgery showed a significant difference in 
clinically examined power in the deltoid, pectoralis and infraspinatous muscles and 
“global MRC score”. Significantly improved reinnervation by EMG criteria, when 
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compared to controls, was found in infraspinatous, biceps and triceps muscles. There 
was no significant difference deltoid muscle or muscles of the hand. Nevertheless, 
MUAPs from distal hand muscles were recorded only from patients of the re-
implantation group, one in FDS and one in FDIO. There was neurophysiological 
evidence of ongoing reinnervation with polyphasic, small amplitude MUAPs 
(nascent units) in 3 patients in the deltoid muscle, 5 in the biceps, 4 in the triceps, 
and 4 in the infraspinatous muscle.  
 
The fundamental question regarding the observed functional recovery in these 
patients is whether reinnervation of muscles of the upper arm has occurred via the 
re-implanted roots. Perhaps the first step towards answering this question is by 
determining whether functioning muscles were denervated due to avulsion of ventral 
roots supplying it. Previous studies of BP re-implantation have included on their 
cohorts patients with two or more avulsed roots. However, it is well known that 
differing opinions exist regarding the nerve supply to muscles and, therefore, one 
cannot exclude reinnervation from collateral sprouting of caudal or cranial uninjured 
nerves. To avoid this phenomenon we studied patients with complete BP avulsion 
involving avulsion injury to all roots supplying the BP. In theory, any reinnervation 
of muscles of the upper limb would have to be supplied via one or more re-implanted 
roots.  
 
Furthermore, it should be determined whether the injury to the root was a true central 
avulsion as the pathophysiological processes that take place following root rupture 
differ from avulsion injury. In this thesis, we only included patients whose injury 
was confirmed with open exploration of the BP, the current gold standard. 
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Nevertheless, our study revealed patients in the control group demonstrating absent 
SNAPs suggesting an infraganglionic injury to the BP. This may be a result of 
incorrect characterization/documentation of the lesion at the time of exploration. It is 
important to note that in patients who do not undergo re-implantation, their dura is 
not opened during the exploratory procedure and, therefore, root remnants attached 
to the spinal cord may not have been clearly visualised. Also, it is common to see 
extensive scarring, and the ruptured nerve endings or damaged DRGs are difficult to 
identify, leading to inaccuracies in documentation. Interestingly, two of those 
patients showed voluntary MUAPs in the deltoid and biceps respectively. 
Alternatively, it suggests a combination of infraganglionic and supraganglionic 
injury, which is possible given the degree of mechanical force exerted to the plexus.  
It is important to note here that in neurophysiological terms an avulsion injury is 
referred as a preganglionic injury and is paradoxically based on the presence or 
absence/disconnection of the DRG and, thus, neurophysiological examination better 
describes dorsal root lesions. The presence of a certain injury to the dorsal root does 
no imply a similar lesion to the ventral root. In fact, the combination of intact dorsal 
and avulsed ventral roots is the second most common type of avulsion injury after 
complete avulsion, preceding intact ventral root with avulsion of the dorsal root, 
which is rare (Carlstedt 2008). As a consequence, neurophysiological studies cannot 
differentiate ventral root avulsion from rupture post-operatively.  
 
In the pre-operative setting, EMG studies can be used to define the location of a root 
lesion in relation to the intervertebral foramen. The posterior primary rami of the 
ventral roots that innervate the erector spinae muscles arise within the exit foramina 
so that in root lesions in which there is no evidence of denervation in these muscles 
 89 
the lesion must be distal to the foramen (Swash 1986).  In root lesions in which the 
erector spinae muscles show evidence of reinnervation, the injury can be localized 
proximal to or within the neural foramen. Nonetheless, it does not localize the injury 
in respect to the transitional zone. Pre-operative neurophysiological examination was 
not common practice at the time of these re-implantation cases studied here and thus, 
such data are not available. The important point however, is that even with 
preoperative evidence of infraganglionic injury, neurophysiological examination 
cannot exclude a concomitant avulsion injury.  
 
Infraganglionic injury was suggested based on their neurophysiological studies in 
four patients with re-implantation in this study. During the re-implantation procedure 
the dorsal root is trimmed to the most distal closest normal appearing segment, most 
often including the DRG. As a result, we were not expecting to find any SNAPs or 
SSR in these patients. The likeliest possibility is that the DRG was not removed 
completely but injured during the trimming process. Alternatively, it may imply a 
combination of lesions in the absence of removal of the DRG.  
 
Furthermore, in the re-implantation group, the extent of denervation and degree of 
reinnervation was not shown to correlate with time since the re-implantation 
procedure, as demonstrated by a lack of correlation using Spearman’s rank 
correlation coefficient. It is well known that neurological recovery is also dependent 
on healthy viable muscle and the release of nerve growth factors from denervated 
muscle which act as catalysts to axonal regeneration. Chronically denervated muscle 
will eventually become ﬁbrotic and electrically inactive within 18 and 24 months 
(Forman et al. 1978). The finding of MUAPs demonstrating early recruitment of 
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large units in deltoid muscle in three patients, in the biceps in four patients, triceps in 
three and infraspinatous recorded from patients with re-implantation surgery 
supports the suggestion that muscle fibre damage is a contributory factor to the lack 
of recovery in the presence of some reinnervation. This is also supported by the fact 
that most patients in this study, but also in the previous publications in humans and 
animals (Carlstedt et al. 2000; Eggers et al. 2010), demonstrate an improved 
recovery in the proximal muscles of the arm and poor recovery distally.  
 
Given the prompt reduction of motor neurons and dorsal horn cells after avulsion 
injury and the assumption that best results are seen when prompt re-implantation 
occurs, we hypothesised that excluding patients who were re-implanted more than a 
month after the injury would perhaps show some relationship. However, excluding 
patients who were operated more than 30 days after the injury did not improve the 
statistical correlations.  
 
Finally, observation of the data revealed that occasionally the clinical examination 
and neurophysiological tests did not correlate i.e. showing evidence of innervation 
for specific muscles in both types of examination. A number of reasons may account 
for these differences. Firstly, accurate clinical examination of these patients proved 
difficult in that when patients were asked to perform a movement they had the 
tendency to contract the whole arm (whether or not there are functional muscles) 
rather than purposefully contract the respective muscle that performs the movement 
asked. In addition, more than one muscle can perform a movement and it was 
difficult to distinguish which muscle actually works to perform that movement. 
Secondly, differences may be due to incorrect positioning of the EMG needle during 
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testing. Accurate positioning of the needle did indeed seem challenging as muscles 
are markedly atrophied and do not hold their usual positions. Thirdly, other factors 
can lead to similar results, including adaptive biomechanical changes, functional 
compensation and muscle substitution patterns (Feinberg 2006). For example, three 
patients from the re-implantation group had some power in shoulder abduction in 
clinical examination, which was no supported by evidence of presence of MUAPs in 
needle electromyography. Typically, to abduct their shoulder, patients shrug their 
shoulder using their trapezius muscle to either assist or achieve the intended 
movement. Alternatively, concomitant use of muscles not tested could produce the 
movement.  
 
 
2.5.2 Recovery of sensory function  
 
Sensory testing in affected dermatomes showed generally poorer recovery in the 
control group. In the re-implantation group there was better recovery at the C5, C6 
and T1 dermatomes. The best recovery was found at the C5 dermatome with a 
statistically significant higher frequency in return of sensation in the re-implantation 
group compared to controls for both soft touch and pinprick sensation.  
 
The return of sensory function in avulsed dermatomes is difficult to explain as only 
the ventral roots have been reconnected to the spinal cord. In addition, during the re-
implantation procedure the DRGs are actively sought for and excised. It has been 
proposed that sensory recovery could be attributed to collateral sprouting of fibres 
from an overlapping dermatome rather than regeneration through repair (Carlstedt 
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2008). This could explain recovery at the C5 and T1 dermatome from C4 and T2 
collateral sprouting respectively. Alternatively, new processes could extend from 
dorsal horn neurons along the implanted ventral root.  The mechanism by which 
sensory recovery occurs is yet to be demonstrated.  
 
Two re-implantation patients perceived referred sensations. Referred sensations have 
been described in a number of conditions including amputation, somatosensory 
deafferentation, and in BP injury (Berman et al. 1998; Htut et al. 2006). The 
pathophysiology of such sensations is also poorly understood, however, one 
proposed mechanism is through sprouting of primary afferent nerve fibres within the 
grey matter of the dorsal horn of the spinal cord. McMahon and Kett-White 
(McMahon et al. 1991) have shown that primary afferent nerve fibres show greatly 
enhanced sprouting when; 1)  vacant synaptic sites are created by the degeneration of 
other primary afferent fibres; and 2)  the peripheral branches of the axons are 
actively regenerating. In our two patients with referred sensations, sensation was 
perceived in dermatomes immediately adjacent to the dermatome examined, making 
it possible that recovery occurs by collateral sprouting. In support of collateral 
sprouting is also the fact that in two patients with positive Tinel’s sign referred at the 
posterior aspect of the hand and thumb respectively, there was also present sensation 
when the dermatome to which the pain referred to was tested. However, in the 
absence of DRGs and SNAPs in the distribution of the median, radial or ulnar nerve 
as demonstrated in the relevant patients the mechanism of return of sensation 
remains a mystery.   
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2.5.3 Pain 
 
Neuropathic pain associated with BP avulsion injury has been well described 
(Berman et al. 1998; Htut et al. 2007) and can be very severe, persistent and resistant 
to treatment.  
 
Initial clinical observations have suggested that pain in the affected arm is related to 
the number of avulsed roots (Berman et al. 1998). It is, therefore, unsurprising that 
our patients in whom all five dorsal roots of the BP are avulsed, are experiencing 
severe pain in the whole arm. Initial clinical observations also suggested that 
successful surgical repair was associated with relief of avulsion pain and that 
improvement in pain severity was correlated with the return of muscle activity 
(Berman et al. 1998; Carlstedt et al. 2000; Htut et al. 2006). In this study, a statistical 
significant correlation between pain and motor recovery or a temporal relationship 
from the time of surgery was not demonstrated. In addition, there was no statistically 
significant difference in the pain severity between the re-implantation and control 
group. There are some fundamental differences between this study and previous 
investigations of pain phenomena in BP injury. Firstly, subjects studied in the 
previous reports included patients with any type of BP injury including ruptures and 
avulsions of only two or more spinal roots involved which, consequently, resulted in 
a greater number of patients. In this study, to avoid variability we studied a more 
homogeneous group of patients, including patients with complete BP injury alone. It 
is, therefore, logical to assume that differences in assumptions made could be due to 
either the inclusion of more modest injuries, where there is more room for synaptic 
plasticity or to a failure to demonstrate such correlations in our small group of 
patients.  
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2.5.4 Outcome measures 
 
The use of patient-reported outcomes as primary measures in clinical trials has 
become increasingly popular over recent decades. The use of condition-specific 
instruments has great potential for evaluating domains of physical functioning and 
health-related quality of life commonly affected by a specific pathology. Since there 
are no such measures specific to brachial plexus injuries, a literature review of all 
outcome measures focusing on conditions of the upper limb was performed and the 
DASH and MHQ were thought to be most adequate in assessing function recovery 
following brachial plexus avulsion injury. These scores have been shown to 
demonstrate reliability and reproducibility in other conditions affecting the upper 
limb (Chung et al. 1998; Beaton et al. 2001). Construct validity refers to the extent to 
which scores on a questionnaire relate to other measures in a manner that is 
consistent with theoretically derived hypotheses concerning the constructs that are 
measured (Kirshner et al. 1985) - by examining its correlation to other generic 
instruments such as SF36 (SooHoo et al. 2002). However, no differences in the mean 
scores of the upper limb outcome measures used between patient groups were 
demonstrated. One reason for this is that although both DASH and MHQ focus on 
the upper limb, they do not have content that exclusively relevant to the population 
studied and do not concentrate on specific disease-associated impairments. In 
addition, it is noted that most patients in both groups scored the worst possible score 
in both instruments indicating that the scale used is not sensitive enough to measure 
improvement in a substantial proportion of patients and that some actual variation in 
the data is not reflected in the scores obtained from that instrument. This reduced 
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limited variability in the gathered data may have reduced the power of statistics on 
correlations between variables.  
  
2.6 Limitations  
 
The present study is subject to a number of limitations. An important limitation in 
the current study is the small number of patients assessed both in the control and re-
implantation group. However, given the uncommon type of injury including more 
patients was not feasible, particularly in the control group who sustained their injury 
more than 10 years ago, making it difficult to trace.  
 
Another limitation of the present study is the identification of patients retrospectively 
making it necessary to rely on documentation of others for the confirmation of 
diagnosis of complete avulsion injury, which may not always be accurate. Ideally, 
patients studied should have their diagnosis confirmed with both open exploration 
and neurophysiological evidence of complete BP avulsion, including paraspinal 
muscle EMG to best localize the lesion. Great effort was made to ensure that only 
patients with explicitly complete avulsion injury were included in this study by 
correlating clinical notes, neurophysiological tests at the time of the injury where 
available and findings of the exploratory procedure. 
 
Moreover, there are a number sources of bias. First, it has been suggested that these 
patients sustain significant concurrent brain injury as demonstrated by 
neuropsychological assessment even in the absence of brain parenchymal 
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abnormalities on imaging. Secondly, the rehabilitation received by each patient 
varies significantly. All patients receive an intensive 2-week rehabilitation program 
in the immediate post-operative period with highly specialized rehabilitation 
specialists, physiotherapists and neuropsychologists at the National Hospital for 
Neurology and Neurosurgery. The program aims to increase and maintain range of 
movement, mobilize tight scar tissue, maintain good joint position, adjust analgesia, 
improve posture and encourage return to activities. Subsequently, patients are 
referred to their local services, which vary significantly depending on the knowledge 
and skills of the responsible physiotherapists. These factors are thought to 
significantly affect clinical recovery and clinical outcome. In addition, differences in 
age, sex and length of time from injury to assessment for this study are further 
factors that may have influenced results. Similarly, the clinical assessment was 
performed by the author who was not blinded to the status of patients, introducing 
observer bias. 
 
Furthermore, the examination of the sensory system proved to be more difficult than 
anticipated and results were too complicated to be able to make accurate 
assumptions. It would be useful to use a more quantitative method of sensory system 
examination with thermal, noxious and mechanical thresholds, as opposed to 
examining clinically. This would, perhaps, reveal small differences between groups 
not evident with clinical examination. 
 
2.7 Future directions 
 
The present study has been important in providing a more robust assessment of 
functional improvement in patients with BP re-implantation surgery after complete 
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avulsion injury. Nonetheless, unanswered questions and room for improvement in 
study design still remain. There are no studies in the literature that compare 
functional recovery of these patients with a control group or with patients who had 
had alternative surgical procedures for repair such as nerve transfers. Given the 
results presented within the present thesis, it would be fruitful to perform a 
prospective study comparing the three aforementioned groups of patients, those 
without re-implantation, those with re-implantation and those with nerve transfers 
using clinical, neurophysiological tests and outcome measures at varying time points 
during their recovery. This would also eliminate confounding factors and also assist 
in better determining the mechanism of regeneration. Moreover, the use of imaging 
methods, as suggested in Chapter 5 and 6 of this thesis, could further provide a more 
robust outcome measure and add to our knowledge of the mechanisms of repair.  
 
 
2.8 Conclusion 
 
In closing, the present study set out to investigate the effects of BP re-implantation 
after complete BP avulsion injury. Patients that have undergone BP re-implantation 
surgery after complete BP avulsion injury were discovered to have better 
neurological recovery in the proximal arm muscles. Nonetheless, they were not 
found to have significant difference when compared to control subjects in the 
outcome measures assessing the function of their arm and activities of daily leaving. 
Neurophysiological findings are vast and complicated demanding a structured 
assessment protocol to be used in the future in order to further understand 
mechanisms of recovery. The subtle differences in clinical and neurophysiological 
tests revealed in this study point out to the need for additional work to determine 
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whether additional strategies such as the use of growth factors or cellular therapies 
may produce further improvement. 
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Chapter 3 
 
Olfactory ensheathing cells: properties, effects on axonal regeneration 
and clinical strategies 
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3.1 Introduction  
 
The failure in achieving greater functional connectivity with peripheral nerve grafts 
alone, partly centers on the cellular nature of the graft-host interface and the 
inhibitory molecular properties of the CNS. The interaction of Schwann cells and 
astrocytes is not favourable. In co-culture Schwann cells and astrocytes occupy 
distinct and non-overlapping areas and there is evidence suggesting that Schwann 
cells may even promote gliosis and the deposition of nonpermissive extracellular 
molecules, such as chondoitin sulphate proteoglycans (Lakatos et al. 2000). 
 
The olfactory mucosa has attracted the interest of neuroscientists due to the 
observation that olfactory neurons present in the olfactory epithelium are able to 
exhibit continual turnover and project axons into the central nervous system (CNS) 
throughout adulthood and after injury to the primary olfactory system. Olfactory 
neurogenesis takes place in the basal cell layer of the olfactory epithelium (Graziadei 
et al. 1979). Newly generated unmyelinated olfactory neurons extend a single 
dendrite that arises from the apical pole and projects into the luminal surface of the 
epithelium, and a basal axon that joins other axons in the lamina propria to form 
bundles (fila olfactoria). These grow through the underlying basal cell layer, cross 
the cribriform plate of the ethmoid bone, traverse the pia mater, enter the CNS and 
navigate within the olfactory nerve and glomerular layers of the olfactory bulb (OB). 
There, they establish new functional connections with mitral, tufted and 
periglomerular neurons in the glomeruli of the OB (Graziadei et al. 1979; Doucette 
1990).  Similar processes have also been observed after injury or transection of the 
fila olfactoria in experimental models (Graziadei et al. 1980). The permissiveness of 
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the OB to axonal regeneration was unexpected compared to other mature CNS 
lesions where axonal regeneration is abortive primarily due to the presence of an 
unfavourable glial environment and the formation of a glial scar after injury (Silver 
et al. 2004). The permissiveness the OB to axonal elongation has been attributed to 
the presence of a different glial cell type supporting olfactory axons; the olfactory 
ensheathing cell (OEC). 
 
 
3.2 Olfactory ensheathing cells 
 
OECs have been characterized from neonatal and adult rodent olfactory tissues. 
Different populations of OECs have been described in terms of morphologic and 
antigenic characteristics. It has been suggested however, that OECs belong to a 
single, malleable cell type that expresses a variety of phenotypic characteristics with 
both similarities, as well as, differences to astrocytes and Schwann cells. 
 
OECs originate from the olfactory placodes, which are two ectodermal thickenings 
in the rostrolateral region of the embryonic head (Cuschieri et al. 1975; Valverde et 
al. 1991) unlike Schwann cells, which are derived from the neural crest. They 
ensheath olfactory axons through their pathway from the olfactory epithelium 
guiding olfactory axons to the OB and preventing from coming into contact with 
other glial cells types (Doucette 1984; Doucette 1993). Within the OB, in which 
OEC processes do not invade, olfactory axons are devoid of glial covering (Raisman 
1985). Unlike Schwann cells, OECs enfold densely packed bundles of unmyelinated 
axons. Their internal surface of their fine glial processes faces directly the nerve 
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bundles dividing them into interconnected fascicles. Their outer surface is apposed 
to a basal lamina in those regions where they contribute to form the external glia 
limiting membrane (i.e. the junction between the olfactory nerve axons and the 
protoglomeruli in the olfactory bulb) (Ramon-Cueto et al. 1998). Consequently, in 
contrast to other PNS-CNS transitional zones, the plasma membranes of ensheathing 
cells and astrocytes are not separated by a basal membrane (Doucette 1984; Doucette 
1991).  
 
Morphologically, OECs have characteristic morphological appearances both in 
development and in the adult. During development ensheathing progenitor cells can 
be distinguished by their scanty cytoplasm containing a lobulated electron dense 
nucleus with patchy chromatin and one or two nucleoli. Mature rodent OECs are 
distinct owing to their indented nuclei with uniformly distributed, but slightly 
clumped chromatin, and an electron dense cytoplasm with scattered filaments. SC 
have electron dense nucleus with chromatin clumped throughout and more electron 
dense cytoplasm compared to OECs. Astrocytes have ovoid nuclei with an electron-
lucent cytoplasm. OECs can form end-feet junctions with blood vessels in a manner 
comparable to astrocytes.  
 
 
3.3 Immunocytochemical properties of OECs 
 
Extensive work has been done to fully characterize OECs. The immunocytochemical 
profile of OECs remains to be determined. Specific antibodies or battery of 
antibodies that uniquely identify this group of cells has not been defined yet.  
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As shown in both in vivo and in vitro studies, OECs express proteins associated with 
both Schwann cells and astrocytes. Differentiating them from astrocytes, OECs are 
immunoreactive for the low-affinity nerve growth factor receptor p75
 
(p75
NTR
) 
(Gong et al. 1994), laminin, the cell adhesion molecule L1, and the neurofilament 
vimentin (Miragall et al. 1988; Ramon-Cueto et al. 1998; Kawaja et al. 2009). They 
both express GFAP (Barber et al. 1982).  Positive immunostaning has also been 
shown for the calcium binding protein S100 (Takahashi et al. 1984) and the cell 
adhesion molecule NCAM (Miragall et al. 1988). Schwann cells are also 
immunoreactive to S100, but they can be differentiated from OECs due to their 
expression of the myelin protein P0. OECs lack immunoreactivity against A2B5, 
Ran2, and MAP 2, all of which mark astrocytes and do not share expression of O-24, 
HNK-1, GD-3, A2B5, which characterize oligodendrocytes. An extensive 
description of the immunocytochemical profile of OECs can be found in the review 
article of Kawaja et al., (Kawaja et al. 2009). 
 
 
3.4 Olfactory ensheathing cells as candidates for promoting CNS repair in the 
olfactory system  
 
3.4.1 Experimental models of OEC-mediated repair 
 
 
The first experiment to demonstrate the effects of OECs on regenerating axons was 
performed by Ramon-Cueto and Nieto-Sampedro (Ramon-Cueto et al. 1994) who 
demonstrated that transplants of adult olfactory bulb OECs mediate the re-entry of 
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regenerating dorsal root axons into the dorsal spinal gray matter following T10 
dorsal rhizotomy and anastomosis. The dorsal root entry zone (DREZ) marks an 
abrupt transition from SC cells to astrocyte and oligodendrocyte ensheathment and 
has been the prototype lesion paradigm for determining the regeneration promoting 
properties of OECs. After injury to a dorsal root, primary afferent fibers within the 
root are able to grow back to their normal region in the spinal cord but arrest there 
and are unable to enter the CNS environment of the spinal cord (Ramon Y Cajal 
1928). In Ramon-Cueto’s and Nieto-Sampedro’s experiment, regenerating sensory 
axons were noted to traverse the glial scar and innervate the correct laminae of the 
spinal cord. The transplanted OECs appeared to accompany the regenerating DRG 
axons into the dorsal horn, beyond the area of the lesion. This work was extended by 
Nieto-Sampedro and colleagues, who reported that the regenerating fibres were also 
able to re-establish functional connections with spinal cord neurons (Navarro et al. 
1999; Pascual et al. 2002).  
 
Thereafter, regeneration-promoting capacity of OECs has been studied in various in 
vitro and acute and chronic lesion paradigms.  In lesions of the corticospinal tract, 
transplanted OECs have been shown to migrate and align themselves with the host 
astrocytes. In addition, they induce axonal branching, which wander and elongate 
through the lesion and into the denervated caudal host tract with evidence of 
associated functional restoration demonstrated using directed forepaw retrieval tasks 
in rats. (Li et al. 1997; Keyvan-Fouladi et al. 2003). OECs were also shown to be 
highly angiogenic and to induce the formation of a dense plexus of microvessels (Li 
et al. 1998).  
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Furthermore, Pascual et al., (Pascual et al. 2002) performed bilateral section of 
identified dorsal roots receiving bladder innervation to demonstrate dorsal root 
afferent regeneration, as well as, bladder activity restoration after unilateral injection 
of OECs in the sacral parasympathetic nucleus of adult rats. L6 to S2 dorsal roots 
were sectioned bilaterally close to the dorsal root entry zone and reattached to the 
cord with fibrin glue. The interruption of bladder sensory innervation led to an 
atomic, unresponsive and distended bladder. Approximately 30,000 purified OECs 
were injected in each of the three sectioned roots. Anatomic regeneration of bladder 
primary afferents was demonstrated by the presence of labeled wheat germ 
agglutinin-horseradish peroxidase fibers in the dorsal horn and sacral 
parasympathetic nucleus. In the olfactory ensheathing group the proximal stump of 
the dorsal root contained labeled fibers that entered the spinal superficial laminae but 
transganglionic transport of the tracer was not identified in any of the control 
animals. Cystometrography demonstrated recovery of bladder activity in the 
transplanted group six weeks after surgery. 
 
Moreover, OEC transplantation has been shown to stimulate the return of 
supraspinal control of breathing and major improvements in climbing after unilateral 
knife cuts to sever the entire spinal gray and white matter at the level of the second 
cervical segment in adult rats abolishing ipsilateral phrenic nerve and diaphragm 
function (Li et al. 2003). In addition, severed adult retinal ganglion cells where also 
used to show the growth promoting effect of OECs (Li et al. 2003). Anterograde 
labeling with cholera toxin B showed that at 2 weeks postoperatively axons 
penetrated the transplants, entered the distal stump and elongated for 10 mm together 
with the transplanted cells.  
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The intimate relationship with astrocytes has been explored in both in vivo and in 
vitro experiments demonstrating that when co-cultured with astrocytes, OECs 
intermingle with astrocytes, do not induce astrocytic hypertrophy and elicit less 
chondroitin sulphate proteoglycan and GFAP expression after transplantation 
(Lakatos et al. 2000; Lakatos et al. 2003; Andrews et al. 2007). In addition, Li et al., 
(Li et al. 2004)  examined the cooperation between the transplanted OECs and the 
host astrocytes following a single lumbar dorsal rootlet transection and re-
implantation with OECs smeared at the cut surface of the root. A characteristic 
ladder-like arrangement of parallel bridging structures aligned in the orientation of 
dorsal roots was identified. Immunostaining showed that these structures were made 
up of intimately intermingled fine fascicles of astrocytic processes recruited from the 
spinal cord and peripheral tissue processes recruited from the peripheral nerve. 
Axons projected through the dorsal OEC formed fascicles into the dorsal horns and 
formed long straight unbranched fibres that traveled for at least 10mm caudally as 
well as rostrally. 
 
In addition, although OECs do not myelinate olfactory axons in their natural 
environment, their ability to assemble peripheral like myelin has been well 
demonstrated. OECs co-cultured with neurons enfold, myelinate and provide a 
favourable substrate for dorsal root ganglion neurite outgrowth (Ramon-Cueto 
2000). In vivo, they have been shown to remyelinate axons after transplantation into 
an ethidium bormide/x-irradiated demyelinated area of the adult rat spinal cord 
(Franklin et al. 1996). OEC remyelination of axons in the posterior columns has also 
been shown to enhance axonal conduction across the previously demyelinated area, 
thus demonstrating a functionally significant degree of remyelination (Imaizumi et 
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al. 1998). Li et al., (Li et al. 1998) provided evidence that OECs also remyelinate 
corticospinal axons that have regenerated into and through the site of an OEC graft 
subsequent to an electrolytic lesion in one-cell-to-one axon myelinating fashion.  
 
 
 
 
 
Figure 3.1: Putative neuroregeneration-promoting effects of OECs after 
transplantation into a spinal cord injury (from Kachramanoglou et al., 
(Kachramanoglou et al. 2011). Permission to reproduce this image has been granted 
by Informa Healthcare). 
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Despite the advances in our understanding of the functional properties of OECs, 
there is still little known about the molecular mechanisms through which OECs 
mediate axonal repair. Cultured OECs have been shown to secrete neurotrophins to 
have implications in axonal regrowth. These include BDNF, GDNF, NGF and glial 
growth factor 2 (GGF2), neurotrophin 4/5 and neuregulin (Chuah et al. 2000; Boruch 
et al. 2001; Woodhall et al. 2001; Pastrana et al. 2007). OECs axonal-promoting 
properties have also been attributed to their expression of membrane surface 
associated molecules. Such growth-associated molecules include laminin, N-CAM 
and L1 (Chuah et al. 1991; Whitesides et al. 1996). Another hypothesis states that 
OECs assist by mechanical means by restoring pathway via which growing axons 
can cross the area of injury (Keyvan-Fouladi et al. 2002; Li et al. 2005). OECs have 
been observed to form tunnel-like structures with their processes within the 
transection lesion site through which groups of previously transected axons are grow 
suggesting that OECs provide a permissive environment through which transected 
spinal cord axons could regenerate across the lesion site (Li et al. 1997). A table with 
all OEC transplantation studies in the spinal cord is provided in the Appendix 5. 
 
In summary, the principal beneficial effects of OECs by which they contribute to 
regeneration and increased functional recovery include: (a) stimulation of axonal 
growth, (b) reduction in astoglial response and decrease scar tissue, (c) promotion of 
angiogenesis, (d) restoration of myelin, (e) free migration within the CNS 
parenchyma and coexistence with astrocytes (Figure 3.1). Consequently, OECs are 
currently considered one of the most promising candidates for cell-mediated repair 
of nervous system injury. Considerable attention has now shifted towards obtaining 
human OECs and testing them in experimental and clinical studies.  
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3.4.2 Clinical studies of OEC transplantation 
 
Despite the incomplete characterization of OECs, clinical trials with OECs have 
already taken place in China, Portugal and Australia. The majority have taken place 
in China using olfactory bulb-derived OECs from aborted foetuses in patients with 
spinal cord injury. Data published involved 171 patients who ranged from 2 to 64 
year of age and received transplants at post injury times extending as much as 30 
years (Huang et al. 2003). Follow-up examinations were performed only 8 weeks 
after transplantation. Analysis was made by grouping patients according to time 
from injury only. No clear clinical or anatomical selection requirements for the 
surgical procedure, either inclusion or exclusion criteria, were apparent for this series 
of participants (Dobkin et al. 2006). Subjects who had incomplete SCI and retained 
functional movements below the lesion were eligible, along with those with a 
complete traumatic SCI. In addition, there were no strict criteria about the 
anatomical location for injection of OECs; for example, one patient had cells placed 
at the rostral C-3 level of an asymptomatic syringomyelia, but the spinal cord injury 
had caused paraplegia at T7 spinal level. Another patient had cells placed bilaterally 
into the frontal lobes of the brain (Dobkin et al. 2006). For the above reasons, no 
definitive conclusions can be drawn from this study based on its experimental 
design.  
 
There have been another four case series describing intraspinal implantation of 
olfactory tissues in patients with SCI. The first autotransplantation paradigm was 
reported by Feron et al., (Feron et al. 2005) This was a Phase 1 study of three adult 
males at 6–36 months after spinal cord injury who received OECs harvested from the 
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nasal septum, dissociated and expanded in culture and transplanted an 
injector/micromanipulator into both normal and damaged spinal cord tissue. No peri-
operative complications were reported, and at 1 year after implantation, there was no 
clinical deterioration in motor, sensory or pain symptoms (Feron et al. 2005). 
 
A subsequent pilot study aimed at determining the safety and feasibility of 
transplanting whole olfactory mucosa autografts from the patients’ nasal septum into 
the spinal cord cavity (Lima et al. 2006). Seven patients ranging from 18 to 32 years 
of age in American Spinal Injury Association (ASIA) Class A were treated at 6 
months to 6.5 years after injury. Lesions were present at C4–T6 levels and ranged 
from 1–6 cm in length. Patients were followed from 18 months after surgery. No 
perioperative complications were reported. One patient reported increase in pain, 
which was controlled with medication. Another patient reported decrease in 
sensation following the surgery. Authors attributed this to the fact that they had 
difficulties in localizing the lesion at the time of surgery. Furthermore, this study 
also reported preliminary advantageous effects of their treatment; two patients had a 
significant functional improvement from ASIA class A to class C (Lima et al. 2006). 
 
Lastly, the same group Lima et al., (Lima et al. 2010) published an unblinded, non-
randomised study of seven paraplegic and 13 tetraplegic subjects (19–37 years old) 
who sustained a traumatic SCI 18–189 months previously and received pieces of 
whole olfactory mucosa in addition to a very aggressive rehabilitation regimen. This 
study reported improvements in 11 of 20 patients from an ASIA Impairment Scale 
score of A to C (motor/sensory complete to motor and sensory incomplete). 
Unfortunately, this study lacked a control group receiving rehabilitation alone. 
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3.5 The human olfactory mucosa cellular composition and architecture 
 
 
In most OEC transplantation paradigms, cells have been obtained from the olfactory 
bulbs of experimental animals. OECs have also been isolated from human olfactory 
bulbs resected during neurosurgery (Barnett et al. 1993), from olfactory bulbs and 
olfactory mucosa of cadavers (Miedzybrodzki et al. 2006) and aborted foetuses 
(Huang et al. 2003). If OECs are to be used clinically, a readily accessible source 
needs to be identified which allows collection of OECs with low risk and 
inconvenience to the patient. Ideally, cells should be obtained from the same patient 
for autologous transplantation to avoid the problems of immune rejection or 
transmission of viral or prion disease. To overcome these ethical and practical 
problems, researchers are now focusing on how to obtain sufficient amounts of 
OECs from the human olfactory mucosa.  
 
 
The olfactory mucosa consists of a pseudostratified columnar olfactory epithelium 
resting on a highly cellular lamina propria, separated by it by a basal lamina. The 
lamina propria contains axon fascicles, blood vessels, connective tissue and 
Bowman’s glands. The olfactory neuroepithelium consists of four major 
cell types, the olfactory receptor neurons (ORNs) and glial-like sustentacular cells, 
microvillar cells and basal cells.  
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The axons of the 10-20 million olfactory receptor neurons ensheathed by OECs cross 
the basement membrane of the epithelium into the lamina propria, join together to 
form bundles or fascicles of axons and pass through the 15-20 foramina of each 
cribriform plate to synapse within the olfactory bulb.  
 
Sustentacular cells are large columnar cells that surround olfactory receptor neurons. 
They are presumed to contribute to regulating and maintaining the appropriate ionic 
milieu around the receptor neurons for olfactory transduction to occur (Morrison et 
al. 1990).  
 
Basal cells do not project to the epithelial surface and rest on the basement 
membrane. It is a current belief that basal cells are the stem cells in the olfactory 
epithelium that divide to give rise to new neural and supporting cells (Roisen et al. 
2001; Schwob 2005) 
 
Microvillar cells are flask-shaped cells that extend axon-like cytoplasmic processes 
into the mucus layer of the epithelium and hypothesized to be a second 
morphologically distinct class of chemoreceptors.  However, their putative role in 
olfaction has not been definitively demonstrated (Montani et al. 2006).  
 
 
3.6 Localization of the human olfactory mucosa 
 
Unlike the rodent olfactory mucosa which is easily recognizable by its yellow colour 
and easily excised from the nasal cavity, in the human, there is no clear delineation 
between olfactory and respiratory tissue (Kolmer 1927). Both light microscopic and 
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scanning electron microscopic observations have shown that the olfactory epithelium 
is intermittently distributed across the nasal mucosa, interspersed with patches of 
respiratory epithelium (Morrison et al. 1990; Lane et al. 2002). The exact 
distribution of human olfactory neuroepithelium, however, is not yet known. There 
is general agreement that it is located high in the nasal cavity, predominantly on the 
dorsal aspects of the nasal vault, the septum and superior turbinate. It occupies 
approximately 1.25% of the nasal mucosa with a total of approximately 1-2 cm
2 
(Smith 1941; Moran et al. 1982). More importantly, the olfactory mucosa has been 
shown to decrease with age in 55% of adults and to be completely absent in 13% of 
elderly patients (Smith 1941). The olfactory ability of these 13% was not measured.  
 
A number of studies have attempted to map the distribution of the human olfactory 
mucosa. Feron et al. (Feron et al. 1998) first obtained mucosa biopsies from patients 
undergoing routine nasal surgery. They reported that olfactory tissue is more likely 
to be found in the posterior nasal cavity, septum, and turbinates; 20% of their 
specimens contained pure olfactory mucosa and 31% contained mixed olfactory with 
respiratory mucosa. The greatest proportion of pure olfactory epithelium was 
detected in the posterior area of the middle turbinate. The highest chance of finding 
any olfactory tissue however was by taking specimens from the superior turbinate.  
 
In another study, healthy individuals were recruited to investigate the distribution of 
the olfactory epithelium in humans by means of the electro-olfactogram using 
vanillin, which specifically excites olfactory receptor neurons and anatomically 
located biopsy specimens (Leopold et al. 2000). The largest responses were recorded 
from the olfactory cleft. Histological examination showed olfactory tissue in 47% 
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specimens from the septum and 41.6% of biopsies from the lateral wall, dorsal to the 
anterior insertion of the middle turbinate and up to 22 mm anterior to the olfactory 
cleft on either the lateral or medial walls of the nasal cavity. Notably, tissue without 
olfactory mucosa was also obtained from the same areas.  
 
Lane et al. (Lane et al. 2002) examined the inferior portion of superior turbinate 
following resection. It was demonstrated that olfactory mucosa exists only in its 
medial aspect. Other studies have demonstrated the presence of olfactory mucosa in 
the anterior septum (Jafek et al. 2002), septum opposite the superior portion of the 
middle turbinate and superior and inferior portions of the middle turbinate (Rawson 
et al. 1995; Rawson et al. 1997; Nibu et al. 1999), and replicated the initial 
observations of the patchy distribution of the olfactory epithelium interspersed with 
respiratory epithelium in histological analyses (Jafek et al. 2002; Lane et al. 2002).  
 
 
 
3.7 Olfactory mucosa biopsy technique 
 
The first study focusing on biopsies of the human olfactory mucosa was published in 
1975 by Douek et al. (Douek et al. 1975) who attempted to correlate clinical 
manifestations with the light and electron microscopic pathologic findings of the 
olfactory epithelium in selected patients with disorders causing smell abnormalities. 
The authors took biopsies from the most upper septal surface, using a long thin pair 
of toothed dissecting forceps, a self-retaining speculum and the operating 
microscope, but recognized the limitations of the procedure, resulting from the 
indistinct margins and variable size of the olfactory epithelium.  
 
 115 
 
In 1982, Lovell et al. (Lovell et al. 1982) designed the “olfactory biopsy instrument” 
(OBI), to avoid crushing artefacts caused by biopsy forceps. It had a 1 mm diameter, 
120 mm long shaft ending in a 1 mm long U-shaped trough, designed to collect 3 
mm
3
 specimens and worked by cutting through the lamina propria and leaving the 
epithelial surface undistorted. The procedure was performed blindly under local 
anaesthesia and vasoconstriction, and the septum was the preferred biopsy site 
because of its vertical orientation and smooth surface. Another study proposed a new 
technique using the more widely available 3 mm, 70 degree upturned, vertical 
opening cupped giraffe forceps (Lanza et al. 1993). The success rate was improved 
when biopsies were performed under endoscopic guidance (2:3.5 as opposed to the 
success rate of 1:4 to 1:6 with the OBI), and no adverse effect was detected in the 
sense of smell after olfactory biopsy with this technique. Other researchers have 
described the use of cupped (Trojanowski et al. 1991) or other special forceps 
(Nakano’s forceps) (Yamagishi et al. 1988) to obtain olfactory tissue. Regardless of 
the design, forceps can obtain large specimens and also avoid the occasional loss of 
the tissue that can occur with the OBI. However, all types of forceps crush the 
specimens resulting in loss of tissue.  
 
Biopsy of the olfactory region carries some inherent theoretical risks, including 
anaesthetic complications, loss of smell and leak of cerebrospinal fluid (CSF). CSF 
leak is the most serious potential complication as it may be complicated by 
intracranial infection and meningitis. The skull base in the region of the olfactory 
niche is the thinnest in the nasal cavity and can be fractured easily. Because the dura 
is adherent to the cribriform bone, it is prone to tearing when the bone fractures, 
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potentially causing a leak of cerebrospinal fluid and an associated risk of meningitis. 
Particularly high risk areas are, firstly, where the anterior ethmoid artery enters the 
anterior skull base at the lateral lamella of the cribriform plate and secondly where 
the middle third of the middle turbinate starts to attach more laterally from the skull 
base to the lateral nasal wall. To date, there have been no instances of severe 
complications related to olfactory biopsy reported in the literature. It is important to 
note however that, as described above, biopsies were taken from lower portions of 
the nasal cavity, avoiding the more risky region of the olfactory niche, which 
potentially can result in better success rates.   
 
 
3.8 OEC yield 
 
 
Culture of OECs from the OB of rats (Ramon-Cueto et al. 1992; Li et al. 1997), 
primates (Rubio et al. 2008), dogs (Krudewig et al. 2006; Techangamsuwan et al. 
2008) and humans (Barnett et al. 2000) has been achieved in relatively large 
numbers. However, laboratories culturing OECs agree that it is more difficult to 
derive a sufficiently large population of cells for human transplantation. Cultured 
OECs from the olfactory mucosa of dogs constituted of approximately 40% OECs at 
7 days and approximately 25% at 21 days, whereas those cultures from the OB of 
dogs yielded 50% OECs at 7 days and approximately 75% at 21 days (Ito et al. 
2006). These changes are accompanied by corresponding increases in the population 
of fibronectin positive cells (fibroblasts) (Ito et al. 2006).  This poses an additional 
difficulty to the culture of OEC from human olfactory mucosa, in addition to, the 
small surface of the nasal cavity area covered olfactory mucosa and its relatively 
unknown location within the nasal cavity.  
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The aforementioned studies in Section 3.5 investigated the acquisition of olfactory 
mucosa alone in an attempt to study olfactory neurons. Only two studies have 
concentrated on the yield of OECs from the obtained biopsy specimen to date. 
Firstly, Bianco et al. (Bianco et al. 2004) mapped the yield of OECs in different 
regions. However, their study included only three patients. Choi et al. (Choi et al. 
2008) studied the submucosal septal approach of 23 patients who where biopsied 
with ethmoid forceps during transphenoidal surgery. The authors attempted to “map” 
of the septal olfactory mucosa to identify rich areas for biopsy. They found better 
results from postero-superior biopsies and suggested that location is more important 
than specimen size. However, authors reported that biopsies did not provide 
sufficient OEC yield for transplantation.  
 
3.9 Conclusion 
 
The presence of ongoing human clinical trials of OEC transplant mediated repair 
following spinal cord injury may imply that the issues regarding the harvest and 
culture of human OECs have been resolved and that open issues only refer to details 
of the clinical application. However, as described in this introductory Chapter, this is 
not the case. The harvest of human olfactory mucosa and yield of OECs from 
biopsies remain a hindrance. Alternative culture and biopsy methods using different 
instruments and from different regions should be investigated to further improve the 
likelihood of successful clinical applications. In the next Chapter, we investigate the 
yield of OECs from biopsies of human olfactory mucosa using a new surgical 
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technique and focusing on the superior turbinate. Factors leading to better cell 
proportions are also examined. 
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Chapter 4 
 
Translating basic research in to clinical practice: Harvesting 
human Olfactory Ensheathing Cells 
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This chapter presents a study investigates methods by which OECs can be harvested 
from the human nasal cavity and features that would lead to a better yield. The study 
describes a new reproducible surgical approach for biopsies of the superior turbinate 
and correlations between OEC yield and specimen- and patient-related features are 
performed to assess conditions that would lead to a higher yield of OECs from 
human specimens of the superior turbinate. Given the finding of previous studies 
investigating the location of the human olfactory mucosa, it was decided to focus to 
the cranial portions of the superior turbinate where it is believed that OECs are more 
closely packed as olfactory axons coalesce to cross through the cribriform plate. 
 
 
4.1 Aims 
 
The aims of this chapter are threefold. The first aim is to describe a safe and 
reproducible surgical technique for obtaining human olfactory mucosa biopsies. Our 
second aim is to determine the areas within the olfactory mucosa of the superior 
turbinate that systematically provide sufficient OEC yields to enable a more targeted 
biopsy. Thirdly, we aim to identify factors within the patients’ medical history that 
may affect the yield of OEC cultures from the human olfactory mucosa.  
 
 
4.2 Materials and Methods 
 
4.2.1 Patients  
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Consecutive patients who presented to the Royal National Throat Nose and Ear 
Hospital and the National Hospital for Neurology and Neurosurgery for functional 
endoscopic sinus (FES) surgery were invited to participate in this observational 
study. The majority of patients required nasal surgery for symptoms of nasal 
obstruction, reduction of sense of smell and excessive secretions, pain and pressure, 
caused by inflammatory polyposis and infective rhinosinusitis refractory to medical 
therapy or benign or malignant tumours. The aim of the operation was to improve 
the ventilation of the sinuses and restore mucociliary clearance.  
 
The patients’ medical history was documented including age, sex, presenting 
complaint, past medical and surgical history, drug history including use of topical 
and/or oral steroids, allergies and smoking status.  
 
 
4.2.2 Surgical Procedure - Endoscopic Method 
 
The surgical technique for our biopsies was developed by the principal surgeon 
(PA). Another three surgeons provided specimens according to the principal 
surgeon’s directions and technique (Table 4.2). All surgeons are Consultants in ear, 
nose and throat surgery with special interest in FES surgery under general 
anaesthesia.  
 
All patients were operated under general anaesthesia. Patients received topical 
treatment with either Cophenylcaine spray (Lignocaine hydrochloride 50mg/ml and 
Phenylephrine hydrochloride 5mg/ml) or Moffatt’s solution (2 ml of 6% cocaine, 1 
ml of 1:1000 epinephrine, 2 ml of 8% sodium bicarbonate, made up to 10 mls with 5 
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mls of normal saline) placed on a thin ribbon gauze in the nasal airway for 
approximately 10 minutes to maximize vasoconstriction and anaesthesia. Ribbon 
gauzes soaked in 1:10,000 epinephrine are placed into the middle and superior meati 
by the operating surgeon, so as to maximize vasoconstriction. Patients were placed 
supine in 20° head-up position to reduce the venous pressure and anaesthetic 
hypotensive technique was used keeping the mean blood pressure between 65 and 75 
mmHg. Surgery was performed using the 0° 4 mm endoscope.  
 
For each patient, we aimed to obtain a specimen from the superior turbinate, as close 
to the olfactory cleft as possible avoiding the risk of a CSF leak but also enabling 
reproducibility. Particular effort was also made to include the whole thickness of the 
mucosa to ensure that the lamina propria is not left behind.  The olfactory biopsy 
specimen was obtained as follows: The superior turbinate was gently medialised and 
inspected. A portion of the middle third of the superior turbinate was resected using 
endoscopic microscissors. Two cuts were made through the superior turbinate, 
perpendicular to the skull base using endoscopic microscissors. A third incision was 
made joining the two parallel incisions using curved microscissors. Using Blakesley 
forceps, the resected middle section was gently retrieved. Biopsies of 3 to 4 mm in 
size were obtained. The position of the specimen was recorded on a diagram of the 
nasal cavity and a snap shot image or movie of the procedure was taken.  
 
The specimen was immediately placed in ice-cold (4°C) complete culture medium 
consisting of Dulbecco’s Modified Eagle Medium/Ham’s Nutrient Mixture (Logan, 
UT) F-12 (DMEM/F12) (1:1 DMEM/F12 with GlutaMAX [Invitrogen]), 1% insulin-
transferrin-selenium (1.0 mg/ml insulin, 0.67 mg/ml transferrin, and 0.55 mg/ml 
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selenium) (insulin-transferrin-selenium; Invitrogen), 10% deactivated foetal calf 
serum (Invitrogen) and transferred to the laboratory.  Postoperatively patients were 
nursed 30° head-up position. An epinephrine (1:10 000) soaked pack was placed for 
more than minor oozing.  
 
 
4.2.3 Processing of olfactory mucosa biopsies 
 
On arrival to the laboratory, the specimen was transferred in Hanks’ Balanced Salt 
Solution (HBSS) (calcium and magnesium free; Invitrogen Ltd., Paisley, UK) 
supplemented with 100 U/ml of penicillin and 100 μg/ml of streptomycin 
(Invitrogen). Blood clots, debris and bone were removed from the specimen. The 
specimen was then photographed and its greatest diameter recorded. Subsequently, 
the specimen was divided into 2 pieces, one for histology and one for culture.  
 
 
4.2.4 Culture Procedure 
 
After removal of the excess solution, the portion of the specimen for culture was 
weighed on an analytical balance (Precisa 262SMA-FR, readability 0.1–0.01 mg; 
Precisa Balances, Ltd., Milton Keynes, UK). Specimens were then transferred to 35 
mm dishes filled with growth media (as described above), cut into small pieces to 
approximately 1-2 mm
2
 in size, transferred to 2 ml of digestion mixture containing 
2.4 U/ml Dispase II (Roche) and 0.25% collagenase (Type H; Sigma) in DMEM/F12 
incubated in at 37°C for 30 min and triturated to remove lumps using a flame-
polished Pasteur pipette. The enzymatic reaction was stopped by adding 8 ml of 
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Hanks’ Balanced Salt Solution.  After centrifuging at 300 x g for 5 minutes the 
supernatant was discarded and the tissue pellet was further triturated into cell 
suspension in the complete culture medium, and penicillin and streptomycin to a cell 
density of 2 to 2.5 x 104/cm2. The resulting cells were plated down in 35 mm culture 
dishes (Nunclon) coated with poly-L-lysine 50 ug/ml (Sigma) and maintained in a 
humidified incubator enriched with 5% CO2 for 10-14 days at 37°C. The culture 
medium was replaced every 3 days. The cell cultures were observed with daily 
inverted light microscopy under aseptic conditions. Beyond 14 days of culture, 
fibroblast proliferation outstripped the growth rate of OECs, and at 14 days, the 
number of OECs was felt to be optimum. 
 
 
4.2.5 Immunocytochemistry 
 
After 10-14 days in culture, cells were rinsed in 0.01 M phosphate-buffered saline 
(PBS), fixed in 4% paraformaldehyde in PBS at 4°C overnight, rinsed in PBS, 
permeabilised and blocked with 2% skim milk (Merck KGaA, Germany) in PBS 
containing 0.1% Triton X-100 (TAAB) for 30 minutes.  They were then incubated in 
primary antibody solution at 4°C overnight, washed in PBS three times with 10 
minute intervals and incubated with appropriate species fluorescent secondary 
antibody solutions at room temperature for 2 hours. After washing three times, cells 
were counterstained with 4', 6-diamidino-2-phenylindole (DAPI; Invitrogen), 
mounted using ProLong® Gold Antifade (Invitrogen) and coverslipped. The primary 
antibodies used to identify OECs were mouse anti-human low-affinity neurotrophin 
receptor (anti-p75
NTR
; 1:500; Sigma, N5408) and rabbit anti-S100β Ig (1:500; Dako, 
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Z0311) and, for olfactory nerve fibroblasts, rabbit anti-human fibronectin (1:1000; 
Dako). The secondary antibodies used for simultaneously visualizing anti-p75 and 
anti-fibronectin were Alexa-488 goat anti-mouse and Alexa-546 goat anti rabbit, and 
for anti-S100β, Alexa-488 goat anti-rabbit. All antibodies were diluted in PBS 
containing 2% milk and 0.1% Triton X-1000. 
 
 
4.2.6 Histology procedure and immunohistochemistry 
 
The pieces of specimens reserved for histology were fixed in 4% paraformaldehyde 
in PBS overnight. They were then cryoprotected in 10% followed by 20 % sucrose in 
PBS solution at 4°C until the specimen sunk.  12 µm sections were cut on a cryostat 
(Leica CM3050), mounted on MAS coated slides (S-9441, Matsunami Glass Ind., 
Ltd.) and allowed to dry at room temperature for 24 hours. The sections were 
washed in PBS several times, blocked with 2% skim milk (Merck KGaA, Germany) 
in PBS containing 0.1% Triton X-100 for 30 minutes, incubated in primary antibody 
solution at 4°C overnight, washed in PBS several times and incubated with 
appropriate species fluorophore-conjugated secondary antibody solutions as above.  
The primary antibodies used to identify OECs were anti- p75
NTR
 (1:500), anti-S100 
(1:500) anti-tubulin (beta III isoform, 1:500, Chemicon) and background staining 
using sytox orange nucleic acid stain (1:500, Invitrogen, CBL412). The secondary 
antibodies used were the same as for immunocytochemistry. 
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4.2.7 Methods of data interpretation and Statistical analysis 
 
4.2.7.1 Confocal Microscopy, Digital Image analysis and estimation of OEC 
yield 
 
Fluorescent microscopy and image acquisition were carried out using a confocal 
laser scanning microscope (TCS SP1, Leica Microsystems, UK Ltd).  Confocal z-
planes were captured for the complete thickness of the culture and the two 
dimensional images were generated by projecting the z-stack using the Leica 
software. Image Pro Plus Version 6.0 (Media Cybernetics, Inc. Bethesda, MD, USA) 
was used to calculate the pixel density of red and green channels representing 
fibroblasts and OECs respectively, which was then converted to surface area of dish 
covered by red and green.  
 
OEC yield was estimated indirectly by calculating the surface area of the culture dish 
covered by red and green of five representative images of each dish. Each image 
covered 1 mm
2
 of each 35 mm culture slide. Representative images captured 
included the area of the dish covered with the worst and best green pixel densities 
and another three randomly selected locations. The proportion of the area covered by 
OECs (green pixels) over the total area covered by cells (red plus green pixels) was 
subsequently calculated and converted to a percentage of the area imaged, 
representing OEC yield. 
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4.2.7.2 Correlation between cell yield and specimen- and patient- related factors 
 
The relationship between OEC and fibroblast yield with patient characteristics and 
specimen factors were assessed using Spearman's rank correlation coefficient (rho) 
after testing for normality. To compare the OEC yield among different surgeons, a 
one-way ANOVA was used correcting with Bonferroni, Scheffe and Sidak multiple 
comparison tests.  
 
Patients’ perception of sense of smell was graded in a scale of 0 to 4; “0” = complete 
absence of sense of smell,  “1” = severe loss of smell, “2” moderate loss of smell and 
“3” = mild loss of smell and “4” = normal sense of smell. 
 
To grade the degree of mucosal disease in the region of the superior turbinate, we 
used the validated Lund-MacKay endoscopic appearances score (Annamalai et al. 
2003) but modified to include only the side of the nasal mucosa the biopsy was taken 
from (Table 4.1). The region the biopsy was assigned a grade according to the 
modified Lund-MacKay endoscopic appearances score by the operating surgeon and 
researcher at the time of surgery.  
 
 
 
 
 
 
 
 
 128 
Table 4.1: Modified Lund – MacKay scoring system: endoscopic appearance (scores 
for side the biopsy was taken from only) 
 
Characteristic  Grade 
Polyp  0 = absence of 
polyps  
1 = polyps in 
middle meatus 
only 
2 = polyps 
beyond middle 
meatus but not 
blocking the 
nose completely 
3 = polyps 
completely 
obstructing the 
nose 
Oedema  0 = absent  1= mild  2= severe - 
Discharge  0 = no discharge 1= clear, thin 
discharge 
2 = thick, 
purulent 
discharge 
- 
Scarring  0 = absent 1 = mild  2 = severe - 
Crusting 0 = absent 1 = mild  2 = severe - 
 
 
 
4.2.7.3 Distribution of olfactory mucosa in the superior turbinate 
 
To systematically map the position of olfactory mucosa within the superior turbinate, 
we devised a reproducible method by which the position of the biopsies were 
recorded at the time of the biopsy. A grid was placed on a schematic representation 
of the superior turbinate dividing the surface area of the superior turbinate in 24 
positions (6 columns in the antero-posterior dimension and 4 rows in the cranio-
caudal dimension) as shown in Figure 4.7 A and B. Spearman's rank correlation 
coefficient (rho) was used to correlate OEC yield and olfactory mucosal positions.  
 
 
All statistical analysis was performed using STATA statistical software Version 11  
(StataCorp LP, College Station, TX).  Statistical significance was accepted at the 5% 
level (p < 0.05). 
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4.2.8 Comparison of OEC yield from the superior turbinate versus septal 
biopsies using blind endonasal approach 
 
Twenty-six consecutive patients who presented to the National Hospital for 
Neurology and Neurosurgery for pituitary surgery were asked to participate in this 
observational study. Informed consent was obtained, and all procedures were 
performed with the approval of the hospital’s research ethics committee. 
 
Specimens of septal mucosa were obtained using an endonasal approach to the 
sphenoid sinus as described in our laboratory’s previous study (Choi et al. 2008). In 
brief, 3-4 mm biopsies were taken from the superioroposterior aspect of the nasal 
septal mucosa using an Angel-James or Williams rongeur. A radiograph was 
obtained using an intraoperative image intensifier to plan and document the position 
of the biopsy. Processing, culture, immunocytochemistry and digital analysis were 
performed as described in the previous sections of this thesis chapter for the superior 
turbinate specimens. A Student’s t-test (t) was used to compare OEC yields achieved 
by the two different methods.  
 
4.3 Results  
 
 
4.3.1 Description of specimens  
 
In total, 43 superior turbinate specimens from different patients were included in the 
statistical analysis. Thirty-seven specimens (86%) were obtained by the primary 
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surgeon (PA), PC obtained 3 (6.97%), CE 2 (4.65%) and MP 1 (2.32%) (Table 4.2). 
An analysis of variance conducted to compare the effects of different surgeons 
performing the surgical procedure on OEC yield, which demonstrated no statistically 
significant differences among the four surgeons (F(3,39) = 2.86; p = 0.049). Posthoc 
analyses using Bonferroni, Scheffe and Sidak post hoc criteria confirmed that the 
mean of OEC yield for each surgeon was not significantly compared with other 
surgeons’. The mean average weight of the specimen used for culture was 26.53 m 
with a range of 3.8 -143 m (sd; 26.2). A Spearman correlation coefficient showed 
no significant correlation between the OEC yield and weight of specimen cultured 
(rho = 0.25; p = 0.14; 95%CI = -0.05 to 0.51).  
 
 
Table 4.2: Number of specimens obtained by each surgeon, mean and standard 
deviation of the proportion of OECs for each surgeon.  
 
Surgeon Frequency 
No (%) 
Average proportion of 
OEC yield per surgeon (%) 
Mean (Sd) 
PA 37 (86.05) 0.21 (0.23) 
PC 3 (6.97) 0.47 (0.66) 
CE 2 (4.65) 0.62 (0.39) 
MP 1 (2.32) 0.13 (0) 
 
 
4.3.2 Histology of human olfactory mucosa and human OECs in culture  
 
There were 34 out of the total 43 available specimens (79.1%) for 
immunohistochemical analysis.  The remaining 9 were not analyzed for one of the 
following reasons: a) the culture specimen was not large enough for both culture and 
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histological analysis, b) the specimen was lost, c) the specimen was destroyed due to 
technical errors.  
 
Figure 4.1 shows the histological organization of the human olfactory mucosa.  The 
olfactory mucosa is composed of two distinct tissue layers:  the outer epithelium and 
the deeper lamina propria. The primary olfactory axons penetrated the basal lamina 
of the epithelium to enter and traverse the underlying lamina propria. The lamina 
propria is composed of numerous olfactory nerve fascicles of varying sized as well 
as arterioles, venules and serous glands. OECs form conduits through which bundles 
of olfactory axons pass during their course in the lamina propria to the olfactory 
bulb.  
 
Within the human LP the olfactory nerve bundles are immunoreactive for 
neurofilament. OECs were easily distinguished within the lamina propria by their 
immunoreactivity to p75
NTR 
and S100. p75
NTR
 and S100 immunopositive olfactory 
bundles were identified in 32 out of the 34 (94.1%) specimens analysed.  
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(A)  
(B)  
 
Figure 4.1: (A) Section of human olfactory mucosa from the superior turbinate 
stained with anti-p75
NTR
 antibody to label OEC (green) and sytox antibody to label 
cell nuclei. Olfactory axons coalesce to form bundles within the lamina propria;  (B) 
Schematic representation of the components of the olfactory mucosa; scale bar = 
100 m; (Kachramanoglou et al. 2012) Permission to reproduce this image has been 
granted by Wolters Kluwer Health. 
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(C)    
(D)   
(E)    
Figure 4.1 cont.: (C) 
Magnified view of a cross 
section through an olfactory 
bundle consisting of OECs 
within the lamina propria, 
immunostained with anti-
S100 antibody (green) (D) 
The same magnified image 
(A) of an olfactory bundle 
showing olfactory axons 
stained with anti-tubulin 
antibody (red), (E) Overlay 
of images C and D 
demonstrating close 
association and 
ensheathment of olfactory 
axons by OECs; scale bar = 
100 m; (Kachramanoglou 
et al. 2012) Permission to 
reproduce this image has 
been granted by Wolters 
Kluwer Health. 
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(F)    
 
 
 
 
 
 
 
 
4.3.3 Morphology of human OECs in Culture 
 
OEC culture was attempted in all 43 specimens collected. At least one p75
NTR
 
immunoreactive cell with the characteristic morphology of OECs was identified in 
42 out 43 biopsies assessed (97.7%).  
 
A representative image of OEC culture from the superior turbinate is shown in 
(Figure 4.2). p75
NTR 
labeling
 
demonstrates elongated, triangular, spindle or stellate 
shaped cells bearing long and thin tapering processes which become segregated into 
swathes of cells. Fibronectin positive cells (fibroblasts) formed a layer beneath the 
Figure 4.1 cont.: (F) 
Longitudinal section of an 
olfactory bundle, OECs 
are stained with anti-
p75
NTR
  (green), 
background stain with 
sytox orange (red) 
staining all nuclei; scale 
bar = 100 m; 
(Kachramanoglou et al. 
2012) Permission to 
reproduce this image has 
been granted by Wolters 
Kluwer Health. 
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p75
NTR 
positive cells and were not seen to extend long processes as the p75
NTR 
positive cells.  
 
 
 
(A)  
(B)  
 
 
(C)  
 
 
 
Figure 4.2: Photomicrograph of human OEC culture; (A) fibroblasts labeled with 
anti-fibronectin antibody (red) (B) OECs labeled with anti-p75
NTR 
antibody
 
(green); 
(C) superimposed images; scale bar = 100  (Kachramanoglou et al. 2012) 
Permission to reproduce this image has been granted by Wolters Kluwer Health. 
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4.3.4 OEC yield 
 
Analysis of OEC cultures obtained from the superior turbinate showed a mean 
surface area stained red of 37.12% (sd; 26.22, range; 0.09-90.60), representing 
fibroblasts and a mean surface area stained green of 7.94% (sd; 9.72, range; 0-
42.45), representing OECs. The mean proportion of the surface area stained green 
(OECs) over the total amount of surface area stained by cells was 0.25 (sd; 0.28; 
range; 0-0.97) (Table 4.3). The proportion of OECs and fibroblast for each specimen 
analysed is given in Figure 4.3.  
 
 
Table 4.3: Mean and standard deviation of surface area stained green (p75
NTR
 
labeling) and red (fibronectin labeling).  
 
 
4.3.5 Description of Patients and influence of patient-related factors on OEC 
yield 
 
Of the 43 patients included in the study, 25 were men patients and 18 were women. 
The mean age was 44 years, ranging from 18 to 81 years of age.  A Spearman 
correlation coefficient did not reveal a statistical significant correlation between 
  Mean SD 
Surface area stained red (%) 37.12 26.22 
Surface area stained green (%) 7.94 9.72 
Proportion of surface area stained green/red+green (%) 0.25 0.28 
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Figure 4.3: Graph showing the percentage of surface area per 1mm
3
 surface area of 
the each slide covered by OECs (Green; anti-p75 labeling) and fibroblasts (Red; 
anti-fibronectin labeling) for each biopsy specimen of the superior turbinate. 
(Kachramanoglou et al. 2012) Permission to reproduce this image has been granted 
by Wolters Kluwer Health. 
 
 
donor gender and OEC yield (rho = -0.02; p = 0.90; 95%CI = -0.32 to 0.28). In 
contrast, OEC yield was found to be negatively correlated with donor age; greater 
OEC yields being achieved with decreasing age of donors (rho = -0.32; p = 0.034; 
95%CI = -0.569 to -0.026) (Figure 4.4).  
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Of the 43 patients included in the study, 7 (17%) reported no sense of smell, 6 (14%) 
reported severe loss of sense of smell, 13 (31%) reported moderate loss of sense of 
smell and 15 (36%) reported only mild loss of sense of smell.  Eleven (25.6%) were 
smokers and 32 (74.4%) were non-smokers at the time of the biopsy. Thirty-five out 
of the 43 patients (81.40%) received topical steroids in the pre-operative period and 
8 (18.6%) patients were administered oral steroids. In 11 out of 43 donors (25.6%), 
the nasal cavity was treated with Cophenylcaine and 32 patients (74.4%) were 
treated with Moffatt’s solution.  
 
Spearman correlations did not demonstrate correlation of between OEC yield and 
sense of smell (rho = - 0.06; p = 0.68; 95%CI = -0.41 to 0.36), steroid use (rho =  -
0.11; p = 0.48; 95%CI = -0.40 to 0.2 for topical steroids and rho = 0.12; p = 0.43; 
95% CI = -0.18 to 0.41 for oral steroids), smoking (rho = -0.25; p = 0.11; 95%CI = -
0.51 to 0.06), or preparatory solution used (rho = 0.22; p = 0.16; 95%CI = -0.09 to 
0.49).  
 
 
4.3.6 Influence of nasal mucosal disease on OEC yield  
 
Histological analysis of specimens included in this study revealed that out of 43 
patients, 20 patients (46.51%) had confirmed benign nasal polyposis, 15 patients 
(34.88%) suffered with rhinosinusitis, 5 (4.65%) showed infections including 1 
fungal infection, 1 (2.33%) showed a simple cyst and 2 showed no evidence of 
mucosal disease (11.63%) (Table 4.4). Of the 20 patients with the diagnosis of nasal 
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polyposis, 5 (11.63% of total 43 of patients) had grade 1, 6 (13.95%) had grade 2 
and 9 patients (20.93%) had grade 3 (Table 4.5).  
 
 
 
Figure 4.4: Graph showing the association between age of patients and OEC yield; 
rho = -0.32; P = 0.034; 95%CI = -0.569 to -0.026 (Kachramanoglou et al. 2012) 
Permission to reproduce this image has been granted by Wolters Kluwer Health. 
 
 
 
 
 
 
Table 4.4: Histological diagnoses for the 43 olfactory mucosa specimens analysed 
 
Nasal Pathology Frequency 
(Number) 
Percent (%) 
Polyposis 20 46.51 
Rhinosinusitis  15 34.88 
Infection 5 11.63 
Cyst 1 2.33 
No nasal disease 2 4.65 
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Figure 4.5: Box plot showing the average proportion of OEC yield for each 
histological diagnosis. (Kachramanoglou et al. 2012) Permission to reproduce this 
image has been granted by Wolters Kluwer Health. 
 
 
Table 4.5: Grading of polyposis and average OEC yield for each grade.  
 
Grade of polyposis  Frequency (Number) Percent (%) of total 43 
patients 
Grade 1 5 11.63 
Grade 2 6 13.95 
Grade 3 9 20.93 
 
 
4.3.7 Influence of mucosal disease on OEC culture yield  
 
The average of OEC yields for each histological diagnosis is given in Figure 4.5. 
There was no significant correlation between OEC yield and histological diagnosis 
or grade of polyposis. The yield of OECs, however, was negatively correlated to the 
modified Lund-MacKay endoscopic appearance score, such that patients with worse 
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mucosal disease yielded poorer cell cultures  (rho = -0.52; p = 0.0003; 95%CI = -
0.71 to -0.26) (Figure 4.6). Greatest yields were found in patients with absence of 
mucosal disease (Figure 4.6).  
 
 
 
 
 
Figure 4.6: Graph showing the association between the Modified Lund – MacKay 
endoscopic appearance scoring system and OEC yield; rho = -0.52; P = 0.0003; 
95%CI = -0.71 to -0.26. (Kachramanoglou et al. 2012) Permission to reproduce this 
image has been granted by Wolters Kluwer Health. 
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4.3.8 Distribution of human olfactory mucosa and influence of biopsy position 
on OEC culture yield  
 
Thirty-eight specimens were included in the statistical analysis of the biopsy 
distribution. The remaining 5 positions were not recorded.  
 
Larger OEC yields were positively correlated with biopsies harvested from the more 
cranial portions of the superior turbinate (rho = -0.61; p = 0.000; 95%CI = -0.78 to -
0.37) (Figure 4.7 and 4.8). OEC yield did not correlate with the ventro-posterior 
location of the biopsy (rho = -0.01; p = 0.0.94; 95%CI = -0.33 to 0.31) (Figure 4.9).  
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(A)  
(B)  
(C)  
Figure 4.7: (A) Schematic representation of olfactory mucosa biopsy location;  (B) 
Magnified image of the superior turbinate. The superior turbinate was divided in 24 
locations to determine locations within the turbinate that result in higher OEC 
yields; (C) Graph showing the average proportion of OEC yield for each location in 
B. (Kachramanoglou et al. 2012) Permission to reproduce this image has been 
granted by Wolters Kluwer Health. 
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 (A)  
 
(B)  
 
Figure 4.8: (A) Schematic representation the superior turbinate divided in four rows 
to determine whether biopsies from more cranial locations result in higher yields. 
(B) Graph showing the association of location of OEC biopsy relative to its 
proximity to the cribriform plate and OEC yield; rho = -0.61; p  = 0.000; 95%CI = -
0.78 to -0.37. (Kachramanoglou et al. 2012) Permission to reproduce this image has 
been granted by Wolters Kluwer Health. 
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Figure 4.9: Graph showing the association of location of OEC biopsy relative to its 
antero-posterior location and OEC yield; rho = -0.01; p = 0.0.94; 95%CI = -0.33 to 
0.31. (Kachramanoglou et al. 2012) Permission to reproduce this image has been 
granted by Wolters Kluwer Health. 
 
 
 
4.3.9 Comparison of OEC yield from the superior turbinate versus septal 
biopsies using blind endonasal approach  
 
OECs were cultured from all 26 specimens of the septal mucosa. The proportion of 
OECs and fibroblast for each specimen analysed is given in Figure 4.10. Analysis of 
OEC cultures obtained from the septal mucosa showed a mean surface area stained 
red of 28.04% (sd; 26.25, range; 0.08 - 87.03), representing fibroblasts and a mean 
surface area stained green of 9.86% (sd; 19.69, range; 0.02 - 83.88), representing 
OECs. The mean proportion of the surface area stained green (OECs) over the total 
amount of surface area stained by cells was 0.25 (sd; 0.29; range; 0 - 0.99). 
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The yield of OECs was found not to show a statistically significant difference 
between specimens from the superior turbinate and septum when compared using a 
Student’s t-test (t (67) = -0.009; 95%CI = - 0.19 - 0.31; p = 0.993) 
 
 
 
Figure 4.10: Graph showing the percentage of surface area per 1mm
3
 surface area 
of the each slide covered by OECs (Green; anti-p75
NTR
 labeling) and fibroblasts 
(Red; anti-fibronectin labeling) for each biopsy specimen of the septal mucosa. 
 
 
4.4 Discussion 
 
In the current study we cultured OECs from 43 specimens obtained from the superior 
aspects of the superior turbinate using an endonasal approach and correlated OEC 
yield with patient and specimen related factors. This is the first study to investigate 
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OEC yield from superior turbinate, as opposed to, purity of olfactory mucosa 
obtained and the first study to assess factors that affect yield. 
 
4.4.1 Olfactory biopsy surgical technique and effects of specimen-related factors 
on OEC yield 
 
In this study, we describe a new surgical approach for the harvesting of human 
olfactory mucosa using endoscopic microscissors and the general principles of FES 
surgery. The biopsy success in obtaining olfactory mucosa from the nasal cavity was 
97.7% and in histological analysis and 79.1% in culture. This is significantly higher 
when compared to previous reports. Feron et al., (Feron et al. 1998) obtained 
olfactory mucosa tissue in 59.1 % of specimens from healthy subjects and 34.6% 
from specimens of patients with nasal disease.  
 
As previously suggested (Lanza et al. 1993) and demonstrated in this study, the use 
of endoscopic guidance assists in the localization of the target mucosal location and 
increases the success of olfactory mucosa harvest. Equally importantly, it allows the 
assessment of the quality of the regional mucosa at the time of biopsy and the 
avoidance of diseased areas resulting in higher OEC culture yield. Nonetheless, the 
significant increase may be solely due to the fact that specimens were taken from 
regions closer to the olfactory cleft.  
 
A review of the literature has revealed that most commonly olfactory mucosa 
biopsies are performed using forceps of different design. Here, we used 
microscissors to dissect the tissue and Blakeley forceps to collect it. This minimized 
the crushing artefact caused by biopsy forceps, regardless of design, and avoids the 
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loss of the tissue obtained which has described with the “olfactory biopsy 
instrument” described in the introductory chapter (Lovell et al. 1982). In addition, 
instruments used are commercially available and commonly present within the 
standard FES surgery surgical pack.  
 
Furthermore, it has been previously suggested that the size of the specimen may 
improve the success rate in obtaining olfactory mucosa (Feron et al. 1998; Leopold 
et al. 2000; Choi et al. 2008). In contrary, in this study it is demonstrated that the size 
(or weight) of the mucosal specimen was not predictive of OEC yield. It can 
therefore, be inferred that location and quality of mucosal tissue is more significant.  
 
One would assume that such a procedure would have a significant learning curve 
and, thus, significant differences in OEC yield among biopsies obtained by different 
surgeons. To investigate whether there are any differences in OEC yield among 
surgeons, multiple comparison tests were conducted which showed no significant 
differences among surgeons. Nonetheless, multiple comparison tests are known to 
reduce the likelihood of type I errors and increase the likelihood of not rejecting the 
null hypothesis (type II error) and therefore, the absence of difference may be due to 
chance. In fact, the p-value of ANOVA was only just significant at 0.49, whereas, 
the difference between surgeon PA and surgeon PC was close to significance with a 
p-value of 0.07.  
 
The most sinister complication of the surgical techniques described is disruption of 
the cribriform plate resulting in CSF leak. CSF leak was not reported in this cohort 
of patients indicating that meticulous technique can avoid serious complications. 
 149 
Another important concern is the loss of smell. The effects of the surgical procedure 
in olfaction could not be investigated in this thesis. This is because the majority of 
patients requiring sinus surgery for polyposis or rhinosinusitis have reduced 
olfaction and surgery most often causes an improvement. It would therefore seem 
unlikely that any subtle loss of sense of smell would be revealed.  
 
4.4.2 Effects of patient-related factors on OEC yield  
 
The yield of OECs was compared to specimen and patient-related factors. Most 
satisfactory yields were obtained from younger patients. This is in accord with 
previous suggestions that the olfactory epithelium is replaced with respiratory 
epithelium with advancing age (Morrison et al. 1992). Patients with brachial plexus 
avulsion injury tend to be of younger age and therefore, the above finding is 
favourable if OEC-meditated repair is to be used in such patients (Kachramanoglou 
et al. 2011). 
 
In addition, it is demonstrated that nasal mucosal disease is a negative predictor of 
OEC yield with best yields achieved from patients without evidence of mucosal 
polyposis, oedema, discharge, scarring or crusting. These findings also suggest that 
although chronic rhinosinusitis with or without polyposis is a disease of the 
respiratory epithelium, the inflammatory changes that occur affect the neighbouring 
olfactory epithelium (Arnold et al. 1997). Nonetheless, the degree of polyposis and 
obstruction was not found to correlate with OEC yield.  
 
Smoking was not found to affect the yield of OECs. Smoking has been shown to 
cause an increase in olfactory sensory neuron apoptosis (Vent et al. 2004) but 
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whether it also causes an increased loss of OECs remains unknown. Statistical 
analysis is complicated by the fact that many patients included in this study had been 
smokers previously, but had ceased for a number of years prior to this study and, 
therefore, the effect of smoking on their olfactory mucosa is difficult to assess.  
 
4.4.3 Changes OEC yields from biopsies of different location in the superior 
turbinate 
 
This study is the only study which has attempted to map the olfactory mucosa in a 
more systematic approach, except a previous study of the same laboratory group in 
which the septal mucosa was studied.  
 
Our goal is to achieve the best possible yield of OECs from mucosal biopsies 
obtained. Since there is a general agreement that the olfactory axons converge in the 
olfactory cleft on their way to the olfactory bulb through the cribriform plate, it 
seems logical to focus on mapping the cranial portions of superior turbinate. The 
success of finding olfactory mucosa from more caudal regions of the superior 
turbinate, middle and inferior turbinate (Feron et al. 1998; Leopold et al. 2000; Lane 
et al. 2002) and septum (Jafek et al. 2002; Choi et al. 2008) has already been studied 
with less than satisfactory results. Consequently, targeting such areas would not add 
significant information in our current knowledge and the likelihood of achieving 
adequate cell cultures for transplantation is low. We, therefore, studied the yield of 
OECs from several locations on the superior turbinate and confirmed that the most 
promising areas of the superior turbinate are those of immediate proximity to the 
olfactory cleft.  
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Contrary to previous reports (Feron et al. 1998; Choi et al. 2008), we did not find a 
significant difference of OEC yield in the anteroposterior position of the biopsy. 
Again, this is not surprising as the superior turbinate extends along the length of the 
cribriform plate.  
 
4.4.4 OEC culture protocol 
 
Despite improvements in surgical technique and localisation of olfactory mucosa, 
this cohort of biopsies still resulted in low yields of OECs. The mean proportion of 
OECs per 1 mm of the dish was 7.94 % with the majority of biopsies (48%) resulting 
in OEC yields of less than 5% and only 23% (10 specimens) with OEC proportion of 
more than 50%. Given the finding that mucosal disease affects the yield of OECs, it 
is not unreasonable to assume that low yields may be attributed to the presence of 
mucosal disease. Low OEC proportions were also obtained from cranial portions of 
septal mucosa. Historically OEC culture has proven difficult primarily due to the 
predominance of fibroblasts over OECs in culture (Li et al. 1997). It is a common 
observation that evolution of cultures involves a time-dependent decrease in OECs 
and corresponding increase in fibroblasts (Nash et al. 2001; Au et al. 2003; Jani et al. 
2004). Hence, cell culture is bound to be a limiting factor in OEC yield. Our prior 
observation of rat OEC cultures with daily light microscopy has demonstrated that 
there is an initial bust of cell growth in the first week, which is attributable to 
fibroblast proliferation, whereas the OECs tend to multiply in the second week. Li et 
al., (Li et al. 1997) reported that OEC cultures acquire their optimal reparative 
properties at around 14 days, during which time the proportion of OECs to 
fibroblasts was close to 50:50; fibroblasts predominate again thereafter. In our 
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human OECs cultures, we applied the principles of our rat culture protocol with a 
view to adjust and further improve based on our findings. We, therefore, cultured 
cells for 10-14 days and did not include any expansion or purification methods to 
obtain a baseline of the natural human OEC growing capabilities. We are currently 
exploring new methods by which to improve culture and yield of OECs, further 
discussed in Section 4.7. Furthermore, we avoided over-purification methods 
because animal data have demonstrated that treatment with OEC transplantation is 
only effective when both OECs and olfactory fibroblasts are transplanted (Li et al. 
1997). However, it remains to be demonstrated whether this is due to the interaction 
of the two cell types during co-culture, whether purified OECs are adequate in 
stimulating regeneration or whether a mixture of the two cell lines after separate 
bioprocessing of each line would be adequate. 
 
The number of OECs required for transplantation is currently unknown and depends 
on the size of the lesion. It has been suggested that approximately 10
7
-10
8
 of pure 
OECs may be adequate for transplantation of human spinal cord injury resulting in 
paraplegia (ASIA A) (Feron et al. 2005) although the effects of such regime has not 
yet been published. 
 
 
4.5 Limitations 
 
The present study is subject to a number of limitations. In what will follow I will 
expose these limitations and explain their implications for our findings.  
 
 153 
One of the main limitations of the current study is the relatively small number of 
biopsies included in the study. Given the fact that we were limited by the number of 
patients presented for FESS procedure and that ability to collect only one sample per 
patient for ethical reasons, collection of a greater number of biopsy specimens was 
not feasible. Nonetheless, the group of biopsies included in this study is a 
representative sample of common nasal mucosal disease, which may be encountered 
in patients presenting with spinal cord injury and need for OEC transplant mediated 
repair. In addition, the number of biopsies assessed in this study is considerable 
greater when compared to most other publications in this field.  
 
Another limitation of the present study the inability of collecting specimens directly 
from the cribriform plate which could potentially result in higher OEC yields. This 
limitation is unavoidable as a biopsy directly from the cribriform plate would 
invariably cause a CSF leak and lead to potentially serious complications for the 
subjects’ health.  
 
An additional limitation may be considered the indirect method of counting OEC 
number in culture as opposed to more robust methods such as Fluorescence 
Activated Cell Sorting (FACS). Unfortunately, this technology was not available in 
our laboratory and therefore not viable. However, it is known that with such 
manipulation of cell cultures a significant number of cells is lost, an undesirable 
feature, given the difficulty of human OEC culture expansion. Furthermore, our 
research group holds the belief that olfactory nerve fibroblasts an essential 
component of the cell suspension for intraspinal implantation that plays a role in the 
growth promoting ability of OEC grafts (Jani et al. 2004). 
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Last but not least, a well recognised difficulty, experienced by all laboratories 
investigating OECs, has been the lack of antibodies that uniquely identifies OECs. 
The same antibodies including p75
NTR
, GFAP and S100 can be used to 
immunolabel Schwann cells (Kawaja et al. 2009). The presence of Schwann cells 
from peripheral nerves in olfactory mucosa biopsies clearly necessitates the 
identification of antibodies or a battery of antibodies that uniquely identify OECs. 
Until this issue is resolved, it is impossible to confirm whether cells grown are 
OECs, a subgroup of Schwann cells or specialized fibroblasts.  
 
 
4.6 Future Directions  
 
The present study has been important in determining some of the factors, which 
affect the yield of human OEC cultures. Nonetheless, we are still left with many 
unanswered questions. With respect to OEC cultures, there is need for further 
improvement in the current human OEC culture protocol. We are currently exploring 
new methods by which to improve the yield. These include explant cultures, 
suppression of fibroblast proliferation leaving a higher purity population of OECs, 
and the use of growth factor Neurotrophic 3 to encourage growth of OECs.  
 
Furthermore, analysis of biopsies of normal healthy subjects without mucosal 
disease would be useful in confirming the effects of age, mucosal disease and other 
patient-related factors affecting yield. Perhaps cadaveric specimens would enable 
this to avoid ethical issues. Lastly, we will attempt to derive an allogenic OEC line 
that can proliferate indefinitely upon activation a transgene by tamoxifen and is 
subsequently arrested when removed from culture. 
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With respect to the safety of the procedure, we are already investigating the effects 
of olfactory mucosa biopsy with the surgical procedure described in this thesis to 
olfaction with standardized olfactory tests before and after surgery.  
 
 
4.7 Conclusion  
 
In sum, the present thesis set out to describe a biopsy technique of human olfactory 
mucosa biopsy and to investigate the effects of specimen- and patient-related factors 
on human OEC yield. Biopsies closer to the olfactory cleft were discovered to 
produce larger yields of OECs, and increasing age and nasal mucosal disease 
adversely affect the culture yield. Contrary to held belief, specimen position in the 
antero-posterior direction was not revealed to affect OEC culture yield. Similarly 
donor gender, smoking, loss of smell, grade of polyposis, preparatory solutions for 
the FES procedure and weight of specimen were not shown to affect OEC yield.  
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Chapter 5 
 
An introduction to the principles of magnetic resonance and 
magnetic resonance spectroscopy 
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5.1 Magnetic resonance spectroscopy 
 
Proton magnetic resonance spectroscopy (
1
H-MRS) is a valuable non-invasive 
technique which is increasingly used to evaluate the metabolic profile of the central 
nervous system. The history of magnetic resonance spectroscopy (MRS) is traced 
back to the first, independent observations of a nuclear magnetic resonance (NMR) 
signal in bulk matter by Block and Purcell in 1946. Two important applications of 
the NMR phenomenon in both clinical and research use are Magnetic Resonance 
Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS). In MRI, the protons 
present predominately in tissue water are detected and used to generate structural 
images. In MRS, it is the protons present in metabolites and macromolecules other 
than water that are of particular importance.  
 
Basic understanding of the fundamental principles of magnetic resonance is crucial 
for appreciating the role of MRS in the clinical setting. This chapter outlines the 
basic principles of magnetic resonance (MR) and MRS, to introduce the clinical 
application that is reported in the subsequent chapter of this thesis.  
 
 
5.1.1 Nuclear magnetic resonance 
 
NMR and NMR spectroscopy are techniques that depend on the magnetic properties 
of the atomic nucleus. Nuclei that have a net charge and are spinning acquire nuclear 
magnetic moments corresponding with spin ½ and are most suitable for detection by 
magnetic resonance. Important examples of such nuclei present in living systems are 
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1
H, 
31
P, 
13
C, 
15
N, and 
19
F. Hydrogen is the most abundant nucleus in the human body 
that possess a nuclear spin, its single proton gives it a relative large magnetic 
moment and is the preferred choice of proton in used in clinical applications.  
 
  
5.1.2 The NMR phenomenon  
 
When magnetic active spin ½ nuclei are placed in a homogeneous static magnetic 
field (B0) the nuclei populate two energy states. A lower energy state, which is 
parallel to the external magnetic field (spin-up) and higher energy state, which is 
aligned almost opposite to the external field (spin-down) (Figure 5.1). There is a 
statistical distribution of protons between the two states, so that there are slightly 
more protons in the parallel state. The ratio is proportional to the main magnetic field 
strength and inversely proportional to temperature. Although both states are stable, 
protons can swap between the two states by gaining or losing a certain amount of 
energy in the form of a photon (a packet of electromagnetic radiation). The energy 
gap () between the two quantum states is proportional to the strength of the 
magnetic field, and increases with increasing field strength. The energy required to 
be absorbed for the nucleus in the lower energy state to jump in the high energy state 
must match exactly  (Equation 5.1).  
 
  ΔΕ = h x f  = (h  B0) / 2  (Equation 5.1)  
 
where h is Planck’s constant and f is the frequency of the energy to be supplied to 
the photon for it to jump in the spin-up state. This frequency is equal to the Larmor 
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frequency. This orientation yields a net nuclear magnetization and a net 
magnetization vector Mz parallel to B0. 
 
 
Figure 5.1: Protons possess a magnetic moment, or “spin”. When placed in an 
external field B0, the low energy spins align parallel to B0 (along the z-axis), 
resulting in a magnetization vector Mz. 
 
 
Furthermore, when protons are placed in B0, they try to align themselves with the 
external field resulting in a circular motion around the axis of B0 (commonly the z-
axis), called precession. The precessional frequency of the protons is proportional to 
the external magnetic field, given by the Larmor equation (Equation 5.2): 
 
 Β0  (Equation 5.2) 
 
where γ is the gyromagnetic ratio, a natural constant specific for a particular nucleus 
and is the precessional frequency (the “Larmor frequency”) in Hertz (Hz). For 
protons  equals 42.576 MHz Tesla
-1
. The resultant longitudinal magnetization can be 
represented as the vector sum, the net magnetization (Mz) of the ensemble of nuclei 
in the magnetic field. It is virtually impossible to measure the magnetization while at 
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equilibrium when lying parallel to B0. If a second, time-dependent magnetic field 
(B1) is applied perpendicular to B0, by using a radiofrequency (RF) pulse at the 
Larmor frequency, the magnetization vector Mz will rotate away from the z-axis 
towards the xy-plane. The angle of rotation (α), or flip angle, of Mz around B1 is 
defined as:   
  α =  B1   (Equation 5.3) 
 
where  is the duration of the RF pulse field B1.  After application of a 90° pulse the 
magnetization vector will be in the xy-plane, and the spins will be in phase 
coherence; Mz will be zero and Mxy will be at a maximum (Figure 5.3). This process 
is commonly referred to as pulse excitation. After the RF pulse is switched off, the 
net magnetization vector will start reverting back to its equilibrium state as a result 
of a process, which is called relaxation. The recovery process along the longitudinal 
axis is called T1 relaxation or spin-lattice relaxation. The dephasing process in the 
transverse plane is referred to as T2 relaxation or spin-spin relaxation.  
 
 
Figure 5.2: Application of a 90° RF pulse flips Mz into the xy-plane (perpendicular 
to B0), resulting in magnetization vector Mxy and phase coherence between spins. 
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An RF coil placed in the transverse plane will detect the transverse component of the 
net magnetization vector as it precesses around B0. The amplitude of the signal in the 
receive coil will decay exponentially to zero in a few milliseconds as the protons 
rapidly dephase with respect to each other. The rate of signal decay is dependent of 
T2 and the process is described as:  
 
  Mxy(t) = Mxymax e
–t/T2
  (Equation 5.4) 
 
In practice, however, the signal will decay at a faster rate than T2 due to field 
inhomogeneities and magnetic susceptibility differences. This shorter relaxation rate 
is known as T2

.  
 
The decaying sinusoidal signal detected in the transverse plane after a single RF 
pulse is known as free induction decay (FID). The time domain signal is 
uninterpretable to the human eye. The FID signal can be subjected to a fast Fourier 
transformation (FFT) to convert the signal as a function of time (time domain) to a 
plot of intensity as a function of frequency (frequency domain) (Figure 5.3). The 
obtained spectrum has one peak for each resonant frequency in the sample. 
Variations in resonant frequencies provide information on the molecular structure in 
which the atom resides. The relative proportion of such molecule can be also then be 
estimated. 
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Figure 5.3: Free induction decay; after a single RF pulse the signal detected in the 
transverse plane is sinusoidal in shape and decays to zero over time under influence 
of the transverse relaxation. The FID signal is then subjected to a FFT to convert the 
signal as a function of time (time domain) to a plot of intensity as a function of 
frequency (frequency domain; Abbreviations: FFT = fast Fourier transform, ppm = 
parts per million. 
 
 
5.1.3 Chemical Shift 
 
Nuclei in different molecular environments resonate at slightly different frequencies. 
This occurs because the bonding electrons create their own small magnetic field that 
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modifies the external magnetic field (B0) in the vicinity of the nucleus. Thus a 
nucleus that is shielded from the static field experiences a smaller net field than that 
which is actually applied (effective field at the nucleus; B0eff) (Equation 5.5) and as a 
result, has a lower precession frequency. The effective field at the nucleus can be 
expressed in terms of a shielding parameter () and its effect is known as the 
chemical shift. While the shielding parameter is constant and stated in parts per 
million (ppm), the chemical shift increases linearly with field strength (Equation  
5.5) and is measured in Hz.  
 
  B0eff = B0 (1 - )  (Equation  5.5) 
  
Many resonances at a given chemical shift are split into two or more subpeaks 
(doublet, triplet, multiplet). These arise through the phenomenon of spin-spin 
coupling; the interaction between the atomic nuclei of neighbouring groups. The 
spacing between these peaks has a fixed frequency value (Hz) called the J-coupling 
constant. The J-coupling constant is independent of magnetic field amplitude. 
Molecules have characteristic number and pattern of subpeaks, which further allows 
identification of metabolites in a sample.  
 
The results of MRS are displayed as a spectrum of resonances (peaks) over a range 
of frequencies distributed along the x-axis, which is centered on the fundamental 
resonant frequency of the nucleus of interest, labeled in parts per million (ppm) 
(Figure 5.4). The signal intensity or amplitude of the resonances is measured on the 
y-axis using an arbitrary scale. The line width provide the “area” which can be used 
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to quantitate the amount of the observed chemical. The width of the peak is inversely 
proportionate to T2* relaxation time. 
 
Figure 5.4: Compounds detected in the brain with in vivo 
1
H NMR spectroscopy. 
Spectrum was acquired from the rat hippocampus at 14.1 T. Image from Duarte et 
al., 2012 (Duarte et al. 2012). Permission to reproduce this image has been granted 
by Elsevier Limited). 
 
5.1.4 Basic in Vivo localization techniques 
 
Basic in vivo MRS uses multiple RF pulses to localize on a given region of the body. 
Spatial localization techniques fall into two general categories: single voxel 
techniques where a spectrum is recorded from a single region and multi-voxel or 
otherwise called MR spectroscopic imaging (MRSI) or chemical shift imaging (CSI) 
where multiple regions are acquired simultaneously.  
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Single voxel techniques generate a cubic or rectangular based volume element 
(voxel) for a region to be sampled with MRS. The analyzed volume is selected by a 
succession of three selective radiofrequency pulses (accompanied by gradients) in 
three different directions in space (Gx, Gy, and Gz). These pulses determine three 
orthogonal planes whose intersection corresponds to the volume studied. Only the 
signal of this voxel will be recorded, by selecting only the echo resulting from the 
series of the three-radiofrequency pulses (Figure 5.5a). The two most common 
methods, used in single-voxel spectroscopy (SVS), are stimulated echo acquisition 
mode (STEAM) (Frahm et al. 1989) and point-resolved spectroscopy (PRESS) 
(Bottomley 1987).  For the work presented here, the PRESS sequence is used.  
 
PRESS generates a cubic or rectangular voxel by using slice-selective excitation in 
combination with two slice-selective refocusing pulse (Figure 5.5b). The initial 90˚ 
pulse is followed by an 180˚ pulse after a time period t1, which is subsequently 
followed by another 180˚ pulse at 2t1. The 90˚ pulse will affect spins in a particular 
slice. The first 180˚ pulse applied in the presence of a magnetic field gradient that is 
orthogonal to the first selection gradient will refocus spins only in the second slice, 
and will diphase spins outside that slice. The second 180˚ pulse is combined with a 
magnetic field gradient orthogonal to the other two gradient directions will result in a 
spin-echo signal from the intersection of all three slices which will appear at a time 
2t1 + 2t2, equal to the echo time of PRESS. The signal originates only from the 
rectangular box, the dimensions of which are determined by the width of the three 
selected slices. Signal outside of the volume of interest (VOI) is either not excited 
leading to rapid dephasing of the signal by the “crusher” magnetic field gradients. 
The block of 90˚-180˚-180˚ pulses is successively repeated. The time to echo time 
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(TE) refers to the time between the 90˚ pulse and signal sampling. The repetition 
time (TR) refers to the interval between successive 90˚ pulses. The PRESS technique 
can be used with short TE (15 – 20 ms) or long TE (135 – 270 ms). PRESS is less 
susceptible to motion, diffusion, and quantum effects and has a better SNR than 
STEAM. 
(A) (B)  
 
Figure 5.5: (A). The slice selective pulses along orthogonal axes define three 
orthogonal slices, with the volume of interest (voxel) located at the intersection of 
the slices. (B) Schematic overview of the PRESS sequence consists of a slice 
selective 90° and two refocusing 180° pulses. The 90° RF pulse rotates the spins in 
the yx-plane, followed by the first 180° pulse (spin rotation in the xz-plane) and the 
second 180° pulse (spin rotation in the xy-plane), which gives the signal. The use of 
crusher gradients on either side of the 180˚ pulses diphase unwanted magnetization 
outside the selected voxel. The entire sequence is preceded by water suppression 
schemes. 
 
 
 167 
5.1.5 Water Saturation  
 
The concentration of water exceeds the concentration (mmol/l) of metabolites of 
interest by a factor of 10,000 or more. If MRS were applied without suppressing the 
signal from water, the dominant resonance (the resonance peak) in a hydrogen 
spectrum will represent protons from the water molecule at 4.7 ppm, obscuring the 
millimolar concentration of other metabolites.   Hence, suppression of the water 
signal is critical for proton spectroscopy in order to reliably observe the much 
smaller metabolite signals.  
 
The most common approach is Chemically Selective Saturation (CHESS) (Haase et 
al. 1985), which is applied prior to the localization technique. It involves three short 
RF pulses of high amplitude applied along with a dephasing gradient to suppress the 
water (Figure 5.6). This allows for frequency selective excitation by permitting the 
metabolite resonances to rotate into the transverse plane, for signal detection, while 
the water is returned to the longitudinal axis, rendering it unobservable.  
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Figure 5.6: Schematic overview of the CHESS water suppression technique; the 
water signal is pre-saturated using frequency selective, 90° prior to the localization 
pulse sequence. By using more than one pulse and with correct choice of pulse flip 
angles, good suppression can be achieved.  
 
 
5.1.6 Shimming 
 
Optimization of the magnetic field homogeneity is an absolute requirement for 
obtaining high quality 
1
H-MRS spectra. A sample brought into the main magnetic 
field of the scanner distorts the magnetic field. The need for maximal field 
homogeneity is that due to the fact that the resonance frequency of the sample 
depends on the magnetic field strength. Spins experiencing the same field strength 
will resonate at the same frequency and thus produce a resonance with narrow line 
and low FWHM.  Narrow resonances will also result in stronger signal as the 
FWHM is inversely related to T2.  
 
1
H MRS requires using a process known as shimming to improve the global and/or 
local magnetic field. Shimming on the individual patient enhances the quality of in 
vivo spectra.  The bigger the region, the harder it is to homogenize the magnetic field 
throughout. These effects need to be corrected as much as possible before starting 
the spectroscopy examination. When human subjects are concerned, one is limited 
by the total examination time and thus a fast and reliable method is required.  
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It is common practice to monitor the MRS signal of the water resonance from the 
region of interest (ROI), and then optimize the magnetic field on the basis of that 
signal. While there are many different approaches to in vivo shimming, the common 
overall goal is to compute the desired corrective fields over the ROI and apply the 
necessary corrective currents as offsets to the imaging gradient or to the higher-order 
shim coils. The advent of automatic ‘shimming’ programs have greatly improved the 
ease of acquisition.  Voxel homogeneity is usually measured as the linewidth (the 
full-width at half height) of the water resonance and may be quoted in Hz or ppm. 
 
 
5.1.7 Physiological movements 
 
Movement of the patient or desired volume of interest relative to the magnet during 
the total acquisition period can result in the signal coming from outside the selected 
voxel leading to underestimation of the metabolite concentrations. In the brain and 
with short scanning times this may not pose a problem. However, in the spinal cord 
and particularly in the cervical region, the flow cerebrospinal fluid around the 
subarachnoid space, dominated by the cardiac cycle, translates into actual cord 
movement in the craniocaudal dimension (Mikulis et al. 1994). Cardiac gating 
techniques prospectively gate the acquisition to periods when the cord is within a 
specific location. 15% loss in signal and 25% increase in linewidth have been 
demonstrated in ungated data compared to gated acquisition. A gating delay of 400 
ms after cardiac systole has been found to provide the most stable spectra (Cooke et 
al. 2004). New methods are being developed including motion tracking with 
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dynamic feedback to adjust volume selection frequencies accordingly (Kozerke et al. 
2002).  
 
 
5.1.8 Post-processing  
 
Common post-processing of SVS spectra, before or after the application of the FFT, 
includes multiplication with a filter in the time domain, zero-filling, FT, phasing, and 
baseline correction (van der Graaf 2010) to improve MRS data obtained.  
 
In addition, in localized MRS gradient switching may cause eddy current artifacts. 
Eddy currents are small, transient currents induced in the magnet structure after the 
application of a pulsed field gradient resulting in small time-varying change in the 
magnetic field strength and, consequently, artifacts in the spectral lineshape. Such 
artifacts can be removed with a reference water signal obtained without water 
suppression using the same sequence and from the same VOI. This so-called eddy 
current correction (ECC) is applied as a first post-processing step, and it results in 
line-shape corrections in the metabolite spectrum together with the removal of 
offsets in zero-order phasing and frequency (van der Graaf 2010).  
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5.1.9 Quantification of metabolites 
 
Quantitative analysis of MRS spectra either requires the determination of peak areas 
in the frequency domain or direct time-domain analysis to estimate the amplitude of 
the first data point of the different frequency components that comprise the FID.  
 
The most sophisticated and most widely software used is the co-called Linear 
combination model (LCModel), which fits the frequency domain data to a linear 
combination of the pure compound spectra known to exist in the spectrum 
(Provencher 1993). The model spectra in the database may be obtained from in vitro 
measurements of metabolite solutions using the same pulse sequence and timings as 
the in vivo measurement or by computer simulations (van der Graaf 2010). The 
advantage of the LCModel program is that the entire spectral pattern associated with 
each metabolite is used for the fitting.  
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Figure 5.7: An example of LCModel analysis method. The LCModel analyzes an in 
vivo spectrum as a Linear Combination of Model in vitro spectra from individual 
metabolite solutions. Automated baseline and phase-correction is performed and an 
estimate of metabolite concentrations is provided using the water reference signal 
for quantitation. In this example a 2.2 ml PRESS spectrum recorded at 3.0 T from a 
normal control subject (TR/TE/number of averages = 3000/30/160), the difference 
between the original experimental data and the results of the curve fit is shown in 
the top trace. Metabolite concentrations highlighted in blue correspond to those with 
an estimated uncertainty (Cramer-Rao lower bounds (CRLB) of less than 20%. 
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This quantification method results in signal intensities in arbitrary units, with ratios 
often used in clinical diagnosis. For brain spectra, the intensity of the methyl 
resonance of creatine is commonly used for normalization. Although this 
normalization removes differences, for example in volume and coil loading, a 
change in a ratio can be caused by changes in both numerator and denominator (Li et 
al. 2003). 
 
 
5.1.10 Quality of MRS spectra and signal-to-noise ratio 
 
In MRS applications, it is generally not the signals of water and fat that are of 
interest, but rather the smaller metabolite signals, thus a magnetic field of sufficient 
strength is required. Therefore, most clinical MRS measurements are performed 
using MR systems with field strengths of 1.5 T or higher. Even with such magnet 
strengths, metabolites with concentrations of 0.5 mM or more can only be 
recognised in in vivo MRS. 
 
In an NMR experiment, the ability to detect a signal depends not only on the signal 
amplitude, but also on the amount of noise in the spectrum i.e. the signal-to-noise 
ratio (SNR).  Noise is generated by the presence of the patient in the magnet and the 
background electrical noise of the system produced by random, thermal motion of 
electrons in the receive coil. Noise occurs at all frequencies and is random in time 
and space, but is constant for a specific patient.  
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SNR and chemical shift dispersion are expected to increase approximately linearly 
with increasing magnetic field strength (B0) and so in vivo MRS is expected to be 
superior at higher field strengths (Equation 5.2). Furthermore, increasing the voxel 
size enables the signal to contain more spins to contribute towards the signal. On the 
other hand, large voxels introduce partial volume effects, which may not be 
desirable. Moreover, to accumulate sufficient SNR most in vivo studies require 
averaging of usually hundreds of acquisitions (n) in order to achieve the desired 
spectral quality. This result in an increase in scan time, the scan time being 
proportional to n and TR.  
 
 
5.1.11 Limitations of MR 
 
There are several limitations to MRS regardless of the technique used. It is difficult 
to perform MRS in or adjacent to tissue with high differences in magnetic 
susceptibility compared with brain tissue, such as bone, air, fat, and hemorrhage. 
This is due to the artifacts arising from these structures and the resultant difficulty in 
obtaining a homogeneous magnetic field, essential for a good MRS study. Hence, 
spectra of good quality are difficult to obtain near the skull base, calvarial bone, 
paranasal sinuses, and mastoid air cells. The artifacts can contribute to so much 
spectral broadening that the spectra obtained from these regions may contain no 
discernible metabolite resonances, often rendering them useless. As a result, 
characterization of lesions in these challenging areas has generally relied on SVS, 
which is less prone to susceptibility artifacts.  
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5.2 Major metabolites in the central nervous system and their significance 
 
The first high resolution proton magnetic resonance spectroscopy (
1
H-MRS) studies 
of the animal brain were performed in 1983 (Behar et al. 1983). These studies 
demonstrated that 
1
H-MRS allows in vivo observation of a number of brain 
compounds, including different aminoacids, phosphocreatinine, trimethylamine 
resonances, myoinositol and lactate. A series of experiments followed, in which 
1
H-
MRS has been applied to examine different aspects of nervous system metabolism 
under various conditions. The bulk of work of 
1
H-MRS has been performed on brain 
tissue because technical factors favour 
1
H-MRS on this organ; motion is a relatively 
smaller problem, shimming is less disturbed by the mass of nearby tissue as well as 
by motion, and lipids interfere less in the normal state they are part of myelin or 
other large molecules that are not mobile enough to give narrow signals.  
 
In the following sections, the major metabolites identified in the brain and potential 
roles are discussed.  
 
 
5.2.1 N-acetylaspartate (NAA) 
 
The most prominent signal observed in brain 
1
H-MRS acetyl group of N-acetyl 
aspartate resonates at 2.01 ppm, with contribution from N-acetyl aspartyl glutamate 
(NAAG) at 2.04 ppm (Frahm et al. 1991; Pouwels et al. 1997). Its detailed 
physiological role is yet unknown. NAA is synthesized in neuronal mitochondria and 
is speculated to be a source of acetyl groups for lipid synthesis, a regulator of protein 
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synthesis, a storage from of acetyl-CoA and aspartate, a breakdown product of 
NAAG and an osmolyte (Barker 2001). More importantly, in the nervous system 
NAA is a putative neuronal marker due to its exclusive intraneuronal distribution 
and expression demonstrated with immunocytochemical staining techniques 
(Simmons et al. 1991).  
 
Reductions in NAA have been noted in conditions associated with neuronal loss or 
axonal degeneration. Reduced NAA levels have demonstrated in acute and chronic 
lesions cerebral multiple sclerosis (MS) plaques and in normal appearing white 
(Tourbah et al. 1996) and gray matter in patients with MS (De Stefano et al. 2001; 
Chard et al. 2002), providing evidence that NAA may be a marker of neuroaxonal 
damage. Furthermore, the relative NAA concentrations have been shown to correlate 
with the neurologic disability in MS patients (De et al. 1998) and, in fact, the NAA 
deficit correlated with MS-related clinical disability better than the traditional MR 
imaging radiologic markers (De Stefano et al. 2001).   
 
In experimental models of spinal cord injury, prolonged decreases in NAA have 
been noted in rostral, epicenter and caudal segments of the spinal cord, which were 
correlated with histological confirmation of neuronal cell death in the grey matter 
and axonal degeneration in the dorsal lateral and ventral white matter columns (Qian 
et al. 2010). 
 
In addition, NAA levels are found to be absent in tumors of glial origin (Sibtain et al. 
2007) and to decrease in neuropathological conditions, correlating with the degree of 
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degeneration in humans and rodents (Kantarci 2007; Tkac et al. 2007; Horska et al. 
2009).  
 
Moreover, Bates et al. (Bates et al. 1996) have shown that NAA is a mitochondrial 
product related to oxygen consumption and adenosine triphosphate (ATP) synthesis 
and that inhibition of electron transport leads to reduced NAA synthesis by isolated 
rat brain mitochondria. In addition, after transient ischemia and brain injury without 
neuronal death, and in longitudinal studies of MS, NAA levels have been shown to 
recover (Brulatout et al. 1996; Audoin et al. 2006; Tiberio et al. 2006). Thus reduced 
NAA can be more generally interpreted as neuronal dysfunction rather than decrease 
in neuronal density or axonal structural integrity (Cader et al. 2007). 
 
 
5.2.2 Creatine (Cr)  
 
The creatine methyl resonance (Cr) is a composite peak consisting of both creatine 
and phosphocreatine (total Cr) and resonates at 3.03 ppm. Creatine is involved in 
energy metabolism via the creatine kinase reaction generating ATP, hence, is a 
measure of global cellular metabolic activity and a marker for brain cell density in 
glial and neuronal cells. Total Cr is used as an internal reference in reporting relative 
concentrations of other metabolites because it is considered to be a relatively stable 
compound. Cr has been shown to have large regional variations with lower levels in 
white matter than grey matter in normal brain (Jacobs et al. 2001) Cr may also 
increase as a hyperosmolar response to craniocerebral trauma, or be absent as in the 
case of creatine deficiency, a rare congenital disease (Zimmerman et al. 1997).  
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5.2.3 Myo-Inositol  
 
Another prominent signal visible at 3.61 ppm in spectra obtained at 3 Tesla with 
short TE is myo-inositol (m-Ins). M-Ins is pentose sugar involved the inositol 
triphosphate intracellular second messenger system, primarily synthesized in glial 
cells and postulated to be a glial marker (Brand et al. 1993). The concentration of m-
Ins increases with glial proliferation or with glial cell-size increase, both of which 
occur in inflammation (Brand et al. 1993; Flogel et al. 1994; van der Graaf 2010). It 
is suggested that this may be related to a difference in m-Ins/Na co-transporter 
activity that appears to play a key role in astrocyte osmoregulation (Strange et al. 
1994). This would explain chronic disturbance in m-Ins in both degenerative and 
inflammatory disease. Alternatively, m-Ins may represent a breakdown product of 
myelin. Levels have been found reduced in hepatic encephalopathy (Singhal et al. 
2010) and increased in Alzheimer’s dementia (Miller et al. 1993), demyelinating 
diseases (Ciccarelli et al. 2007; Marliani et al. 2010) and HIV infection 
(Laubenberger et al. 1996).  
 
Following complete transection of the spinal cord of rodents, conspicuous increases 
of m-Ins in the pericontusional zone below the level of injury in the acute (3 days 
post injury) and chronic period (4 months post injury) have been observed below the 
level of injury (Erschbamer et al. 2011). These increases correlate with the well 
known increases in glial fibrillary acidic protein (GFAP) immunoreactivity in 
histological examination, confirming an association of m-Ins and astrogliosis 
(Erschbamer et al. 2011). 
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5.2.4 Choline  
 
The choline (Cho) signal resonates at 3.2 ppm and is a composite peak consisting of 
contributions from the trimethyl amine groups (N(CH3)3) of glycerophosphocholine 
(GPC), phosphocholine (PC) and a small amount of free choline (Barker et al. 1994). 
Choline-containing compounds are essential for membrane lipid synthesis. Choline 
is released from the breakdown of phosphatidylcholine found in membranes, 
salvaged and reused by the action of choline kinase, converting it to 
phosphorylcholine. It is then converted to phosphatidylcholine and incorporated into 
new membranes (Daly et al. 1987). Therefore, fluctuations of this marker are 
considered an indicator of cellular turnover related to both membrane synthesis and 
degradation (Carpentier et al. 2006) and increased Cho/Cr ratios have been observed 
with demyelination (Cecil et al. 1998), inflammatory reactions (Friedman et al. 
1999; Brooks et al. 2000), and glial proliferation (Garnett et al. 2000). 
 
Elevations in Cho/Cr ratio have, also, been observed in human 
1
H-MRS studies after 
traumatic brain injury in normal-appearing gray matter, which correlated with injury 
severity and outcome and were attributed to pathological alterations in membrane 
turnover (Friedman et al. 1999; Brooks et al. 2000; Garnett et al. 2000). In 
experimental brain studies, elevations have been observed in the pericontusional 
brain regions (Schuhmann et al. 2003) following an initial decrease in Cho/Cr 
compared to controls.  
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Furthermore, brain tumors generally show an increase in the Cho signal, and the Cho 
level is believed to correlate directly with proliferative potential and malignancy 
(Herminghaus et al. 2002). Therefore, an increase in the total choline signal is often 
used in the diagnosis of a brain tumor. 
 
 
5.2.5 Lactate 
 
Lactate (Lac) is a doublet and resonates at 1.31 ppm. It indicates anaerobic 
metabolism and an alteration in the normal cellular biochemical oxidative process 
(Veech 1991). It is undetectable in most brain studies due to its low concentration 
within the brain under normal conditions. It may, however, be increased and detected 
in pathological conditions involving inflammation, local hypoxia or ischaemia 
and/or neuronal mitochondrial dysfunction with the resultant production of excess 
Lac (Petroff et al. 1992; Simone et al. 2001; Holly et al. 2009). Lactate may difficult 
to detect in MRS studies due to overlapping lipid resonances. Special editing 
techniques or long TE is required to achieve detection (Kelley et al. 1999).  
 
 
5.3 MRS of the spinal cord  
 
In vivo 
1
H-MRS of the spinal cord is challenging because of the technical difficulties 
that limit the quality of the spectroscopic data. The main obstacles encountered are 
the strong magnetic field inhomogeneities around the cord, physiological movements 
and the small cross sectional size of the spinal cord. Therefore, it is no surprising that 
relatively few 
1
H-MRS studies of the spinal cord have been performed to date.  
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The first human study of 
1
H-MRS in the spinal cord was performed in a cohort of 6 
healthy patients, which demonstrated the feasibility of 
1
H-MRS of the spinal cord 
using a 1.5 Tesla system. Satisfactory spectra were acquired and the major metabolic 
peaks could be accurately identified and quantified (Gomez-Anson et al. 2000). The 
development of 3 Tesla systems with increased SNR allowed a good compromise 
between the size of the acquisition volume and the number of repetitions required to 
obtain a total acquisition time that is feasible in a clinical environment. Marliani et 
al, (Marliani et al. 2007) first devised an acquisition and post-processing single-
voxel MRS protocol on the cervical spinal cord of healthy subjects on a 3 Tesla 
system with standard equipment and successfully evaluated the mean relative 
concentrations of the main normal metabolite concentrations and ratio in respect to 
Cr, including NAA (mean = 1.4, sd; 0.3), Cho (mean = 0.5, sd; 0.1) and M-Ins (mean 
= 1.7, sd; 0.2).  
 
The majority of human spinal cord 
1
H-MRS studies have been performed on patients 
with MS plaques since the commonly used T1- and T2-weighted MR sequences 
provides poor specificity and sensitivity in detecting pathophysiologic MS changes 
and correlation with clinical disability. These studies demonstrated changes in 
metabolites ratios that were in accord with the metabolic abnormalities already 
described in brain plaques of patients with MS, confirming that 
1
H-MRS allows 
examination of spinal cord integrity at a biochemical level and may be sensitive to 
subtle changes occurring during the course of MS disease. Significantly reduced 
levels of NAA in respect to Cr compared to healthy controls are shown in all studies 
(Kendi et al. 2004; Blamire et al. 2007; Ciccarelli et al. 2007; Marliani et al. 2010), 
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which correlated with neurological assessment measures (Blamire et al. 2007; 
Ciccarelli et al. 2007; Marliani et al. 2010). Furthermore, increases in m-Ins/Cr and 
Cho/Cr levels in comparison with healthy cervical spine tissue have also been shown 
(Marliani et al. 2010), suggesting an increase in the activity or number of glial and 
inflammatory cells and attacks of demyelination and remyelination respectively. M-
Ins levels have also been correlated to MS-specific disability scores further 
supporting that 
1
H-MRS spectroscopy is sensitive to metabolic changes in the spinal 
cord in these patients.  
 
Moreover, 
1
H-MRS studies in patients with amyotrophic lateral sclerosis have 
demonstrated 40% and 38% reductions in NAA/Cr and NAA/m-Ins respectively 
(Carew et al. 2011) with significant correlations with forced vital capacity (FVC).  
 
A methodologically interesting study of volume selective 2T 
1
H-MRS of the spinal 
cord in healthy subjects Cooke et al. in which concentrations of NAA, Cr and m-Ins 
of the cervical spine were compared with data from the brainstem, cerebellum and 
cortex of the same individuals provided important technical information (Cooke et 
al. 2004). Firstly, it demonstrated that the distortion of the B0 field was dominated by 
the interfaces between the vertebral spinous processes and interspinous connective 
tissue and that the atypical anatomy of the first two cervical vertebrae allowed 
slightly larger voxel to be adequately shimmed. The ideal voxel size was shown to 
be 9 mm in the transverse direction by 7 mm in the anteroposterior by 35 mm in the 
craniocaudal direction, resulting in a voxel volume of 2.21 ml. This was placed 
aligned with the spinal cord at the level of C2 vertebral body.  Secondly, it showed a 
15% increase in signal and 25 % decrease in linewidth by varying the trigger delay 
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such that the acquisition period occurred 400 ms after cardiac electrical systole, 
therefore, reducing the effects of physiological movements.  
 
 
5.4 MRS of traumatic spinal cord lesions 
 
Only two studies have been performed in traumatic conditions of human spinal cord. 
Holly et al. (Holly et al. 2009) compared patients with cervical spondylotic 
myelopathy on a 1.5 T scanner and demonstrated significantly lower NAA/Cr ratios 
(mean = 1.27, sd; 0.52) than the controls (mean = 1.83, sd; 0.18).  No significant 
difference was seen in the Cho/Cr ratios.  In addition, 7 of the 21 patients had 
demonstrable Lac peaks, which were not present in the control group. There were 
statistically significant differences in the NAA/Cr ratio in patients with or without 
Lac peaks compared with the controls. However, there was no significant correlation 
between the NAA/Cr ratio and neurological status within patient group.  M-Ins 
levels were not quantified.  
 
In a study of whiplash injury(Elliott et al. 2011), metabolite ratios were quantified in 
5 patients and 7 controls.  Significant reductions in NAA/Cr ratio was found in 
patients when compared with healthy controls (mean = 1.3, sd; 0.5 and mean = 2.0, 
sd; 0.7 respectively). No differences were demonstrated in Cho/Cr ratio and m-Ins 
was not studied.  
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5.5 Proton MRI in brachial plexus avulsion and re-implantation  
 
In the previous sections, the principles of magnetic resonance imaging and major 
metabolites and their function were discussed. In addition, the limited number of 
studies in the human spinal cord affected by different conditions were described. In 
the next chapter, we present a study of 
1
H-MRS of the spinal cord in patients with 
brachial plexus re-implantation surgery compared with control subjects.  
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Chapter 6 
 
1
H-MRS as a diagnostic and prognostic tool in brachial plexus avulsion 
injury and re-implantation surgery 
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This chapter investigates the application of spinal cord 
1
H-MRS and its usefulness in 
revealing metabolic changes occurring in the spinal cord following re-implantation 
surgery for complete brachial plexus avulsion.  
 
 
6.1 Aims 
 
The present study applies 
1
H-MRS of the spinal cord in an attempt to reveal 
abnormalities in patients with spinal cord pathology and provide information 
regarding neuronal viability, cellular composition and thus provide diagnostic and 
prognostic insights.  We aim to assess whether 
1
H-MRS of the upper cervical cord 
(i.e. above the site of injury) detects pathological changes in patients with complete 
brachial plexus root avulsion who have received re-implantation surgery and patients 
with complete brachial plexus root avulsion who have not had any surgical 
intervention when compared with healthy subjects. In addition, we aim to explore 
the relationship between metabolite concentrations and clinical disability in patients.  
 
 
6.2 Methods 
 
6.2.1 Patient recruitment 
 
For the purposes of this study we have recruited a population of patients with 
complete brachial plexus avulsion injury from the surgeons’ complete database of 
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brachial plexus avulsion injury and list of re-implantation cases. In order for this 
cohort to be uniform we have included only patients that have had a diagnosis of 
complete avulsion injury by open exploration of the brachial plexus by TC.  Patients 
in whom, at the time of exploration, the diagnosis of complete brachial plexus 
avulsion could not be confirmed (for example when there was suspicion of intradural 
rupture rather than avulsion or rootlets of one or more root remained attached) were 
excluded. The important findings described in Chapter 2 were not known at the time 
of recruitment of these patients.  
 
This study was approved by the National Hospital for Neurology and Neurosurgery 
and Institute of Neurology Research Ethics Committee. Once informed consent was 
obtained, we collected clinical data and performed MR spectroscopy.   
 
 
6.2.2 Participants 
 
To the date of data collection for this study, twenty-five patients who have had re-
implantation surgery (re-implantation group) and sixteen patients with complete 
brachial plexus avulsion injury who have had no surgical intervention (control 
group) were identified for participation in our study. From these, 10 patients from 
the re-implantation group and five patients from the control group were scanned. The 
remaining patients were not assessed for one of the following reasons: (a) had been 
lost to follow up,  (b) patients declined participation, (c) patient had MRI-
incompatible metal implants or tattoos (d) have had amputation of the affected arm 
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or, (e) had associated lower limb weakness. Nineteen age- and sex-matched healthy 
subjects (healthy group) recruited from the community were also studied.  
 
 
6.2.3 Clinical assessment 
 
On the day of the scan, patient disability was assessed using the following scales: (i) 
Disability for Arm, Shoulder and Hand (DASH) (Beaton et al. 2001), which is a 30-
item self-report questionnaire designed to measure physical function and symptoms 
in people with musculoskeletal disorders of the upper limb. A higher score indicates 
greater disability; (ii) Visual Analogue Pain Scale (VAS), a widely used tool for 
measuring pain by asking the patient to indicate his/her perceived pain intensity by 
marking a point along a 100 mm horizontal line (Flaherty 1996); (iii) Michigan 
Hand Outcomes Questionnaire (MHQ) (Chung et al. 1998; Chung et al. 1999), 
which is a hand-specific questionnaire including six subscales: overall hand 
function, activities of daily living (ADL), pain, work performance and patient 
satisfaction with hand function and aesthetics. Higher scores indicate better hand 
function, except for the pain subscale on which higher scores correspond to more 
pain (13).  
 
A summated muscle score of the MRC grade of 7 upper limb muscles of the affected 
arm was used to assess global power in the affected arm (“global MRC score”) as 
described in Chapter 2 (Section 2.3.2). 
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6.2.4 MR protocol and spectroscopy 
 
All MR data were collected on a Magnetom Tim Trio 3T system (Siemens AG, 
Erlangen, Germany), using the posterior half of a 12 channel head coil, the posterior 
part of a neck array coil, and the upper element of the spine array coil.  
 
All subjects underwent conventional T2-weighted sagittal and coronal images 
(sagittal-oblique: turbo spin echo with effective TE = 96ms; TR = 3s; parallel 
imaging with acceleration factor 2; field of view (FoV) = 220mm
2
, in-plane 
resolution 0.69 x 0.92 mm
2
, slice thickness = 1.5 mm, gap = 0.15 mm; coronal-
oblique: 3D-HASTE with TE = 247 ms; TR = 3 s; parallel imaging with acceleration 
factor 2, FoV = 200mm
2
, in-plane resolution = 0.78 x 0.78 mm
2
, 52 partitions, slice 
thickness = 0.8 mm), which confirmed the normal radiological appearance of the 
spinal cord in all patients. These scans were acquired aligned with the main axis of 
the spinal cord, essential for correctly positioning the spectroscopy voxel. 
 
Single-voxel spectra were obtained by cardiac-gated point resolved spectroscopy 
(PRESS) sequence with TR ≅ 3000 ms (depending on the cardiac cycle), TE = 30 
ms and 160 averages, with chemical-shift-selective (CHESS) water suppression 
(Haase et al. 1985). We used the PRESS sequence provided by the manufacturer, 
and no additional saturation bands were used. The excitation frequency was -2.3 
ppm, with respect to the water reference frequency, i.e. 2.4 ppm. Readout bandwidth 
was 1200 Hz (1024 points collected). Our longer TR compared with previous studies 
reduced sensitivity to metabolites T1 changes. A non water-suppressed spectrum (2 
averages) was also acquired for eddy-current correction. The spectroscopic voxel 
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was placed along the main axis of the cord, centered at C2 spinal level with its 
prescription boundaries completely contained within the cord on the T2-weighted 
images in all three planes (Figure 6.1). Optimal shim currents for all first-order (X, Y 
and Z) and second-order (Z
2
, ZX, ZY, X
2
-Y
2
 and XY) shim gradients were calculated 
off-line with in-house software based on: i) acquisition of field maps (gradient-
recalled sequence generating two images with TE = 4.92 ms and TE = 7.38 ms 
respectively, 2 mm isotropic resolution, 1 min. acquisition time); ii) minimisation of 
the magnetic field variation within the prescribed MRS voxel using calibrated field 
maps for each shim coil (Webb et al. 1991; Kim et al. 2002).  
 
All MRS spectra were analysed by means of the user-independent frequency-domain 
fitting software LCModel 6.1 (Provencher 1993) within the 0.2 - 4.0 ppm range. 
Ratios of the following metabolite concentrations were calculated with respect to 
total Creatine (Cr) concentration (Creatine plus Phosphocreatine): total N-acetyl-
aspartate (NAA) (equal to NAA plus NAAG), total Choline (Cho) (equal to 
Glycerylphosphorylcholine GPC plus Phosphocholine) and myo-Inositol (m-Ins). 
LCModel standard error estimates (%SD, Cramer-Rao lower bounds (CRLB)) were 
used to assess the confidence of the concentration estimates.  
 
 
6.2.5 Statistical analysis 
 
Statistical analysis was performed on data which passed quality control criteria. 
Initially, all in-vivo data was fitted using LCModel and spectra with a signal-to-noise 
ratio, SNR < 6 and full width at half maximum, FWHM > 0.14 were deemed to be of 
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poor quality and eliminated from further analysis. The values for SNR and FWHM 
were calculated by LCModel as part of the fitting process. LCModel estimates were 
retained if the %SD was equal to or lower than 21% for Cr and for the metabolite of 
interest.  
 
Statistical comparisons and correlations were performed using STATA statistical 
software Version 10.1 (StataCorp LP College Station, TX). Data for each metabolite 
were tested for normal distribution and for homogeneity of variances. Differences in 
metabolite ratios between groups were estimated using the unpaired two sample 
Student’s t test (t). The relationship between disability and metabolite ratios was 
tested in patients using multiple linear regression, using the clinical scores, in turn, 
as the dependent variable and the metabolite ratios as independent variables. 
 
 
6.3 Results  
 
6.3.1 Excluded patients and description of study groups 
 
The water suppression technique or shimming procedure failed due to technical 
errors in 4 healthy subjects, 2 patients with re-implantation and 1 patient without re-
implantation. In addition, spectra of 1 healthy subject and 1 patient without re-
implantation demonstrating CRLB %SD of [Cr] > 21%  (%SD = 32 and %SD = 73 
respectively) were excluded. Thus, the final MRS data following exclusions came 
from: 14 healthy subjects; 13 men and 1 woman with and average age of 36.1 yrs 
(sd; 10.7).  
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The re-implantation group consisted of 8 men with average age of 35 years (sd; 
10.8). All patients underwent ventral root re-implantation within one month from the 
day of their injury. The mean duration from injury to assessment for this study was 
5.5 years (sd; 4.3). M-Ins/Cr ratio was excluded from the analysis in three healthy 
subjects because of %SD of m-Ins >21%. NAA/Cr was excluded in three different 
healthy subjects and one patient with re-implantation because of %SD for tNAA 
>21%.  
 
Following exclusions, 3 patients were included in the control group (patients without 
re-implantation). These were all men and had an average age of 39.3, (sd; 10.3). 
However, the spectrum of one control patient showed an FWHM of 25 Hz (group 
mean; 18.2 Hz, sd; 6.5) deeming the data of this patient unreliable for statistical 
analysis and, therefore excluded (Figure 6.2 (D)). Consequently, that left only 2 
control patients, rendering group comparisons of metabolite concentrations and 
correlations with disability scores of little value.  
 
6.3.2 Spectroscopic voxel  
 
Typical location and size of the VOI in the spinal cord is shown in Figure 6.1 (A and 
B). The average size of the spectroscopic voxel was 5.9 mm (sd; 0.3 mm) in the 
anteroposterior dimension, 49 mm (sd; 5 mm) in the cranio-caudal dimension and 
7.4 (sd; 0.7 mm) in the transverse dimension. The mean volume of the spectroscopic 
voxel was 2.1 ml (sd; 0.6 ml). 
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(A)     (B)  
 
Figure 6.1: Location of the spectroscopic voxel between C1 and C3 on the T2-
weighted image of a healthy subject in the sagittal (A) and coronal (B) dimension.  
 
The mean FWHM and SNR values estimated by LCModel were 11 Hz (sd; 2.2 Hz) 
and 2.4 (sd; 0.8) respectively for the healthy subjects. The corresponding values for 
the re-implantation group were 10 Hz (sd; 4 Hz) and 2.9 (sd; 1.0) respectively. A 
Student’s t test showed no significant difference in FWHM between the healthy 
subjects and re-implantation groups (t(21) = 0.12, p = 0.91). The overall chemical 
shift was fairly small in terms of volume shift and mis-positioning of the VOI. 
Representative spectra for each patient group are shown in Figure 6.2. 
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(A) 
 
 
(B) 
 
 
 
 
Figure 6.2 (A and B): Representative spectra derived from each patient group; (A) 
healthy subject, (B) patient with re-implantation surgery. The spectrum derived from 
the healthy subject (A) shows reduced m-Ins/Cr ratio (m-Ins/Cr  =1.37; %SD 11) in 
comparison with a spectrum obtained from a patient with re-implantation (B) (m-
Ins/Cr  = 2.11 (%SD 10). 
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(C)
 
(D)
 
 
Figure 6.2 (C and D): (C) A spectrum obtained from a patient without re-
implantation surgery. FWHM= 13, SNR = 6, %SD Cr = 7,  %SD NAA = 11, %SD 
m-Ins = 16, %SD Cho = 8,  (D) An unreliable spectrum of a control patient. FWHM 
= 25, SNR = 1, %SD Cr = 20,  %SD NAA = 25, %SD m-Ins = 17, %SD Cho = 16. 
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6.3.3 Metabolite concentrations 
 
The group mean %SD values obtained by LCModel analysis for the main 
metabolites in healthy volunteers were 11 for Cr, 13 for NAA, 16 for m-Ins and 14 
for Cho. For the patient group with re-implantation surgery mean %SD values for 
each metabolite were 12, for Cr, m-Ins and Cho and 15 for NAA (Table 6.1).  
 
 
Table 6.1: Cramer-Rao lower bounds (CRLB) quantified by LCModel in the spinal 
cord between C1 and C3 spinal level for each metabolite (%). 
 
 Cr (sd) NAA (sd) m-Ins (sd) Cho (sd) 
Healthy  11 (3) 13 (5) 16 (6) 14 (4) 
Re-implantation 12 (3) 15 (8) 12 (5) 12 (4) 
No re-
implantation 
11 (8) 23 (11) 12 (7) 11 (5) 
 
 
The mean concentrations of metabolites quantified by LCModels in the spinal cord 
between C1 and C3 relative to total Cr are presented in Table 6.2. Comparison with a 
Student’s t test revealed a statistically significant difference in m-Ins/Cr ratio 
between healthy subjects and the re-implantation group (t (19) = -3.73; 95%CI = -
1.05 to -0.29; p = 0.001) (Table 6.2). No significant differences in absolute Cr 
concentrations were observed between groups. There was no significant difference in 
Cho/Cr (t (20) =  -0.76; 95%CI = -0.11 to 0.05; p = 0.45) or NAA/Cr concentration 
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ratios between healthy subjects and patients with re-implantation (t (15) =  -0.19; 
95%CI = -0.38 to 0.31; p = 0.85) (Table 6.2).  
 
 
Table 6.2: Mean concentrations of metabolites quantified by LCModels in the spinal 
cord between C1 and C3 in healthy controls and patients with re-implantation and 
comparisons of metabolite concentrations between the two groups. Asterix (*) 
denotes statistically significant difference between groups. Concentrations are 
quantified relative to total creatine (Cr).  
 
Ratio Controls 
Mean (SD) 
 
Re-implantation 
Mean (SD) 
p value 
NAA/Cr 1.19 (0.29)      1.21 (0.38) 0.85 
m-Ins/Cr   1.18 (0.38)* 1.86 (0.41)*   0.001* 
Cho/Cr 0.30 (0.08) 0.33 (0.45) 0.45 
 
 
6.3.4 Correlation of metabolite ratios with disability scores and patient 
variables in patients with re-implantation surgery 
 
Multiple regression analysis of m-Ins/Cr ratio of the patients with re-implantation 
showed that m-Ins/Cr ratio was independently associated with both DASH scale and 
time from injury (R
2
 = 84%; F = 13.56; p = 0.0096). In particular, a higher m-Ins/Cr 
ratio correlated with greater disability, as measured by the DASH scale (t (7) = 2.86; 
95%CI = -0.001 to -0.02; p = 0.035) (Figure 6.3), and with shorter time from injury 
(t (7) = -5.15; 95%CI = -0.02, -0.006; p = 0.004) (Figure 6.4). Comparison of 
predictor coefficients shows that a one standard deviation increase in DASH score 
leads to a 0.55 standard deviation increase in predicted m-Ins/Cr ratio and a one 
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standard deviation increase in the length of time since the injury (in months) results 
in 0.99 standard deviation decrease in m-Ins/Cr ratio. The addition of age, MRC 
grade for individual muscles, “global MRC score”, or MHQ or pain scores did not 
improve the regression model. Changes in m-Ins/Cr ratio did not correlate with 
changes in NAA/Cr (p = 0.29). 
 
Multiple regression analysis of NAA/Cr and Cho/Cr ratios in patients with re-
implantation surgery did not show significant correlations with disability, scores, 
MRC scale or pain scores. However, Spearman’s correlation coefficient revealed a 
positive correlation of Cho/Cr with “global MRC score” (r = 0.814, p = 0.0138, 
(95%CI = 0.258 to 0.965).  
 
 
 
Figure 6.3: Scatter plot showing the relationship between m-Ins and Dash score (R
2
 
= 84%; F = 13.56; p = 0.0096).  
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Figure 6.4: Scatter plot showing the relationship between m-Ins and months from 
injury (R
2
 = 84%; F = 13.56; p = 0.0096).  
 
 
6.4 Discussion 
 
To date, only a small number of 
1
H-MRS studies of the spinal cord have been 
performed due to the technical difficulties. The local field inhomogeneities and the 
small voxel size are the main difficulties encountered. The aim is to simultaneously 
obtain narrow line-width and adequate SNR in an acceptable acquisition period. The 
present thesis assesses the feasibility of volume selective 3T 
1
H-MRS of the spinal 
cord and evaluates its potential use as a prognostic tool in central nervous injury of 
the spinal cord in humans. We have compared a cohort of patients with complete 
brachial plexus avulsion injury who have undergone re-implantation surgery with 
healthy volunteers aiming to demonstrate differences in major metabolite 
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concentrations including Cr, NAA, m-Ins and Cho. In the following section, the 
feasibility of volume selective 3T 
1
H-MRS of the cervical spinal cord is discussed 
and its weaknesses are addressed.  
 
 
6.4.1 Feasibility of volume selective 3T 
1
H-MRS of the spinal cord and quality 
of spectra 
 
When in vivo 
1
H-MRS spectra obtained from the spinal cord above the level of 
injury were analysed using LCModel, concentrations of Cho, M-Ins, NAA and Cr 
were reliably quantified according to CRLB in 25 out of 34 patients scanned in total 
(73.5%).  
 
In 7 out 9 (77.7%) failed scans were attributed to inadequate shimming or water 
suppression due to either patient/physiological movements or operator errors, rather 
than due to protocol design. Therefore, in 27 out of total 34 scans (79.4%), 
metabolite peaks of interest were adequately resolved. However, another 2 patients 
were excluded their CRLB %SD of total Cr was > 21%. CRLB is a statistical 
estimate of uncertainty of metabolite concentrations and < 21% has been arbitrarily 
chosen based on previous experience and thought to represent reliable metabolite 
concentrations (Ciccarelli et al. 2007).  
 
In general, the use of larger voxels improves SNR but this has trade-offs against fat 
contamination and partial-volume effects. As suggested by previous reports of 
1
H-
MRS of the cervical spinal cord (Cooke et al. 2004), we aimed to use the largest 
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possible voxel, which was placed parallel to the spinal cord, in such a way that the 
voxel was entirely within the spinal cord to avoid fat and CSF contamination. We 
optimised our protocol in healthy volunteers and obtained an averaged voxel size of 
5.9 mm ( 0.3) (anteroposterior) x 7.4 mm ( 0.7) (transverse) x 49 mm ( 5) 
(craniocaudal) resulting in an average volume of 2.1 ml. This is comparable to 
previous studies investigating the optimal voxel size in the cervical spinal cord with 
average voxel volumes of 2.2 ml. (Cooke et al. 2004) and 2.4 ml (Marliani et al. 
2007). In contrast to the study of Cooke et al., (Cooke et al. 2004) we increased the 
length of the voxel to the maximum possible with the voxel always centered at C2, 
covering the length of the spinal cord from the tip of C2 to the level of C3, thereby 
increasing the voxel size while keeping the number of tissue interfaces to minimum. 
These maneuvers increased the resultant spectroscopy signal.  We were unable to 
increase the transverse dimension to 9 mm average in the transverse direction, as 
suggested by Cooke et al., (Cooke et al. 2004), as the voxel would enter the CSF 
space. 
 
The average SNR was 2.4, comparable with other 
1
H-MRS studies of the human 
spinal cord, (Marliani et al. 2007; Marliani et al. 2010). To reduce scanning time and 
patient discomfort and based on previously acquired pilot data, we opted for 
collecting 160 repetitions with a TR of 3 sec and cardiac gating. This resulted in total 
nominal acquisition time of 8 min (in practice, close to 10min). Our long TR 
provided an 8% boost in SNR (Traber et al. 2004). In the study of Marliani et al., 
(Marliani et al. 2010) who achieved SNR of 4, 400 repetitions, a TR of 2 sec and no 
cardiac gating were used, resulting in a 13 min and 20 sec scanning time but 
increased sensitivity to cardiac pulsation. A 15 % loss in signal and 25 % increase in 
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FWHM has been demonstrated in non-gated compared to gated data (Cooke et al. 
2004); for this reason we used cardiac gating. It is worth remembering SNR reported 
by the LCModel is, by definition and design, only a ‘rough’ indication of spectral 
quality, since it is simply calculated as the maximum in the spectrum minus baseline 
over the analysis window. The %SD reported for each metabolite in LCModel is a 
better indicator of the reliability of the metabolite estimates as it accounts for both 
spectral resolution and noise level. Therefore, the reported %SD of our metabolites 
in 25 out of 27 scans (92.6%) confirms that our data quality was adequate. 
 
With regards to mis-positioning of the VOI for the metabolites, great effort was 
made to ensure that the target region of the cervical cord was on resonance between 
field map and acquisition. Despite maximal efforts, the location of the VOI was 
shifted between -4.9% and +14.3% of 7 mm, i.e. -0.34 mm, (sd; 1.00 mm) in the 
transverse plane, and between -1.5% and +4.2% of 49 mm, i.e. -0.74 mm, (sd; 2.06 
mm) in the cranio-caudal direction. This was considered acceptable given the size 
and positioning procedure applied in this study. 
 
 
6.4.2 Interpretation of metabolite concentration ratios obtained 
 
6.4.2.1 Inositol/Cr ratio 
 
In this study, patients with re-implantation showed a significantly greater m-Ins/Cr 
ratio in the cervical spinal cord above the level of injury when compared with 
healthy subjects. In addition, m-Ins was positively correlated with increasing 
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disability in patients with re-implantation. These are novel findings, which have not 
been observed in previous 
1
H-MRS studies of patients with spinal cord injury lesions 
(Holly et al. 2009; Elliott et al. 2011). M-Ins increases have been observed in white 
matter lesions in patients with multiple sclerosis (Fernando et al. 2004; Marliani et 
al. 2010). Increased m-Ins is thought to be due to reactive gliosis, including 
astrocytic proliferation and hypertrophy, possibly in response to the Wallerian 
degeneration of avulsed neuronal fibres. This is in agreement with observations in 
histopathological studies including: (i) increased vimentin (VIM) and glial fibrillary 
acidic protein (GFAP) immunoreactivity, markers of astrocytic proliferation and 
gliosis, in the pericontusional zone described in animal models of acute and chronic 
stage after spinal cord injury (Verma et al. 2008; Erschbamer et al. 2011); and (ii) 
proliferation of astrocytes forming a non-permissive glial scar surrounding the 
transitional zone, found in models of nerve root avulsion injury (Risling et al. 1983; 
Risling et al. 1983; Koliatsos et al. 1994). Alternatively, given the roles of m-Ins in 
intracellular signalling pathways, changes in m-Ins/Cr ratios may be due to 
alterations of cell signalling in spinal cord segments that no longer have bilateral 
axonal connections with the remainder of the spinal cord and/or brain (Erschbamer 
et al. 2011).  
 
Furthermore, in the current thesis it was demonstrated that m-Ins/Cr concentration 
ratio is negatively correlated with length of time from injury. Increases in m-Ins and 
corresponding GFAP immunoreactivity in experimental models of spinal cord injury 
at 7 days, but not 24 hours after the insult (Schuhmann et al. 2003) and remaining at 
4 months (Erschbamer et al. 2011). In sum, these findings suggest that there may be 
in initial increase in the m-Ins/Cr ratio in the acute stage, but a progressive decrease 
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in the chronic stage of disease in patients with re-implantation surgery. This can is 
yet to be demonstrated with either prospective studies or by comparing with a 
control group of patients with BP avulsion injury but without surgical intervention, 
which was the initial but unsuccessful aim in the current thesis.  
 
 
6.4.2.2 NAA/Cr ratio 
 
No significant difference in NAA/Cr concentration between patients who have 
undergone re-implantation surgery and healthy volunteers or a correlation with 
disability scores was observed in this study. Decreases in NAA in various 
neuropathologies of the brain are thought to represent irreversible loss of neurons 
and/or metabolic dysfunction because under normal conditions NAA is synthesised 
in and exported from the mitochondria, predominantly of neurons (Moffett et al. 
2007; Sajja et al. 2009). On the aims of re-implantation surgery is to counteract the 
effects of the avulsion injury, prevent apoptosis of injured motoneurons and support 
axonal regeneration (Linda et al. 1985; Risling et al. 1992; Koliatsos et al. 1994; 
Bergerot et al. 2004). The lack of difference in NAA/Cr ratio between the two 
groups in this study may be due to the either the small number of patients and low 
statistical power, or due to a true replenishment of nerve fibers in the re-implantation 
group. Furthermore, in successful ventral root re-implantation, one would expect an 
increase in NAA/Cr ratio with time. In this cohort of patients, however, there was no 
significant correlation between NAA/Cr ratio and time from injury. It could be 
hypothesized that NAA/Cr concentration has normalised over time.  
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A key question is whether patients who have not undergone re-implantation surgery 
show significantly reduced levels of NAA/Cr levels compared with healthy subjects 
and patients who underwent re-implantation. Unfortunately, we were able to scan 
only 3 such patients, and the small number of patients and spectral quality does not 
allow reliable statistical comparison among groups. Nonetheless, an attempt to 
interpret the data has shown observation 42% and 43% reductions in NAA/Cr ratio 
in patients without re-implantation compared with patients who underwent re-
implantation and healthy subject respectively. Analysis of variance showed revealed 
a significant difference among the three groups studied (F(2,7) = 5.53; p = 0.0141). 
Planned comparisons revealed that healthy subjects have a mean of 0.03 (95% CI: -
0.32 to 0.38) higher than patients who have had re-implantation surgery (mean -.067, 
95% CI: -1.12 to -0.22), which is not a statistically significant difference (p 0.86). 
However, the control group (avulsion injury without reimplantation) has a mean of -
0.67 (95% CI: -1.12 to -0.22) lower NAA/Cr ratio than healthy subjects with a 
significant difference (p = 0.006). This finding also suggests that NAA/Cr levels 
may normalise with time. However, taking into consideration the small number of 
patients in the control group (avulsion injury without reimplantation), it was felt 
more appropriate to use a non-parametric test to assess comparisons. A Kruskal-
Wallis was, therefore, also used to explore whether there is a difference between the 
three groups in NAA/Cr ratio, which showed only a marginal difference among 
groups (p = 0.057).  In summary, there is a suggestion from the results presented that 
there is a trend towards significance in the difference of NAA/Cr ratio between the 
three groups. However, this needs to be confirmed in subsequent studies with larger 
patient groups.  
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6.4.2.3 Cho/Cr ratio 
 
There was no significant difference in Cho/Cr ratio, which reflects inflammation 
with membrane turnover, between healthy subjects and patients with re-implantation. 
Our results are in accord with previous human studies in patients with cervical 
spondylotic myelopathy (Holly et al. 2009) or chronic whiplash injury (Elliott et al. 
2011). In contrast, elevations in Cho/Cr has been observed in normal-appearing gray 
matter after traumatic brain injury (Friedman et al. 1999; Garnett et al. 2000) in the 
acute setting and in pericontusional brain regions in experimental brain studies 
following an initial decrease in Cho/Cr ratio compared to controls (Schuhmann et al. 
2003). Again, it may be that in the chronic phase Cho/Cr levels normalise, as shown 
in a study of experimental model of crushing spinal cord injury by Qian et al., (Qian 
et al. 2010) who demonstrated recovery of Cho/Cr ratio in the epicentre and caudal 
regions of the spinal cord at 56 days post injury.  
 
Although Cho:Cr ratio did not differ between groups, it showed a positive 
correlation with increasing “global MRC score” i.e. greater neurological recovery, 
suggesting increased inflammation and membrane turnover in patients with better 
neurological status.  
 
 
 
6.4.2.4 Absolute Cr concentration 
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No differences in absolute Cr concentrations were observed between groups 
confirming that Cr is a reliable internal standard when investigating the effects of 
spinal cord injury above the level of injury upon metabolite concentration.  
 
6.5 Limitations 
 
The main limitation of this study is the limited number of patients that were 
available in both the re-implantation group and control group. The main reasons for 
this is the rarity of the injury and institutional constrains in scanning patients with 
metal implants. Most of these patients had been involved in high impact motor 
vehicle accidents resulting in multiple fractures requiring fixation with metal 
implants most of which have not been cleared for 3 Tesla MRI. At the time of 
scanning, the “default” field strength indicated for and “MR safe” implant was 1.5 
Tesla, evidence that is adequate for scanning in the clinical setting as benefit 
outweighs risks. However, for research purposes, specific evidence of testing at 3 
Tesla was required to deem a metal implant safe in the institution we scanned our 
patients. Every effort was made to acquire sufficient data that proved implants safe, 
however, most manufacturers have not performed or would not release their data. 
The major concern was the risk of metal heating that could result in internal burns 
especially with older implant designs, rather than implant movement.  
 
Furthermore, as already discussed, findings of this current thesis were limited by the 
absence of a control group. Future and collaborative work, perhaps with a multi-
centre setting, may be able to address this question. 
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Spectroscopy analysis was limited to NAA, Choline and myo-inositol, whereas other 
potentially measurable metabolites such as Lactate (Lac) and Glutamine/Glutamate 
(Gln/Glu) were not studied. Lac resonance is at the very limit of detectability in most 
brain MRS studies due to the low concentration of lactate under normal conditions 
but is often detectable in pathological conditions where anaerobic metabolism 
ensues.  However, our patients are well into the chronic stage of their injury and such 
elevations would not persist years after the injury. Secondly, lactate resonance is 
difficult to distinguish due overlapping lipid resonances and requires long echo time 
(~140 ms) or other spectral editing techniques. To our knowledge, Lac spectra from 
the spinal cord have been acquired in one study of cervical spondylotic myelopathy 
patients in the acute stage, where Lac peaks were demonstrated in 7 out of 21 
patients, 6 of which had T2 signal abnormality in the same region of the spinal cord 
(Holly et al. 2009). Furthermore, Gln/Glu quantification is complex and challenging 
and to our knowledge has not been reported in the spinal cord to date. We aim to 
perform pre- treatment MRS and prospective longitudinal follow up MRS studies 
during the rehabilitation period to demonstrate temporal changes in the spinal cord 
and correlate to clinical recovery, which will also enable us to obtain Lac spectra 
during the acute stage.  
 
 
6.6 Future directions 
 
To date, there is no imaging available to indicate the success of the re-implantation 
including progress of regeneration and the relationship between imaging and 
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neurological improvement and surgical outcome in patients with spinal cord re-
implantation. Standard MR imaging provides excellent macroscopic anatomical 
detail but limited specific information regarding the cellular function of the spinal 
cord microarchitecture. MRS has the potential to provide microcellular biochemical 
information as well as advance our current understanding of nerve regeneration 
following re-implantation.  
 
Future work should focus on recruiting a larger cohort of patients including patients 
without surgical intervention perhaps by recruiting patients from other centers to 
show reproducibility of finding presented here.  
 
In addition, a great deal of information could be obtained by retrospectively 
assessing patients prior to patients’ surgery and at intervals after surgical 
intervention. Perhaps, this method may demonstrate any metabolic changes over 
time. For example, it is interesting to find out whether NAA is reduced in the spinal 
cord after brachial plexus injury in the acute phase, and then normalizes over time.  
 
Lastly, the combination of functional MRI with metabolic and structural MRI may 
allow to better understand recovery after spinal cord injury and fully characterize 
CNS plasticity, which is the ultimate goal of multi-modal imaging. 
 
 
6.7 Conclusion  
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In closing, the present study set out to investigate the metabolic changes that occur in 
the spinal cord with 
1
H-MRS. Findings suggest that it is feasible to quantify 
metabolites of the upper cervical cord above the site of injury, close to focal 
traumatic lesion, with volume selective 3T 
1
H-MRS using the LCModel. Patients 
with re-implantation surgery showed increased m-Ins/Cr ratio compared to controls, 
which was associated with (1) the level of function of the affected arm and (2) time 
from injury. These differences in metabolite concentrations may prove a useful tool 
in predicting outcome and provide insights into the underlying pathological 
processes in these patients.  
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Overall conclusion 
 
 
This thesis set out to investigate three different perspectives of the management of 
complete brachial plexus avulsion injury. The first experiment of this thesis 
investigates the long-term functional improvement of re-implantation surgery in 
patients with complete brachial plexus avulsion injury using standardized 
assessments. The second study relates to the potential use of olfactory ensheathing 
cell transplantation as an adjunct therapy to root reimplantation surgery. It involves a 
prospective observational study of the olfactory ensheathing cell yield from biopsies 
of nasal mucosa from different locations. A new surgical technique for harvest is 
described. Specimen- and patient-related characteristics, in addition to, location are 
assessed in an attempt to determine what factors affect yield and could result in 
adequate yields for transplantation. The third experiment describes the use of 
1
H-MR 
spectroscopy in predicting outcome in patients undergoing brachial plexus re-
implantation surgery, which may also provide a more robust measure for comparing 
different strategies of brachial plexus repair.   
 
Brachial plexus re-implantation surgery is a relatively new surgical strategy for the 
management of brachial plexus avulsion injury. In this thesis, we assessed the 
functional recovery of such patients with clinical and neurophysiological means, as 
well as, patient reported outcome measures and compared functional recovery to a 
control group of patients who have had complete brachial plexus avulsion injury but 
no implantation surgery. Previous preliminary reports investigating the functional 
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recovery of re-implantation surgery have been non-specific in determining recovery 
in a homogeneous group of patients, incorporating patients with incomplete brachial 
plexus injury in studies and therefore failing to confidently revealing the true effects 
of this strategy. More importantly, previous reports are not supported by objective 
assessment methods such as neurophysiological evidence of recovery and lack a 
comparison control group of patients.  
 
In this thesis, it was shown that patients with brachial plexus re-implantation surgery 
following complete brachial plexus avulsion demonstrated some improved motor 
and sensory function in the proximal muscles of the upper limb when compared to 
patients with complete brachial plexus avulsion injury who have not had re-
implantation surgery.  In particularly, patients with re-implantation surgery showed 
greater return of function in the deltoid, pectoralis and infraspinatous power on 
clinical examination with a significantly improved recovery in the global function of 
the upper limb assessed by a “global MRC power “score incorporating 7 different 
upper limb muscles. In addition there was a significant difference in the voluntary 
control between the two groups with patients with re-implantation surgery 
demonstrating evidence of reinnervation in the infraspinatous, biceps and triceps 
muscles in patients with re-implantation surgery when compared to as demonstrated 
by needle EMG studies. There was also evidence of ongoing reinnervation in 
deltoid, biceps and triceps in patients who have had re-implantation surgery, 
demonstrated by the presence of polyphasic nascent units in electrophysiological 
studies. Furthermore, an exciting finding was the presence of motor unit action 
potentials in distal muscles of the upper limb including the FDIO and FDS in two 
separate patients who have undergone re-implantation patients while there was no 
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evidence of reinnervation of distal muscles of the upper limb in the control group. 
Interestingly, an improved recovery in sensory function was also revealed in the re-
implantation group. Sensory testing in affected dermatomes showed generally 
improved recovery in the re-implantation group in C5, C6 and T1 dermatomes with a 
significant higher frequency in return of sensation in C5 dermatome for both soft 
touch and pinprick sensation in the re-implantation group compared to controls.  
 
Despite the evidence of improved function in the aforementioned muscles in clinical 
and neurophysiological assessment, the functional recovery was limited and operated 
patients did not report a significant difference in function compared to those without 
re-implantation in the patient reported outcome measures. Research has focused in 
finding adjuvant therapies to re-implantation surgery by which the re-innervation 
seen with re-implantation surgery can be further enhanced.  
 
One such strategy involves the use of cell transplantation at the time of re-
implantation of avulsed roots.  While OEC mediated repair of spinal cord injury has 
been well described in animal experiments, the translation to human studies is partly 
limited by the difficulty in achieving adequate culture yields of human OECs for 
autotransplantation. Previous reports have documented their success in localizing 
olfactory mucosa but studies investigating actual human OEC yields have been 
insufficient.  In the second experiment, it is shown that biopsies from the cranial 
portions of the superior turbinate using a new safe and reproducible endoscopic 
surgical technique produce greater OEC yields. The success rate in obtaining 
olfactory mucosa from the nasal cavity was also significantly higher compared to 
previous reports. In addition, it is demonstrated that increasing age and nasal 
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mucosal disease adversely affect the culture yield, while other factors including 
smoking and antero-posterior location of the biopsy did not affect culture yields. 
While location and patient characteristics are not the sole limiting factors in 
achieving adequate culture yields, the findings presented in this thesis assist in better 
predicting the adequacy of the patients’ own olfactory mucosa, avoiding exposing 
patients to the potential risks of the biopsy procedure.  
 
Lastly, in the third experiment the use of 
1
H-MR spectroscopy in predicting outcome 
in patients who have undergone brachial plexus re-implantation surgery is explored. 
Studies of 
1
H-MR spectroscopy of the spinal cord are scarce due to the small size 
and central location in the spinal cord resulting in low signal to noise ratio and 
susceptibility artefacts. In this thesis, it is demonstrated that 
1
H-MR spectroscopy 
can reliably quantify concentrations of major metabolites including Cho, M-Ins, 
NAA and Cr. In addition, it is shown that 
1
H-MR spectroscopy above the level of 
injury is sensitive to pathological changes occurring in the spinal cord of patients 
with brachial plexus avulsion injury with and without re-implantation surgery to 
predict outcome. Major findings include (i) a positive correlation between m-Ins/Cr, 
a marker of gliosis, and disability, as measured by the DASH scale (ii) a negative 
association between m-Ins/Cr time from injury and (iii) a positive association 
between Cho/Cr, a marker of inflammation and membrane turnover, and global 
upper limb function. Whilst the use of 
1
H-MR spectroscopy was intended for 
outcome prediction, it also provided interesting findings regarding the underlying 
pathophysiological changes. For example, the decrease of m-Ins/Cr with time 
suggests that there may be a decrease in gliosis near the site of injury with time and 
increased Cho/Cr levels in patients with improved function may suggest ongoing 
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attempt for repair. With the advent of more sensitive radiofrequency coils, higher 
magnetic field strength magnets and prospective studies 
1
H-MR spectroscopy may 
prove an invaluable tool for understanding the underlying processing that take place 
in spinal cord injury and repair.  
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Appendix 2 - Disabilities of the Arm, Shoulder and Hand (DASH) 
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Appendix 3 – Michigan Hand Outcomes Questionnaire 
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Appendix 4 – SF36 version 2 
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Appendix 5 – Experimental studies involving OEC mediated repair of the 
nervous system 
 
Type of lesion Study Source of OEC Results 
T10 dorsal root 
rhizotomy  
Ramon-Cueto 
et al. 1994 
ONL and GL  
Purified 
Regeneration of dorsal root axons into the dorsal spinal 
gray matter 
Multiple 
rhizotomy at L3 to 
L6 
Navarro 
et al. (1999) 
ONL and GL, frozen 
OEC, 
purified 
Recovery of electrophysiological functions. 
Rhizotomy of L4 
dorsal root 
Li et al. (2004) ONL and GL, not 
purified 
Intermingling of OEC with astrocytes at the DREZ 
permitted axons to grow into the spinal cord. 
Cervical or lumbar 
dorsal 
root crush 
Ramer et al. 
(2004b) 
LP, purified Increased angiogenesis and altered astrogliosis. 
No regeneration of axons into the spinal cord  
 
Multiple 
rhizotomy at C3–
T3 
Gomez et al. 
(2003) 
ONL and GL, frozen 
OEC, 
purified 
No regeneration or sprouting observed. No migration of 
OEC. Endogenous SC rather than OEC associated with 
axons 
Rhizotomy of L4 
dorsal root 
Riddell et al. 
(2004) 
Whole bulbs, purified Electrophysiological and histological analysis show no 
effects 
Cervical or lumbar 
dorsal 
root crush 
Ramer et al. 
(2004) 
LP, purified No regeneration of axons into spinal cord. 
Demyelinating 
lesion at the 
thoracolumbar 
spinal cord 
(Franklin et al. 
1996) 
OEC cell line, purified In vivo remyelination of larger-diameter axons by 
peripheral-like myelin sheaths. 
Demyelinating 
lesion 
at T10–T11 
(Imaizumi et al. 
1998) 
ONL, not purified Remyelination and recovery of electrophysiological 
properties. 
Demyelinating 
lesion 
at T10–T11 
Kato et al. 
(2000) 
Human olfactory 
nerve, 
not purified 
Peripheral-like remyelination. 
Demyelinating 
lesion in the 
dorsal funiculus at 
T13 
Lakatos 
et al. (2003b) 
Outer layer of bulb, 
purified and not 
purified 
Limited capacity of OEC to remyelinate was improved by 
co-transplantation of meningeal cells. 
Demyelinating 
lesion at T7 
and/or T9 in 
monkeys 
Radtke et al. 
(2004) 
ONL and GL from 
pigs, 
purified 
Remyelination of dorsal funiculus axons in non-human 
primate spinal cord by pig OEC. 
Demyelinating 
lesion 
at T10–T11 
Akiyama et al. 
(2004) 
ONL, purified OEC and SC remyelinated equally and both cell types 
improved conduction velocity. 
Demyelinating 
lesion at T9 
Sasaki et al. 
(2006a) 
ONL, purified Remyelination, reconstitution of nodes of Ranvier, 
recruitment of Na+ and K- channels and increased 
 238 
conduction velocity. 
Unilateral 
electrolytic lesion 
of 
CST at C1–C2 
(Li et al. 1997) ONL and GL, not 
purified 
OEC and axons bridged the lesion and this was 
accompanied by functional recovery 
Electrolytic lesion 
of CST 
at C1–C2 
(Li et al. 1998) ONL and GL, not 
purified 
Corticospinal axons traversed the lesion site, were 
enwrapped by peripheral myelin, and reentered the caudal 
spinal cord, where they became myelinated by central 
myelin. 
Unilateral heat 
lesion of 
dorsal CST at C1 
Keyvan-
Fouladi 
et al. (2003) 
ONL and GL, not 
purified 
Delayed transplantation resulted in functional recovery. 
Axons entered and traversed transplant and formed 
collateral branches. 
Dorsal CST 
transection 
at T8–T9 
Chuah et al. 
(2004) 
Mix of ONL and 
mucosa, 
purified 
Increased collateral branching of uninjured ventral CST. 
Ruitenberg 
et al. (2005) 
Unilateral CST 
transection 
at C4 
ONL, purified OEC promoted axonal regeneration only when 
genetically modified to express NT-3. 
Photochemical 
injury 
at T12–L1 
Verdu et al. 
(2001) 
Whole bulbs, frozen 
OEC, purified 
Reduced astrogliosis and cavity formation. 
Photochemical 
injury at T8 
Verdu et al. 
(2003) 
Whole bulbs, purified Preservation of spinal cord. Electrophysiological and 
behavioral recovery. 
Photochemical 
injury at T8 
Garcia-Alias 
et al. (2004) 
Whole bulbs, purified Both OEC and SC transplantation resulted in behavioral 
recovery, OEC transplantation resulted in more 
electrophysiological recovery and less astrocytic 
reactivity. 
Photochemical 
injury at T8 
Lopez-Vales 
et al. (2004) 
Whole bulbs, purified Upregulation of COX-2 and VEGF, neoangiogenesis and 
improved locomotor function. 
Dorsal column 
transection 
at T11 
Imaizumi 
et al. 
(2000a) 
Anterior tips of bulb, 
not purified 
Xenotransplantation of OEC and SC equally resulted in 
remyelination and long-distance recovery of 
electrophysiological properties 
Dorsal column 
transection 
at T11 
Imaizumi 
et al. 
(2000b) 
Anterior tips of bulb, 
not purified 
Both OEC and SC transplantation resulted in 
remyelination and recovery of conduction velocity 
Dorsal column 
transection 
at C4 
Lu et al. (2006) LP from 5-day-old 
pups, 
purified 
OEC did not migrate, but rather diffused within one hour 
after injection from the injection site into the lesion. This 
paper challenges the migratory properties of OEC. Similar 
results with OEC,  
bone marrow stromal cells and fibroblasts. 
Non-lesioned 
dorsal funiculus 
at T13 
Lakatos 
et al. (2003a) 
Outer layer of bulb, 
purified 
Less GFAP and CSPG expression after OEC 
transplantation compared with SC transplantation. 
Dorsolateral 
funiculus 
crush at C4 
Ramer et al. 
(2004a) 
LP from mice, purified OEC showed limited survival and migration, but reduced 
cavity formation, enhanced SC invasion, reduced 
astrocytic response and induced axonal sprouting and 
angiogenesis. 
Dorsal funiculus 
transection 
Sasaki et al. 
(2004) 
ONL, purified OEC associated with axons and formed myelin. 
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at T9 
Dorsal funiculus 
crush 
at T8–T9 
Andrews and 
Stelzner (2004) 
ONL and GL, purified 
and 
not purified 
Both heterogeneous and enriched populations of OEC 
stimulated axon growth. A conditioning lesion had an 
additive effect. 
Dorsolateral 
funiculus crush 
at C3–C4 
Richter et al. 
(2005) 
ONL or LP, purified Comparison between LP–OEC and ONL–OEC. LP–OEC 
were superior in migration ability, in reducing lesion size 
and in stimulating outgrowth of axonal subpopulations. 
Dorsal funiculus 
transection 
at T9 
Sasaki et al. 
(2006a) 
ONL, purified Neuroprotective effect on the survival of cortical 
projection neurons 
Unilateral 
rubrospinal tract 
transection at C4 
Ruitenberg 
et al. (2003) 
ONL and GL, purified Neuroprotective effects of OEC. Effects on lesion size 
reduction, sprouting and functional recovery were 
augmented when OEC were transduced with neurotrophin 
encoding AdV vectors. 
Hemisection at 
upper 
cervical level 
Li et al. 
(2003) 
ONL and GL, not 
purified 
Functional repair of breathing and climbing. 
Hemisection at 
C2–C3 
Polentes et al. 
(2004) 
ONL and GL, purified Recovery of respiratory function 
Injection alone 
compared with 
injection after 
hemisection 
at T9 
Deng et al. 
(2006) 
LP, purified Rat and human OEC survived and migrated equally, but 
both cell types migrated for longer distances when injected 
in the uninjured cord than after hemisection. They stopped 
dividing after 24 h. 
Complete 
transection and 
removal of 
segment including 
dorsal roots at T9 
(Ramon-Cueto 
et al. 1998) 
ONL and GL, purified OEC induced axonal growth into SC-containing channels 
and further into host spinal cord resulting in long-distance 
regeneration (2.5 cm). Extensive migration of OEC. 
Unilateral 
electrolytic lesion 
of 
CST at C1–C2 
(Li et al. 1997) ONL and GL, not 
purified 
OEC and axons bridged the lesion and this was 
accompanied by functional recovery 
Electrolytic lesion 
of CST 
at C1–C2 
(Li et al. 1998) ONL and GL, not 
purified 
Corticospinal axons traversed the lesion site, were 
enwrapped by peripheral myelin, and reentered the caudal 
spinal cord, where they became myelinated by central 
myelin. 
Complete 
transection + 
removal of 
segment including 
dorsal roots at T9 
(Ramon-Cueto 
et al. 1998) 
ONL and GL, purified OEC induced axonal growth into SC-containing channels 
and further into host spinal cord resulting in long-distance 
regeneration (2.5 cm). Extensive migration of OEC. 
Complete 
transection at T10 
Lu et al. 
(2001) 
LP OEC and pieces of 
lamina propria, 
not purified 
Both OEC and pieces of lamina propria transplantation 
resulted in functional recovery and regrowth of axons 
traversing the transection site. 
Complete 
transection at T10 
Lu et al. 
(2002) 
Pieces of lamina 
propria, 
not purified 
Locomotor recovery and axonal regrowth after delayed 
transplantation. 
Complete 
transection at T8 
Cao et al. 
(2004) 
ONL, purified Increased axonal outgrowth and functional recovery. 
Effects were enhanced when OEC were transduced by 
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GDNF-encoding retroviruses. 
Complete 
transection at T8 
Lopez-Vales 
et al. (2006) 
Whole bulbs, frozen 
OEC, 
purified 
Electrophysiological, histological and behavioral recovery. 
Better results with acute transplantation than with delayed. 
Complete 
transection at T8 
Lopez-Vales 
et al. (2007) 
Whole bulbs, frozen 
OEC, 
purified 
Electrophysiological, histological and behavioral recovery 
after 45 days delayed transplantation. 
Complete 
transection at T8 
Lee et al. 
(2004) 
ONL and GL, not 
purified 
Migration of OEC may be dependent on lesion type. OEC, 
labeled by magnetodendrimers, did not migrate in 
transected cords. 
Complete 
transection at T10. 
Steward et al. 
(2006) 
Delayed implantation 
of 
pieces of lamina 
propria, 
not purified 
Replication of experiment by Lu et al. (2002). In 
contrast to this study, no recovery in motor function or 
enhanced axonal outgrowth was observed. 
Moderate 
contusion at T9 
Takami et al. 
(2002) 
ONL, purified First study on OEC implantation after contusion. Delayed 
transplantation of OEC, SC or OEC/SC resulted in equal 
tissue sparing. SC transplants resulted in more GFAP and 
CSPG expression, but were most effective in promoting 
axonal sparing/ regeneration, myelination and in 
improving functional recovery. 
Moderate 
contusion at T9–
T10 
Plant et al. 
(2003) 
ONL, purified Immediate and delayed transplantation promoted tissue 
sparing. Delayed transplantation resulted in more axonal  
regeneration/sparing and improvement in functional 
outcome. First and only study that reports positive effects 
of OEC transplantation after contusion. 
Moderate to 
severe contusion 
at T8 or T9 
Resnick et al. 
(2003) 
Whole bulbs, purified Survival of OEC, but no improvement in functional 
outcome. 
Boyd et al. 
(2004) 
Clip 
compression at 
T10 
Fetal ONL, not 
purified 
After delayed transplantation, OEC remained in cystic 
cavities and did not associate with axons. Numerous SC–
axon units were observed, surrounded by OEC 
cytoplasmic processes. 
Barakat et al. 
(2005) 
Moderate 
contusion at T8 
ONL, purified In contrast to OEC, SC survived, supported axon 
growth and improved functional outcome after 
delayed transplantation 
Moderate 
contusion at T8 
Pearse et al. 
(2007) 
ONL, purified Poor survival and no migration of OEC. No axon 
regeneration into injury site and no major behavioral 
improvements. More myelination in SC graft than  
in OEC graft. 
Reimplantation of 
avulsed 
ventral root S1 
Li et al. 
(2007a,b) 
ONL and GL, not 
purified 
OEC migration into the root and increased axon growth 
into the ventral root. 
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